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Background: Advanced maternal age (≥35 years at delivery) is associated with 
increased rates of operative delivery, stillbirth, and post-term labour induction 
(Bewley et al., 2009). The physiological causes for such complications remain to be 
ascertained, although myometrial function has been implicated (Smith et al., 2008, 
Arrowsmith et al., 2012). To investigate the hypothesis that maternal age directly 
influences successful parturition, timing of birth and fetal outcome were assessed in 
a pregnant mouse model at three months (young) vs. eight months (older) of age 
using infra-red video recording. The impact of maternal age on the function of 
myometrium and cervix were also examined ex vivo using qPCR, isometric tension, 
immunohistochemistry, and measurement of the enzymatic activities of the 
mitochondrial electron transport chain complexes. 
Results: Older pregnant mice compared to three month old mice had significantly 
longer mean gestation and labour durations (p<0.001), as well as reduced litter size 
(p<0.01). Cervical tissues from older mice demonstrated greater distension 
compared to younger mice (p<0.05). However, collagen content and matrix 
metalloproteinase-2 protein expression were similar in late pregnant cervical tissues 
from three, five and eight month old mice. Expression of oxytocin receptor and 
connexin-43 mRNA were significantly reduced in myometrium from eight month vs. 
three month old mice (p<0.05, p<0.01 respectively).  Spontaneous myometrial 
contractions were more frequent but of shorter duration in older pregnant mice 
(p<0.05); tissues from these older mice also exhibited reduced contractile response 
to oxytocin. Mitochondrial copy number was reduced in myometrium from eight 
month old mice, but there were no age-induced changes to the enzymatic activities 





Conclusions: In this mouse model of reproductive ageing, gestation and labour 
duration were prolonged.  This is unlikely to be associated with delayed cervical 
softening.  However, the alterations in spontaneous and oxytocin augmented 
contractions, coupled with a reduction in myometrial mitochondrial copy number in 
older mice, could potentially result in poorly coordinated myometrial contractions in-
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Chapter 1 : General Introduction 
The global increase in life expectancy over recent years has led to an 
unprecedented rise in the ageing population (Bewley et al., 2009). This in turn has 
caused a myriad of clinical challenges and a considerable burden on society and 
healthcare providers. Life expectancy in women has risen from 42 years of age from 
1838-54 to 82 years of age in 2006-10 (Table 1.1) and concurrent with this, there 
has been a trend for women to delay childbirth into their later years of fertility, with 
women who have babies at the age of 35 years and above being referred to as 
‗advanced maternal age‘ mothers (Kirz et al., 1985, Bewley et al., 2009, Bayrampour 
and Heaman, 2010). 
 
Table 1.1 Life expectancies at birth for England and Wales between 1838-2035 
 
Years Males Females 
1838-54 40 42 
1901-10 49 52 
1950-52 66 72 
1980-90 72 78 
1991-2000 74 79 
2001-05 76 81 
2006-10 77 82 
2015-25 (estimate) 81 85 
2026-35 (estimate) 83 86 
 
Data from the Office for National Statistics for England and Wales (Office for National 
Statistics for England and Wales, 2011a).  Adapted from: Reproductive Ageing (Bewley et 




Over recent decades, the average age of primigravid mothers in developed 
countries has risen steadily, with women (including multiparous women) over the 
age of 35 comprising a significant proportion of the pregnant population (Bewley et 
al., 2009). Such trends are reflected by a simultaneous rise in the reported incidence 
of complications in pregnancy and labour including preeclampsia, gestational 
diabetes mellitus, miscarriage, stillbirth, preterm labour, post-term inductions, 
increased Caesarean section and instrumental delivery rates, failure to progress in 
labour, and postpartum haemorrhage (Gilbert et al., 1999, Ecker et al., 2001, Ziadeh 
and Yahaya, 2001, Tough et al., 2006, Chan and Lao, 2008, Jahromi and Husseini, 
2008, Smith et al., 2008, Bewley et al., 2009, Ludford et al., 2012, Karabulut et al., 
2013, Khalil et al., 2013).  Although maternal reproductive ageing has been well 
documented with loss of fertility, risk of multiple births and birth defects (Gindoff and 
Jewelewicz, 1986, Heffner, 2004, Bewley et al., 2009, Balasch and Gratacos, 2012, 
Weeg et al., 2012), much less is known about how reproductive ageing impacts on 
parturition especially that of the first child and in particular, how  myometrial and 
cervical functions may be altered in labour. 
Theoretically, there are three potential mechanisms that could explain why 
advanced maternal age mothers experience complications in the initiation of birth 
and progression in labour.  Firstly, there may be a disruption of the complex 
maternal-fetal hormonal signalling cascade that is involved in the timing/initiation of 
labour; secondly, the physiological preparation of the myometrium (the smooth 
muscle of the uterus) and the cervix for labour could be altered or delayed; and 
thirdly, the ability of the myometrium to contract may be impaired due to age-related 
mitochondrial dysfunction.  
To explore how these potential mechanisms could be altered in advanced maternal 
age mothers, an understanding of the biology of ageing is first required.   
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1.1 The Biology of Ageing 
 
Ageing can be broadly described as the universal, intrinsic, progressive and 
deleterious inevitable biological changes that occur over the course of a lifetime.  
Questions remain at the most basic level about what triggers ageing in our cells and 
tissues, why it occurs and which biological processes underlie these age-related 
changes.  More than 300 theories of ageing have been postulated to date and the 
number is still increasing (Vina et al., 2007).  A detailed analysis of all of these 
theories of ageing is beyond the scope of this thesis, but the interlinking key areas of 
research within this field will now be discussed, with a particular focus on 
mitochondrial dysfunction. 
1.1.1 Ageing and genetic influences 
A fundamental focus of ageing research has been on the identification of genes, 
which may control or contribute to longevity.  Most longevity genes identified to date 
influence one of the following cellular pathways: insulin/IGF-1, sirtuins, or 
mammalian target of rapamycin (mTOR).  Friedman and Johnson (1988) discovered 
the first gene shown to limit lifespan in the nematode (worm) Caenorhabditis 
elegans, which they named age-1 (Friedman and Johnson, 1988). Further 
investigation revealed that when the activity of the age-1 gene was silenced, the 
insulin/IGF-1 pathway activity decreased and prolonged lifespan in Caenorhabditis 
elegans (Dorman et al., 1995, Tissenbaum and Ruvkun, 1998).  The sirtuin pathway 
is another significant area of interest in ageing research.  Sirtuin genes are present 
in all species and are involved in the regulation of metabolism, transcription, 
inflammation, apoptosis and mitochondrial biogenesis in the cell (Horio et al., 2011).  
Kaeberlein et al., (1999) confirmed that inserting an additional copy of the sirtuin 
gene, Sir2, increased the lifespan of Saccharomyces cerevisiae (yeast) (Kaeberlein 
et al., 1999).   
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The mTOR pathway is considered to regulate cell growth, proliferation, metabolism 
and survival (Johnson et al., 2013).  The pathway has been linked to ageing of 
Saccharomyces cerevisiae, Caenorhabditis elegans, Drosophila melanogaster 
(flies), and mice (Powers et al., 2006, Jia et al., 2004, Kapahi et al., 2004, Harrison 
et al., 2009).  It is commonly accepted that inhibiting the mTOR pathway in mice 
genetically, or pharmacologically using rapamycin, leads to increased longevity 
(National Institute on Aging, 2011). 
Genetic ageing is also linked to the accumulation of genetic damage throughout life 
(López-Otín et al., 2013).  The stability and integrity of DNA are continuously 
challenged by exogenous chemical, physical and biological agents as well as 
endogenous threats including DNA replication errors, spontaneous hydrolytic 
reactions, and reactive oxygen species (Hoeijmakers, 2009). Age-related genetic 
impairments include point mutations, translocations, chromosomal gains and losses, 
telomere shortening, and DNA copy number variation.  To minimise these insults, 
organisms have evolved a complex network of DNA repair mechanisms that are 
collectively capable of dealing with most of the damage inflicted to nuclear DNA 











Telomeres are regions of repetitive nucleotide structures located at the ends of 
linear eukaryotic chromosomes (Shawi and Autexier, 2008); they do not encode any 
proteins but instead protect the protein-encoding part of the DNA.  Telomeres are 
most susceptible to the accumulation of DNA damage with age (Blackburn et al., 
2006).  During cell division, telomeres become shorter and in most cells, the 
telomeres eventually reach a critical length when they can no longer protect the 
cell‘s DNA. In most cells, telomere length cannot be restored. Extreme telomere 
shortening triggers one of the following responses: the cell stops replicating and 
becomes senescent; the cell stops replicating and apoptosis occurs, or the cell 
continues to proliferate.  Telomere exhaustion explains the limited proliferative 
capacity of some types of in vitro cultured cells, as summarised by the Hayflick limit 
(replicative senescence) (Hayflick and Moorhead, 1961).  Telomeres are bound by a 
characteristic multi-protein complex known as shelterin (Palm and de Lange, 2008). 
A central function of shelterin is to prevent the access of DNA repair proteins to the 
telomeres; otherwise, telomeres would be ‗‗repaired‘‘ as DNA breaks leading to 
chromosome fusions.  Due to their restricted DNA repair, DNA damage at telomeres 
is particularly persistent and highly efficient in inducing cellular senescence and/or 
apoptosis (Fumagalli et al., 2012).  In particular cells types, such as oocytes, the 
enzyme telomerase is able to restore telomeres to the ends of chromosomes. 
However, most mammalian somatic cells do not express telomerase.  This telomere 
lengthening ensures that cells can continue to safely divide and multiply.  
Telomerase has been shown to be activated in most immortal cancer cells, since 




Telomere shortening is observed during normal ageing, both in humans and mice 
(Blasco, 2007).  The importance of telomere shortening is highlighted by genetically 
altered mice with shortened or lengthened telomeres that exhibit decreased or 
increased lifespans respectively (Armanios et al., 2009, Herrera et al., 1999, Tomas-
Loba et al., 2008).  Recent evidence also indicates that ageing can be reversed by 
telomerase activation. In particular, the premature ageing of telomerase-deficient 
mice can be reversed when telomerase is genetically reactivated in these aged mice 
(Jaskelioff et al., 2011). In humans, recent meta-analyses have reinforced the 
existence of a strong correlation between short telomeres and mortality risk, 
particularly at younger ages (Boonekamp et al., 2013).  These observations have 
led to the proposal that telomere length is a biomarker of ageing. 
 
1.1.2 Ageing and alterations in intercellular pathways 
Ageing induces changes to intercellular communication, inclusive of endocrine, 
neuroendocrine and neuronal pathways (Russell and Kahn, 2007, Laplante and 
Sabatini, 2012, Rando and Chang, 2012, Zhang et al., 2013). Consequently, 
signalling cascades such as the renin-angiotensin-aldosterone, adrenergic and 
insulin-IGF1 pathways tend to be deregulated with increasing age as the incidence 










The immune system declines in reliability and efficiency as mammals age, resulting 
in greater susceptibility to infectious disease.  These changes are further multiplied 
by reduced responsiveness and impaired communication between all cells of the 
immune system. The overall cellular exhaustion of the immune system with age is 
termed ―immunosenescence‖ (Goronzy and Weyand, 2013).  A large part of the 
ageing phenotype, including immunosenescence, is explained by an imbalance 
between inflammatory and anti-inflammatory signal networks, which results in the 
low grade, chronic pro-inflammatory status which accompanies ageing in mammals, 
termed ―inflammaging‖ (Franceschi et al., 2007).  ―Inflammaging‖ is believed to be a 
consequence of cumulative lifetime exposure to antigenic load caused by both 
clinical and subclinical infections as well as exposure to non-infectious antigens 
(Baylis et al., 2013).  The resultant inflammatory response, tissue damage, and 
production of reactive oxygen species that cause oxidative damage, trigger the 
secretion of additional proinflammatory cytokines from the innate immune system 
and also from the acquired immune response.  This subsequently results in the 
failure of an ever more dysfunctional immune system (Salminen et al., 2012, Baylis 
et al., 2013).   
All of these contribute to drive the immune system in favour of a chronic 
proinflammatory state where pathophysiological changes, tissue injury and healing 
occur simultaneously; production of IL-1, tumor necrosis factor, and interferons are 
elevated and irreversible molecular and cellular damage that is not clinically evident 
gradually accumulates over decades (Baylis et al., 2013).  ―Inflammaging‖ is a 
complex cycle of progressive negative impact on the immune system, as 






Figure 1.1 The cycle of “inflammation”  
―Inflammaging‖ is a consequence of multiple contributors, leading to a chronic pro-
inflammatory state.  Figure from: Understanding how we age: insights into Inflammaging 
(Baylis et al., 2013). 
 
Ageing studies have emphasised over activation of the NF-B pathway as one of 
the key transcriptional signatures of ―inflammaging‖.  Genetic and pharmacological 
inhibition of NF-B signalling has been shown to prevent age-associated features in 
different mouse models of ageing (Osorio et al., 2012, Tilstra et al., 2012).  A recent 
study by Zhang et al. (2013) also highlights a link between inflammation and ageing. 
Inflammatory and stress responses activate NF-B in the hypothalamus which 
triggers a signalling pathway that results in reduced production of gonadotropin-
releasing hormone (GnRH) by neurons. This GnRH decline may contribute to age-
related changes such as muscle weakness, bone fragility, skin atrophy, and 
diminished neurogenesis. Consistently, GnRH treatment in mice has been shown to 
prevent age-impaired neurogenesis and slow down ageing development (Zhang et 
al., 2013). These findings suggest that the hypothalamus may modulate systemic 
ageing by integrating NF-B-driven inflammatory responses with GnRH-mediated 
neuroendocrine effects (López-Otín et al., 2013). 
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Anti-inflammaging is a mechanism considered to stabilise the ―inflammaging‖ 
process by increasing blood cortisol concentrations.  Cortisol is secreted via the 
activation of the hypothalamic-pituitary-adrenal (HPA) axis (Goncharova, 2013), and 
is considered to be an immunosuppressant.  Neuronal cells within the HPA axis 
contain multiple cytokine receptors, particularly for IL-1, IL-6 and TNF and it has 
been demonstrated that injection of IL-6 or TNF in humans induces a marked 
upregulation in HPA axis. Therefore, a predictable physiological response to 
―inflammaging‖ is an elevation in the concentration of blood cortisol, which may also 
have a negative response of inducing systemic immunosuppression (Straub et al., 
2000, Giunta, 2008, Baylis et al., 2013). 
Dehydroepiandrosterone (DHEA) and its sulphated precursor, DHEA sulphate 
(DHEAS), have opposing actions to cortisol and may provide protection from the 
negative effects of anti-inflammaging. DHEA and DHEAS are mainly secreted from 
the adrenal cortex and in smaller amounts from the testis and ovary, where both are 
later converted to sex steroids; they account for 30% to 50% of testosterone in men 
and 100% of oestrogen in postmenopausal women.  Like cortisol, DHEAS is also 
secreted in response to ACTH.  Blood DHEAS concentrations reach a maximum 
level in early adulthood and subsequently decline with age to approximately 10 to 
20% of maximal concentration levels by 70 years (Labrie, 2010).  Phillips et al., 
(2010) have described an immuno-modulating role for DHEAS; they proposed that 
low concentrations are associated with chronic inflammatory conditions and 
counteracts the effects of cortisol via glucocorticoid receptor antagonism.  Further, 
DHEAS may directly inhibit glucocorticoid receptor production (Phillips et al., 2010, 




In summary, cortisol causes immune suppression and is increased in concentration 
with age.  DHEA(S) is immune modulating, antagonises the effects of cortisol, and 
its concentration declines with age. Therefore, when considering the effects of the 
HPA axis on inflammaging, the ratio of cortisol to DHEAS is highly important.  
 
1.1.3 Influence of environmental factors on ageing mechanisms 
There have been numerous studies that examine the impact of the environment and 
lifestyle on the control of ageing.  For example, exercise-induced stress has been 
linked to an apparent increase in life span (Marton et al., 2010, Sanchis-Gomar et 
al., 2011, Corbi et al., 2012).  Similarly, life span is considered to be regulated by 
environmental conditions that may impact on circadian rhythms (Froy, 2011).  
However, the best-documented environmental/lifestyle theory related to ageing is 
that calorie/dietary restriction may prolong life span.   
 
Calorie Restriction 
Calorie restriction (CR) can extend the average and maximum life span and delay 
the onset of age-associated changes in many organisms.  It is commonly defined by 
at least a 10-30 % decrease in calorie consumption compared to a regular calorific 
intake with a balanced amount of protein, fat, vitamins and minerals (National 
Institute on Aging, 2011).  McCay et al., (1935) noted that restriction of intake by 
40% in laboratory rats from the age of weaning dramatically extended lifespan 
(McCay et al., 1989). Further work confirming the success of calorie-restricted 




Model organisms used to confirm calorie-restricted longevity include 
Saccharomyces cerevisiae (Fabrizio and Longo, 2007), Caenorhabditis elegans 
(Klass, 1977, Yuan et al., 2012), Drosophila melanogaster (Bross et al., 2005, 
Burger et al., 2010, Zeng et al., 2011), some but not all strains of mice (Weindruch, 
1996), dogs  (Lawler et al., 2008, Richards et al., 2013) and non-human primates 
(Kemnitz, 2011, Mattison et al., 2012).   
Two prospective investigations designed to evaluate the effects of CR on general 
physiology, health, and lifespan in non-human primates began nearly 25 years ago 
and are still on going. The first study is being conducted by the National Institute on 
Aging of the National Institutes of Health (USA) and the other by the University of 
Wisconsin, through funding from the National Institute on Aging. These studies 
began in 1987 and 1989 respectively.  Findings to date from these investigations 
have confirmed that CR is associated with an extension in lifespan of rhesus 
monkeys.  Monkeys exhibited reduced body fat, slower rate of age-related muscle 
loss, and improved insulin sensitivity and glucose tolerance. The incidence of 
cardiovascular disease, type 2 diabetes mellitus and endometriosis were lower and 
there was no apparent adverse effect on bone health or on total energy expenditure.  
In addition, there are no reports of deleterious effects of CR on reproductive 
endpoints (Kemnitz, 2011).   
Despite its apparent widespread acceptance, CR does not lengthen lifespan in all 
animal models as genetic influences seem to play a key role in the success of 
calorie-restricted longevity.  In studies of wild mice, CR did not have any overall 
effect on lifespan; rather they showed higher mortality in CR wild mice compared to 
laboratory mice early in life.  This may be due to differences in the genetic 
background of the wild mice (Harper et al., 2006).  To attempt to answer the ultimate 
question of whether CR can influence human longevity, the Comprehensive 
Assessment of Long-Term Effects of Reducing Calorie Intake (CALERIE Phase1) 
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study was setup in 2002.  Participants of this study after the first year on CR, had 
lowered their fasting glucose, total cholesterol, core body temperature, body weight, 
and fat. At the cellular level, they demonstrated improved mitochondrial function and 
reduced DNA damage (Fontana et al., 2010, National Institute on Aging, 2011).   
In addition, many studies have focused on identifying the mechanisms and 
pathways by which CR works.  CR is suggested to counteract age-associated 
changes by modulating the mTOR signalling pathway, IGF1/insulin signalling, 
adiponectin expression, DNA methylation, histone acetylation and deacetylation and 
reducing free radical production from the mitochondrial electron transport chain 
(Finley and Haigis, 2009, Fontana et al., 2010, Ribaric, 2012).  Increased 
understanding of these pathways has contributed to the development of two drugs 
that may mimic effects of CR; namely resveratrol and rapamycin.  Resveratrol (a 
natural phenol known to have antioxidant and anti-inflammatory properties) activates 
the sirtuin pathway and has been shown to increase the lifespan of Saccharomyces 
cerevisiae, Caenorhabditis elegans, Drosophila melanogaster and fish (Baur, 2010, 
Bass et al., 2007, Gualdoni et al., 2013).  In mice, resveratrol appeared to diminish 
the negative effects of high fat and high calorie diet-induced disease and has been 
shown to prevent age-related decline in heart function. However, the compound did 
not have an impact on the overall survival or maximum lifespan of mice (Baur, 
2010).  Rapamycin acts on the mTOR pathway and its main clinical use is as an 
immunosuppressant.  However, rapamycin has been shown to extend the median 
and maximum lifespan of mice, likely by inhibiting the mTOR pathway. Rapamycin 
exerted positive effects even when fed to the mice at very old age (600 days old), 
suggesting that an intervention started later in life may still be able to increase 




These examples of CR mimicking drugs highlight that the mechanisms and 
pathways underlying CR are key to the progression of future healthy ageing 
therapies. It is likely that control of the ageing process via calorie restriction works 
through a combination of the mechanisms listed earlier, and others yet to be 
identified.  However, the mechanisms and pathways of CR mimicking drugs are yet 
to be confirmed in humans, and although model organisms have provided some 
insight they cannot be extrapolated directly to humans.  Model organisms such as 
Caenorhabditis elegans and Drosophila melanogaster, are commonly used since 
they are well established, and a great proportion of human disease-causing genes 
are believed to have a functional homolog in such organisms (Pandey and Nichols, 
2011). However, limitations of these models include the absence of some human 
molecular pathways, lack of a sophisticated immune system, and absence or 
structural differences in key organs such as the heart preventing them to model the 
complete physiology of humans (Kaletta and Hengartner, 2006).  The most 
important drawback of such model organisms in relation to human ageing would be 
that all known experimental models have a considerably shorter life span than 
humans, for example, Caenorhabditis elegans has an extremely rapid life cycle of 
approximately four days (Kaletta and Hengartner, 2006).  Therefore, the ageing 








1.1.4 Mitochondrial dysfunction 
Whilst the above mechanisms have been implicated in ageing, one of the major foci 
of this thesis has been mitochondrial dysfunction, which is discussed here in more 
detail.  The role of mitochondrial reactive oxygen species (ROS) generation and 
subsequent mitochondrial DNA (mtDNA) mutations have been of particular interest 
in the field of ageing.  Mitochondria are double-membrane organelles located in the 
cytosol of most eukaryotic cells.   They are responsible for maintaining cellular 
energy balance, specifically by carrying out oxidative phosphorylation (OXPHOS) 
energy production to produce adenosine-5'-triphosphate (ATP) (Malik and Czajka, 
2012). 
ROS are produced by various pathways of aerobic metabolism, however the major 
source of their production is in mitochondria (Van Remmen and Richardson, 2001) 
on the basis that more than 90% of the oxygen used by aerobic cells is metabolised 
in mitochondria by the electron transport chain (ETC) (Sastre et al., 2000, Van 
Remmen and Richardson, 2001).  The generation of mitochondrial ROS is a normal 
consequence of OXPHOS, an essential process of mitochondria, which transfer 
electrons from nicotinamide adenine dinucleotide (NADH) or succinate to a series of 
electron carriers in order to generate ATP.  The substrates NADH and succinate 
deliver electrons to the ETC, which is composed of four complexes (I, II, III and IV) 
that transfer electrons in a stepwise manner to finally reduce oxygen, forming water.  
Three of the four complexes (I, III and IV) couple the electron transfer to vectorial 
proton translocation outside the matrix space.  Due to the low proton conductance of 
the inner mitochondrial membrane, protons accumulate and create an 
electrochemical gradient across the inner mitochondrial membrane. This osmotic 
energy is used to drive ATP synthesis as the protons re-enter the mitochondrial 
matrix through ATP synthase (Mitchell, 1961, Balaban et al., 2005, Larsson, 2010, 
Lagouge and Larsson, 2013).  
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At several sites along the ETC, electrons derived from NADH or succinate oxidation 
may escape and react with oxygen or other electron acceptors to generate free 
radicals.  Complexes I and III are predicted to be the major sites for ROS production 
(Chance et al., 1979, Lee and Wei, 2007, Rigoulet et al., 2011). The reduction of 
oxygen by one electron generates the superoxide anion (O2
-), which can then be 
further reduced to the hydroxyl radical (OH-) and hydrogen peroxide (H2O2) (Murphy, 
2009). These ROS can damage lipids, proteins and DNA.  However, the cell is 
equipped with a variety of defence mechanisms to scavenge ROS. Catalysed by two 
intramitochondrial superoxide dismutase (SOD), Cu–Zn SOD (SOD1) and MnSOD 
(SOD2), the superoxide radical is converted to hydrogen peroxide (H2O2), which can 
then be transformed into water by catalase or glutathione peroxidase.  Cells also 
contain non-enzymatic ROS scavengers such as ascorbate, flavonoids, carotenoids 
and glutathione, which may all contribute to the inactivation of otherwise damaging 
ROS.  This low level of ROS production is an unavoidable by-product of ETC 
function, and therefore mitochondria are the major source of ROS in eukaryotic cells 
(Chen et al., 2003, Chan, 2006). 
 
Mitochondrial free radical theory 
In 1956, Denham Harman first proposed the free radical theory of ageing (Harman, 
1956). The basis of this theory is that the production and accumulation of 
intracellular ROS over time has a damaging effect on numerous cellular 
components, contributing to the decline in physiological function of tissues with age.  
Since the discovery of the SOD enzymes in 1969, it became widely accepted that 
enzymatic scavenging systems have evolved to clear superoxide and other types of 
ROS (McCord and Fridovich, 1969).  As explained above, the mitochondrial 
respiratory chain is a principal site of ROS production in cells and it has therefore 
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been proposed that mitochondria themselves are the prime targets for oxidative 
damage.  This understanding has led to a modification of Harman‘s free radical 
theory into the mitochondrial free radical theory of ageing (Harman, 1972).  The 
mitochondrial theory of ageing proposes that ageing is a consequence of 
mitochondrial ROS accumulation, which in turn causes progressive damage to 
mtDNA and other mitochondrial constituents during an individual‘s lifetime.  
Cumulative mtDNA mutations result in dysfunction of the mitochondrial respiratory 
chain, causing increased ROS production in mitochondria and subsequently more 
mtDNA mutations. This vicious cycle has been proposed to account for an increase 
in oxidative damage during ageing, which leads to the progressive decline of cellular 
and tissue functions as a result of an insufficient supply of energy and/or increased 
susceptibility to apoptosis (Lee and Wei, 2007, Lagouge and Larsson, 2013).  This 
theory has provided a stable framework into the research of mitochondrial function 
and ageing; however, it has been extensively debated since there is a lack of 
conclusive experimental evidence to support it.  New theories, like the one recently 
described by Hekimi et al. (2011) predict that mitochondrial ROS play a subtler role 
in ageing.   
It is believed that ROS generation is not a direct cause of ageing, but rather 
represents a stress signal, activating compensatory homeostatic responses in 
response to age-dependent damage.  As chronological age advances, cellular 
stress and damage increase and the numbers of ROS rise in parallel in an attempt 
to maintain survival.  However, beyond a certain threshold, the increase ROS 
ceases to be homeostatic and eventually exaggerate, rather than alleviate, the age-
associated damage.  This new outlook on the mitochondrial free radical theory of 
ageing may help to balance the conflicting evidence regarding the effects of ROS on 







Figure 1.2 The vicious cycle of the mitochondrial free radical theory of ageing 
Reactive oxygen species are normal by-products of the mitochondrial electron transport 
chain.  ROS progressively damage the components of mitochondria, inducing the 
dysfunction of the electron transport chain (oxidative phosphorylation) and increased ROS 
production through a vicious cycle, ultimately leading to cellular dysfunction and ageing.  
Adapted from: The role of mitochondrial DNA mutations and free radicals in disease and 








Accumulation of mtDNA mutations with age 
Mutated mtDNA have been demonstrated to accumulate with age, this can be 
explained by two principles: replication errors and unrepaired damage.  It has been 
suggested that the considerable mtDNA replication occurring during embryogenesis 
will result in replication errors due to the inherent error rate of the mtDNA 
polymerase (Larsson, 2010, Lagouge and Larsson, 2013). The mtDNA mutations 
formed during embryogenesis are then exposed to segregation and clonal 
expansion in postnatal life. Secondly, an alternative theory is that accumulated 
damage, for example caused by ROS, will overpower the repair machinery and 
result in accumulation of mtDNA mutations.  There are mechanisms to maintain 
mtDNA integrity, such as base excision repair, but the number of available repair 
systems seems to be much more limited in mitochondria than in the nucleus. It 
should be highlighted that mtDNA is not unprotected but rather packaged into 
protein–mtDNA aggregates named nucleoids (Kukat et al., 2011). This is likely to 
physically protect mtDNA from chemical damage (Lagouge and Larsson, 2013).  
The mechanisms that impair the efficiency of the repair machinery with ageing 
remain unclear, but a decline in the mitochondrial import capacity with age could be 
one such mechanism.  For example, it is considered that 8-oxo-2′deoxyguanosine 
(8-oxoG) is one of the most abundant oxidative lesions that accumulate in mtDNA 
over time.  Of interest, it has been reported that accumulation of 8-oxoG in mtDNA 
occurs with age possibly because OGG1, a DNA glycosylase enzyme involved in 
base excision repair of 8-oxoG, accumulates in an uncontrolled manner in the 
mitochondrial intermembrane space and fails to be imported inside the mitochondrial 




Numerous studies have been published in which the level of mtDNA mutation 
accumulation has been correlated to life span.  One such study by Barja and 
Herrero (2000) hypothesised that if oxidative damage to mtDNA is involved in 
ageing, long-lived animals which age slowly should show lower levels of mtDNA 
damage markers in comparison to short-lived animals. Levels of 8-oxodG were 
compared to deoxyguanosine (control for oxidative damage) using high performance 
liquid chromatography in the mtDNA and nuclear DNA from heart and brain samples 
of six mammalian species ranging in maximum life span from 3.5 to 46 years (Figure 
1.3). Significantly higher 8-oxodG/dG values were found in mtDNA than in nuclear 
DNA in all the species studied in both tissues.  The results support the hypothesis 
that mitochondrial free radicals cause damage to mtDNA in a way related to the 
ageing rate of each species, and provide evidence of a causative link between 



































Figure 1.3 Inverse correlation between 8-oxodG/105dG in heart mitochondrial DNA 
(mtDNA) and maximum life span in eight mammalian species. 
8-oxodG/105dG values were plotted as a function of maximum life span, and data were ﬁtted 




, where b is the scaling exponent used to model the curve, y is 
8-oxodG in mtDNA and x is maximum life span (r= -0.92, P<0.001). Values are means ± 
SEM. The number of animals per species was eight mice and rats, six guinea pigs and pigs, 
and seven rabbits, sheep, cows, and horses.  Figure from: Oxidative damage to 
mitochondrial DNA is inversely related to maximum life span in the heart and brain of 
mammals (Barja and Herrero, 2000). 
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Mitochondrial OXPHOS Function Declines with Age 
Mitochondrial oxidative phosphorylation performance has been shown to decline 
with age.  There is a reported age-related decrease in mitochondrial membrane 
potential and an increase in proton leakage of the ETC in tissues of old animals and 
humans.  Given that the mitochondrial membrane potential is the driving force for 
OXPHOS, these were found to correlate with reduced ATP synthesis in these 
tissues (Harper et al., 1998, Sastre et al., 2000, Short et al., 2005, Lee and Wei, 
2007).  Acute oxidative stress causes inhibition of mitochondrial respiration, which 
affects the mitochondrial membrane potential.  Mitochondrial morphology is 
important because changes in the ultrastructure of mitochondria can modulate their 
function.  Enlargement, matrix vacuolisation and altered cristae have been found in 
mitochondria from old animals by electron microscopy and flow cytometry.  
Alterations of mitochondrial cristae in old mitochondria may be responsible for the 
age-related impairment in mitochondrial membrane potential (Sastre et al., 2000).  
Acute oxidative stress is well known to cause mitochondrial swelling. Therefore, 
age-associated chronic oxidative stress may be the cause, at least in part, of 
mitochondrial swelling seen with age (Kumaran et al., 2005, Yasuda et al., 2006).  
Bioenergetic studies of humans and animals indicate that the respiratory function of 
mitochondria declines in ageing, post-mitotic tissues. The electron transport 
activities of respiratory enzyme complexes gradually decline with age in the brain, 
skeletal muscle and liver of normal human subjects (Cooper et al., 1992, Ojaimi et 
al., 1999, Yen et al., 1989, Muller et al., 2010, Short et al., 2005).  Similar changes 
have been reported in various tissues including brain, heart and skeletal muscle of 
experimental animals (Torii et al., 1992, Sugiyama et al., 1993, Takasawa et al., 
1993, Kwong and Sohal, 2000).   
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Lin et al. (2000) showed that bladders from aged rats (24 months old) fatigued faster 
than bladders from young rats (3 months old) following repeated contractions 
induced by electrostimulation. This correlated with a reduction in 
the mitochondrial enzyme activity (indicative of mitochondrial dysfunction) in bladder 
tissues from the older rats resulting in a lower energy-production capability, which 
might explain some of the voiding dysfunctions found in the elderly (Lin et al., 2000).   
In addition to the age-related decline in the activities of respiratory chain enzyme 
complexes, the respiratory control ratio, OXPHOS efficiency, and ATP synthesis of 
mitochondria all decline to varying degrees with age in human and animal tissues 
(Yen et al., 1989, Lee and Wei, 2007).  The deterioration in mitochondrial respiratory 
function can result in lower ATP production and greater ROS generation in aged 
tissues, which provides evidence to support the mitochondrial free radical theory of 
ageing.   
To summarise, chronological age progression is associated with a marked decline in 
mitochondrial function, characterised by an increase in mtDNA mutations, abnormal 
mitochondrial cristae structures and free radical production coupled with a decrease 
in oxidative phosphorylation and ATP synthesis (Bossy-Wetzel et al., 2003, Huang 
and Manton, 2004, Linford et al., 2006).  There is a lack of evidence showing 








1.2 Obstetric Complications Related to Advanced Maternal Age 
 
The average age of childbirth is rising in the UK.  The percentage of women aged 35 
years and older from the total numbers of UK live births has risen from 8% in 1985 
to 20% in 2011 (Office for National Statistics for England and Wales, 2011c, Bewley 
et al., 2009).  Statistics from England and Wales in 2011 indicate that the average 
age of a woman giving birth was 29.7 years, and the average age of a woman 
having her first birth was 27.9 years (Office for National Statistics for England and 
Wales, 2011c).  By 2011, nearly a fifth of all births in England and Wales were to 
mothers aged 35 years and over (Figure 1.4).  The overall percentage rise since 
1973 suggests a general shift in the age of childbearing. Possible influences for 
delayed conception include increased participation in higher education, increased 
female participation in the labour force, the increasing importance of a career, the 
rising opportunity costs of childbearing, labour market uncertainty, housing factors 
and instability of partnerships (Benzies et al., 2006, Tough et al., 2006, Jefferies, 
2008, Chan and Lao, 1999, Ziadeh and Yahaya, 2001, Fitzgerald et al., 1998).  
Parallel with delayed natural conceptions, there has also been a rise in women aged 
35 and older being treated with assisted reproductive technologies to overcome 
fertility complications; the total number of women being treated in the UK has more 
than doubled between 1996 and 2007 (Human Fertilisation and Embryology 
Authority, 2011).  Escalation in the employment of assisted reproductive 
technologies has also inevitably contributed the shift in the age of childbearing over 
the past decades.  Women of advanced maternal age frequently experience 
adverse difficulties achieving and maintaining pregnancy and delivering a healthy 
baby in comparison to younger pregnant women (Chan and Lao, 2008, Chan and 




The impact of paternal age on the parturition process is unknown, but it is worth 
noting that nearly two-thirds of babies (65%) were fathered by men who were aged 
30 and over in England and Wales in 2011(Office for National Statistics for England 
and Wales, 2011b). 
 
 
Figure 1.4 Percentage of live births by mothers aged 35 and over, between 1938– 2011 
Data from the Office for National Statistics for England and Wales (Office for National 
Statistics for England and Wales, 2011c) 
 
Women of advanced maternal age also exhibit a greater prevalence of fetal mortality 
during pregnancy and labour.  Based on a European cohort of 634,272 women, it 
has been reported that approximately 20% of all wanted pregnancies in women 
aged 35 years result in fetal loss due to stillbirth, miscarriage or ectopic 













































































2000).  The risk of miscarriage alone is a major concern for mothers of advanced 
maternal age, with a risk of 24.6% in women aged 35-39, 51% aged 40-44 and 
rising to 93.4% at 45 years and above (Nybo Andersen et al., 2000, Bewley et al., 
2009). 
Mothers above the age of 35 years also have a greater risk of Caesarean section 
delivery (Bewley et al., 2009, Ziadeh and Yahaya, 2001, Gilbert et al., 1999, Smith 
et al., 2008, Ecker et al., 2001, Mbugua Gitau et al., 2009, Main et al., 2000, 
Bayrampour and Heaman, 2010).  Gilbert et al. (1999) report a 47% Caesarean 
section rate in nulliparous women aged 40 and over in comparison to 22.5% for 
women aged between 20-29, based on a cohort of 24,032 women in USA.  They 
also highlight that 61% of the nulliparous women over the age of 40 require some 
form of operative delivery (Caesarean section, forceps, vacuum) (Gilbert et al., 
1999).  In a recent UK population cohort study looking at 215,344 births, it was 
confirmed that the risk ratios for Caesarean sections were considerably higher in 
mothers aged 40 and above [RR = 1.83, (95% CI: 1.77–1.90)] (Kenny et al., 2013).  
Other studies assessing labour characteristics report that length of labour and 
incidence of prolonged labour does vary with maternal age.  In a retrospective 
cohort study of 31,976 births in USA, older nulliparous women aged 40 years and 
above were shown to persistently have higher rates of prolonged first and second 
stages of labour, compared to younger nulliparous women aged 20 years old and 
under.  The second stage of labour was reported to be 97 minutes longer in older 






1.3 The Reproductive Cycle and its Secession with Age 
 
The reproductive life span in both humans and animal models is determined by 
regularity of the menstrual cycle (humans) or oestrous cycle (rodents).  For all 
species, menstrual/oestrous cycling ceases at a defined age, normally mid-life; for 
humans this usually occurs between the late 40s and early 50s and for C57BL/6J 
mice between 11-16 months (Nelson et al., 1982, Felicio et al., 1984, Bromberger et 
al., 1997, Gold et al., 2013).  The basic hormonal profiles of the menstrual/oestrous 
cycle are generally similar between most species.   
Humans have a long reproductive lifespan of an average 36 years, from menarche 
at 8.5-13 years to menopause (defined as one year of anovulation) at around 50 
years (Park et al., 2002, Aydos et al., 2005, Mihm et al., 2011).  The ‗textbook‘ 
menstrual cycle in young healthy women with proven fertility is 28 days.  However, 
menstrual cycle length is highly variable, ranging from 25 to 34 days, and becomes 
noticeably shorter from 35 years of age with high variability, long cycle lengths and 
bleeding irregularities in the 5 years preceding menopause.  Most of the cycle length 
variability is due to variability of the follicular phase, which shortens by three to 
seven days over time (Waller et al., 1998, Wilcox et al., 2000). 
Since this present study investigates parturition in mice of advancing reproductive 
age, the oestrous cycle in mice will now be briefly discussed.  Mouse oestrous cycle 
lasts between four to six days and is divided into four discrete but overlapping 
phases: pro-oestrous, oestrous, metoestrous and dioestrous (Nelson et al., 1982, 
Tan et al., 2003, Caligioni, 2009).  Dioestrous is characterised by basal circulating 
concentrations of oestrogen and progesterone, atrophic endometrium and sexual 




Low concentrations of oestrogen and progesterone permit the synthesis of FSH by 
the pituitary gland.  During pro-oestrous, uterine oedema and proliferation of 
endometrial cells occur, accompanied by gradually increasing oestrogen 
concentrations.  Oestrous is when ovulation occurs and mice are sexually receptive, 
and the uterus becomes trophic under peak concentrations of oestrogen and other 
ovarian steroids.  This is the critical period for sperm capacitation and the 
subsequent transition of the uterine environment toward the receptive stage after 
mating (Fata et al., 2001). In mice, there is a surge in circulating progesterone 
concentrations just prior to ovulation, which then drop during ovulation and rise 
marginally again during metoestrous.  In the absence of successful fertilisation, 
degeneration of the corpus luteum occurs and the uterus undergoes regression, 
which is associated with cell apoptosis in all uterine cell types. This parallels the fall 
in serum oestrogen concentrations and the conversion of progesterone to less 
active 20-hydroxyprogesterone, resulting in the initiation of another follicular 
maturation cycle (Fata et al., 2001, Tan et al., 2003).  Nelson et al., (1982) 
confirmed that peak oestrous cycling periods (defined by regularity of cycles) begin 
to decline by 9 months of age and can cease as early as 11 months of age in mice, 
meaning that the reproductive lifespan of mice is limited to as little as 11 months 








1.4 The Timing of Parturition 
 
One of the principle components of this present study has been to address the 
mechanisms that underpin the impact of ageing on parturition.  The hormonal 
processes involved in the timing of parturition in both humans and mice will now be 
discussed.  Parturition is the process of giving birth or to be in labour, and requires 
ripening of the cervix and development of rhythmic myometrial contractions.  In 
humans, the timing and triggers for these events have not been fully elucidated 
(Lopez Bernal, 2003, Smith, 2007, Kamel, 2010).  However, it has been proposed, 
as a result of detailed in vivo animal studies and in vitro human investigations, that 
there is a cascade of hormonal signals driven by maternal-fetal interactions that 
prime the uterus and cervix, and induce labour (summarised in Figure 1.5) (Norwitz 
et al., 1999, Smith, 2007, Smith and Nicholson, 2007).  
The hormonal cascade involves positive-feedback loops, which initiate an integrated 
series of changes within target reproductive tissues (the myometrium, decidua, fetal 
membranes and uterine cervix) over a period of days or weeks. Central to these are 
i) the development of the fetal hypothalamic adrenal axis (HPA) resulting in the 
secretion of  fetal corsitol, dehydroepiandrosterone sulphate (DHEAS) and 
oestrogen (although the HPA is considered to play only a supportive role in human 
parturition) (Bernal, 2001, Mendelson, 2009, Kamel, 2010); ii) increased placental 
synthesis and release of corticotropin-releasing hormone (CRH) (Smith and 
Nicholson, 2007); iii) The process of a ‗functional‘ progesterone withdrawal (Allport 
et al., 2001, Smith et al., 2012b). All of these events are believed to feed forward to 
enhance synthesis of uterotonins (agents that stimulate contractions) including 
prostaglandins and oxytocin, and upregulate the expression of contractile 
associated proteins including oxytocin receptor, connexin-43 and prostaglandin-
endoperoxide synthase 2, resulting in the priming of the uterus, ripening of the 
cervix and rupture of fetal membranes (Norwitz et al., 1999, Bernal, 2001, Tribe, 
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2001, Smith, 2007, Smith and Nicholson, 2007, Vidaeff and Ramin, 2008, 
Mendelson, 2009).  A slow and progressive shortening of the ripened cervix can 
then be mediated in labour by lower segment uterine contractions and strong 
expulsive contractions originating in the fundal region of the primed uterus allowing 
the cervix to fully dilate and resulting in the delivery of the baby. A more detailed 
summary of how these hormonal changes directly impact the target tissues (cervix 
and myometrium) are discussed in sections 1.5 and 1.6.   
 
Figure 1.5 Proposed mechanism of labour induction at term 
The major hormones and paracrine/autocrine factors responsible for promoting uterine 
contractions at term in an integrated parturition cascade are shown. Plus signs indicate 
activation or up-regulation. Minus signs indicate negative feedback mechanisms.  ACTH: 
adrenocorticotrophic hormone, CRH: corticotropin-releasing hormone, DHEA: 
dehydroepiandrosterone, DHEAS: dehydroepiandrosterone sulfate, OXTR: oxytocin 
receptor, PGs: prostaglandins, PGRs: prostaglandin receptors, SROM: spontaneous rupture 




1.4.1 Fetal Signals and the Initiation of Parturition 
There is increasing evidence to suggest that the fetus may generate signals that 
contribute to the initiation of labour in both human and animal models.  These 
include cortisol release via the fetal HPA, CRH secretion from the placenta and the 
synthesis and secretion of pulmonary surfactant lipids and proteins by the fetal lung. 
The fetal hypothalamic-pituitary-adrenal axis 
As the fetus grows, the fetal HPA matures in preparation for the production and 
secretion of hormones such as CRH and adrenocorticotrophic hormone (ACTH), 
particularly during late gestation; the subsequent increased cortisol production by 
the fetal adrenal gland has been suggested to serve a role in the initiation of labour 
in humans and sheep (Liggins et al., 1973, Kamel, 2010).  The major difference in 
the pregnant mouse model from sheep and humans is that the fetus does not 
appear to play such a dominant role and it is in fact the progesterone withdrawal ,as 
a result of luteolysis, which is considered to initiate labour (Mitchell and Taggart, 
2009).  The luteolytic mechanism does not relate to human parturition, as the corpus 
luteum is not required for the last two thirds of gestation.  There is some belief that 
the fetal HPA appears only to have a supportive, rather than direct role in labour. 
This theory arises from observations in anencephalic pregnancies where there is 
little or no residual pituitary/adrenal function.  Examination of the length of gestation 
in women carrying single anencephalic fetuses who went into spontaneous labour 
showed that the mean length of gestation was similar to that in women carrying 
normal singleton fetuses, but with a much wider scatter around the mean. This 
suggests that spontaneous labour can occur in anencephaly, but that a normal fetal 





Corticotrophin-releasing hormone secretion 
In the humans and non-human primates, it has been suggested that CRH, which is 
secreted in increasing amounts by the placenta near term, provides a fetal signal for 
the initiation of labour (Nathanielsz, 1998, Smith and Nicholson, 2007, Smith et al., 
2012b).  Such increased level of free active CRH near term not only triggers fetal 
cortisol production, which subsequently promotes fetal lung maturation via positive 
feedback mechanisms, but also increases placental oestrogen synthesis and 
prostaglandin release in fetal membranes, decidua and myometrium.  Increased 
prostaglandin production is considered to potentially influence the upregulation of 
other contraction associated proteins in the myometrium such as gap junctions and 
oxytocin receptor (Smith, 2007, Kamel, 2010).  The efficiency of CRH action is 
governed by the expression of its functional receptors (CRH-R), which are increased 
by 2 to 3-fold at the onset of labour (Markovic et al., 2007).  Increased fetal CRH is 
proposed to up-regulate fetal pituitary secretion of ACTH, which enhances 
production of cortisol and dehydroepiandrosterone sulphate (DHEAS) by the fetal 
adrenal.  DHEAS is subsequently metabolised to DHEA and then further converted 
by the placenta to oestrogen, which is necessary for spontaneous delivery (Smith 
and Nicholson, 2007, Smith et al., 2012b) (summarised in Figure 1.5). 
In the mouse, CRH mRNA is developmentally induced to high levels in the 
bronchiolar epithelium of fetal lungs between days 13.5 and 17.5 days of gestation 
and is then depleted by day 18.5.  This rise in CRH expression comes before the 
developmental induction of synthesis of the major surfactant protein, surfactant 
protein A (SP-A), by the fetal lung.   Induction of SP-A expression was found to be 
delayed together with lung maturation in CRH-null murine fetuses from CRH-
deficient mothers (Muglia et al., 1999).  Therefore, CRH may contribute to the 
initiation of mouse labour by acting indirectly to stimulate fetal ACTH and adrenal 
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cortisol production and/or directly enhancing fetal lung maturation and the 
production of surfactant components (Mendelson, 2009). 
Fetal lung surfactant lipids and proteins 
The contribution of fetal lung surfactants to human parturition is debated, although it 
seems they may be more important in the mouse parturition.  The synthesis and 
secretion of pulmonary surfactant by the fetal lung is initiated during the third 
trimester of human gestation.  Surfactant, a glycerophospholipid-rich lipoprotein, is 
produced by alveolar type II pneumocytes and is secreted into amniotic fluid.  
Surfactant contains four principle lung-specific proteins, SP-A, SP-B, SP-C, and SP-
D; SP-A is assumed to be the key signal for the initiation of labour (Mendelson, 
2009, Yadav et al., 2011).  Pulmonary surfactant isolated from human amniotic fluid 
has been shown to promote the synthesis of prostaglandin E in discs of human 
amnion.  It is believed that surfactant phospholipids secreted by the fetal lung into 
amniotic fluid provide a source of arachidonic acid as a precursor for prostaglandin 
synthesis (Lopez Bernal et al., 1988).  Mendelson and colleagues observed that SP-
A gene expression is increased by proinflammatory stimuli such as IL-1 and NF-B 
and by hormones and factors that increase cAMP in human fetal lung type II cells in 
culture (Islam and Mendelson, 2002, Condon et al., 2004).   
In the mouse, SP-A mRNA and protein levels have been shown to be barely 
detectable in fetal lung on day 16 gestation, at day 17 there is an upregulation, 
followed by further rapid increase peaking at day 19 (Korfhagen et al., 1992, Alcorn 
et al., 1999, Condon et al., 2004).  This gestational surge in SP-A secretion by the 
fetal lung is accompanied by a parallel increase in IL-1 protein expression in 
macrophages isolated from amniotic fluid, migration of activated macrophages to the 
pregnant uterus and activation of uterine NF-B (Condon et al., 2004).  Condon et 
al., (2004), directly assessed the ability of SP-A to initiate labour in vivo, by injecting 
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parallel groups of mice with purified SP-A or with a control (SP-A-depleted 
preparation). The majority of mice injected with SP-A on day 15 of gestation 
delivered prematurely on day 16-17 of gestation.  Fetal macrophage migration and 
NF-B activation were detected within the SP-A injected uterine horn but not in the 
control horn, suggesting a local inflammatory response (Condon et al., 2004). The 
authors went on to evaluate the role of endogenous SP-A in the initiation of labour. 
Pregnant mice on day 15 of gestation were intra-amniotically injected with an 
antibody raised against SP-A to deplete endogenous levels of the surfactant protein 
in amniotic fluid.  All of the injected mice delivered viable pups 1 day later than 
normal gestational length, whereas the control group (pregnant mice intra-
amniotically injected with non-immune rabbit antibody on day 15 of gestation) 
delivered at term; suggesting that the depletion of surfactant protein in amniotic fluid 
was able to considerably delay parturition by 5% of the normal gestation length in 
this model.  However, the size of control group (n=3), was half of that of the test 
group (n=6); for a more conclusive outcome, authors should have matched sample 
sizes in both test and control groups.  Condon and colleagues concluded that 
increased production of SP-A by the maturing fetal lung towards term provides a 
hormonal stimulus for the activation of an inflammatory cascade within the maternal 
uterus that results in enhanced myometrial contractility leading to parturition 







1.4.2 Role of progesterone in the onset of parturition 
Secretion of progesterone during pregnancy prevents the secretion of FSH, which 
stops the selection and growth of a dominant follicle from the pool of follicles in the 
ovary.  In the human, the initial site of progesterone production during gestation is 
the corpus luteum.  However, five to six weeks after conception, the placenta is the 
major source of progesterone thereafter. Removal of the corpus luteum before this 
period of ―luteal-placental shift‖ can result in abortion.  In most experimental animal 
models, concentrations of maternal plasma progesterone remain relatively elevated 
throughout gestation, with an abrupt withdrawal of progesterone from the maternal 
circulation at the onset of parturition; this is paired with a simultaneous elevation in 
oestrogen concentrations (Mitchell and Taggart, 2009).  Only in the guinea pig and 
human are circulating progesterone levels maintained at high concentrations 
throughout gestation and parturition (summarised in Figure 1.6).  Progesterone is 
considered to act mainly to suppress the induction of pro-contractile pathways, 
whereas oestrogen, the other primary steroid hormone released by the placenta, is 
considered to be responsible for the upregulation of genes associated with labour, 
particularly the oxytocin receptor and connexin-43 (Nissenson et al., 1978, Lefebvre 
et al., 1995).   
Mice depend on an active corpus luteum for progesterone synthesis throughout 
pregnancy.  The onset of labour is triggered by luteolysis, which is mediated by 
activation of prostanoid FP receptors in the corpus luteum by prostaglandin 
F2released from the endometrium.  Luteolysis induces a rapid fall in maternal 
progesterone levels, which triggers the onset of labour (Mitchell and Taggart, 2009, 
Lopez Bernal, 2003).  This rapid decline in progesterone levels prompted the 
progesterone block theory by Csapo (1956), where it was proposed that a 
withdrawal of progesterone from the maternal circulation was necessary to cause 
the required uterine and cervical changes resulting in parturition.   
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According to this theory, progesterone promotes uterine quiescence by stimulation 
of relaxant pathways and suppression of stimulatory pathways, for example by 
reducing myometrial oestrogen sensitivity through inhibiting the expression of 
oestrogen receptor alpha (ER) in human myometrium.  In animal models, 
parturition occurs only after a withdrawal of progesterone.  It has been shown that 
progesterone suppressed the expression of several pro-contractile pathways in the 
pregnant uterus and stimulated expression of relaxant systems; at the onset of 
labour, the fall in progesterone triggers uterine activation (Csapo, 1956, Zakar and 
Hertelendy, 2007, Mitchell and Taggart, 2009, Kamel, 2010).  In mice, these 
changes are also associated with a sharp increase in uterine oxytocin receptor 
levels, leading to the assumption that oxytocin has a physiological role in the 
activation of uterine contractions in labour (Lopez Bernal, 2003).   
Similar to the mouse, circulating progesterone concentrations are altered at term 
and at labour onset in humans; progesterone concentrations are still high but stop 
increasing and have a tendency to plateau. There is also a change in progesterone 







Figure 1.6 Maternal serum concentrations of progesterone through gestation 
In most experimental animal models, there is an abrupt withdrawal of progesterone from the 
maternal circulation before parturition. Only in the guinea pig and human are progesterone 
levels maintained at a high and increasing concentration throughout parturition.  Figure from: 
Are animal models relevant to key aspects of human parturition? (Mitchell and Taggart, 
2009) 
 
The mechanism(s) through which progesterone block/withdrawal triggers onset of 
parturition still remain to be fully elucidated.  It has been suggested that the actions 
of progesterone in target cells are complicated and are mediated by multiprotein 
complexes that include progesterone-binding components (receptors) that modify 
components (coregulators and adaptors) and effector proteins (RNA-polymerase, 
chromatin remodelling proteins, and RNA-processing factors) (Zakar and 
Hertelendy, 2007).  From all of the existing work published to date, Mitchell and 
Taggart (2009) have summarised two major models that could explain what could 




The first mechanism, for which most experimental evidence exists, is the ―paracrine 
hypothesis‖. Progesterone is synthesised within a local intrauterine network, 
including the fetal membranes (amnion and chorion) and maternal decidua, which 
controls progesterone concentrations in the underlying myometrium.  Significant 
changes in progesterone production or metabolism could occur in this network and 
this could affect myometrial progesterone concentrations and contractility without 
changes occurring in the maternal systemic circulation.  It has been shown that both 
oestrogen and progesterone are produced and metabolised by human fetal 
membranes and decidua (Khan-Dawood, 1987, Mitchell et al., 1987, Mitchell and 
Taggart, 2009).  In addition, this intrauterine paracrine network produces other 
potentially important hormones such as oxytocin, endothelin (ET)-1, prostaglandin 
F2(PGF2), prostacyclin (PGI2) and nitric oxide (NO).  It is now considered that 
paracrine interactions within the pregnant uterus are physiological regulators of 
uterine contractility and play a key role in human parturition onset (Mitchell and 
Taggart, 2009).   
The second mechanism of functional progesterone withdrawal is linked to the 
expression of progesterone receptor (PR) isoforms.  The full-length isoform, PR-B, 
is the primary mediator through which progesterone exerts its effects.  However, 
there is an alternate transcription start site that codes for a protein, PR-A, that is 
identical to PR-B apart from missing the NH2-terminal 163 amino acids that contain 
one of the activating functional domains (AF3) of PR-B (Hovland et al., 1998).  PR-A 
tends to have opposing effects to those of PR-B through the actions of an inhibitory 
function due to the absence of AF3.  In both rat and human uterus, mRNA for PR-A 
appears to increase significantly before labour onset at term, and in the human, this 
also is true at protein level. The possibility of an alteration of PR-A:PR-B ratio 
causing functional progesterone withdrawal has been widely published (Pieber et 
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al., 2001, Fang et al., 2002, Mesiano et al., 2002, Merlino et al., 2007, Zakar and 
Hertelendy, 2007).   
Other recently postulated mechanisms are the catabolism of progesterone into 
inactive metabolites, changes in the cofactor protein levels affecting PR activation 
and regulation of PR responsive genes through the competitive blocking by NF-B 
at promoter sites. In addition, progesterone has been shown to directly inhibit 
binding of oxytocin to its receptor, potentially interfering with the effects of this potent 
contractile agonist. This explains why disruption of progesterone alone could trigger 
the full parturition cascade (Mesiano et al., 2011, Allport et al., 2001, Zakar and 
Hertelendy, 2007, Dunlap and Stormshak, 2004, Lindstrom and Bennett, 2004). 
 
1.4.3 The immune system control on the onset of parturition 
The relationship between the immune system and parturition remains unclear, but 
for many decades it has been postulated that labour is associated with an 
inflammatory cascade.  The process of a ‗functional‘ progesterone withdrawal is 
proposed to modulate the influx of inflammatory cells and release of inflammatory 
mediators.  Two major components of this pathway are cytokines and 
prostaglandins. Romero and his colleagues have documented concentrations of 
proinflammatory cytokines in the amniotic fluid of women in the presence and 
absence of positive amniotic fluid bacterial cultures. They found that IL-1IL-6 and 
TNF concentrations were all significantly increased at term and with the onset of 
human labour (Romero et al., 1992b, Romero et al., 1992c, Romero et al., 2006).  
Expression of cytokines in the fetal membranes and the decidua suggests an 
inflammatory reaction occurs at term.  These inflammatory cytokines regulate the 
release of uterotonins such as prostaglandins (Romero et al., 2006). 
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Many proinflammatory cytokines initiate signalling pathways that include 
transcription factors such as NF-B, CAAT-enhancer binding protein -isoform 
(CEBP), activator protein-1 (AP-1) and specificity protein-1 (Sp-1).  Response 
elements for these transcription factors are commonly found in the regulatory 
regions of genes that are considered to be important in the cascade leading to 
parturition such as oxytocin receptor , prostaglandin FP, prostaglandin-
endoperoxide synthase 1 and 2, and Cx-43. Many more studies have investigated 
the roles of proinflammatory cytokines on the expression of, and signalling pathways 
associated with, these factors.  The results have been mixed, with many positive 
and some negative conclusions.  One downstream effect of several proinflammatory 
cascades is the generation of PGF2. Whereas this causes luteolysis and 
subsequent progesterone withdrawal in mouse models, the role of PGF2in the 
human is much less clear.  Lastly, one of the more consistent findings in microarray 
experiments investigating molecular events of parturition is an increase in 
expression of genes associated with an immune response (Tan et al., 2012, 
Havelock et al., 2005).   
Prostaglandins are vital in the initiation of parturition in the mouse, and are also 
considered to play a key role in the human parturition pathway (Winchester et al., 
2002).  Prostaglandins are formed from arachidonic acid that is converted to 
prostaglandin H2 by the enzyme prostaglandin H synthase, also known as 
cyclooxygenase (Kota et al., 2013).  Amniotic fluid concentrations of prostaglandin 
E2 (PGE2) and prostaglandin F2 (PGF2have been shown to be increased before 
the onset of human labour (Lee et al., 2008). Similarly, the peak in uterine 
PGF2 levels occurs at day 19.0 of gestation in mice, correlating with the onset of 
labour (Winchester et al., 2002).  Allport et al., (2001) have demonstrated that 
human parturition is related to an up-regulation of prostaglandins within the uterus, 
synthesiszed by PTGS2.  This leads to remodelling of the fetal membranes and 
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cervix and stimulation of myometrial contractions (Allport et al., 2001).  Furthermore, 
myometrial contractions are shown to be mediated by PGE2, PGF2and 
thromboxane through targeting prostanoid EP, FP and TP receptors, respectively 
(Fischer et al., 2008).  
There is much data suggesting a role of NF-B, which is classically linked to 
inflammation, in the pathophysiology of labour.  NF-B activity increases with onset 
of labour, which in turn up-regulates expression of PTGS2 which contributes to the 
functional progesterone withdrawal and synthesis of prostaglandins (Lappas and 
Rice, 2007).  An array of receptors, pro-inflammatory cytokines and inducible factors 
connected with the onset of human parturition have been shown to be regulated by 
NF-B including TNF, IL-1, IL-8, PTGS2, oxytocin receptor and phospholipase-A2.  
These have been examined in gestational tissues including the amnion, decidua, 
cervix and myometrium.  Additionally, inhibitors of NF-B activity such as IL-10 have 
been shown to suppress both LPS-induced pre-term labour in rodents in rodents 
(Schottelius et al., 1999, Dudley and Dangerfield, 1996, Terrone et al., 2001) and IL-
1 induced uterine contractions in Rhesus monkeys (Sadowsky et al., 2003, 
Cookson and Chapman, 2010). These findings suggest that NF-B is a key 
regulator of pro-inflammatory agents during parturition.  However, it is not clear 
whether the role of NF-B is a cause or effect of the parturition process.  
In summary, these studies reinforce the association between immune activation and 
mechanisms of parturition in both mouse and human, however full understanding of 






1.5 The Cervix in Pregnancy and Labour 
 
1.5.1 Structure of the cervix 
One of the proposed mechanisms investigated in this thesis are the potential delays 
in cervical softening and/or ripening in ageing mice.  The following section describes 
the preparation of the cervix for labour. The cervix is a structure that allows 
attachment of the uterus to the vagina.  It is approximately four centimetres long in 
the human and five millimetres long in the mouse.  Human and mouse basic 
anatomy are similar as shown in Figure 1.7.  The cervix can be divided into the 
ectocervix and the endocervical canal.  The ectocervix is the portion of the cervix 
that projects into the vagina. It is lined by stratified squamous non-keratinised 
epithelium. The opening in the ectocervix, the external os, marks the transition from 
the ectocervix to the endocervical canal.  The endocervical canal is the ‗inner‘ 
portion of the cervix. It is lined by a mucus-secreting simple columnar epithelium. In 
the human cervix, the endocervical canal ends and the uterine cavity begins at the 
internal os.  It is principally composed of connective tissue, the majority of which is 
collagen arranged in ﬁbres and embedded in proteoglycans. There is a small 
amount of smooth muscle (<10%) and ﬁbroblast cells(Leppi, 1964, Graham, 1966, 











Figure 1.7 Schematic frontal section through human and mouse cervix 
The cervix is the structure that allows attachment of the uterus to the vagina.  The structure 
of the cervix is similar in both human and mouse.  In both, it can broadly be divided into two 
components: the ectocervix (lined by stratified squamous epithelium) and the endocervical 
canal (lined by a mucus-secreting columnar epithelium). A: Human cervix; figure from 





1.5.2 Distinct phases of cervical ripening 
The non-pregnant cervix is a fibrous organ with a high connective tissue content that 
undergoes extensive remodelling throughout gestation and the postpartum period 
(Maul et al., 2006, Yu and Leppert, 1991).   Early in gestation, the cervix increases 
in volume as its primary function is to maintain rigidity, termed physical integrity. 
This physical integrity is critical so that the developing fetus can remain in the uterus 
until the appropriate time for delivery.  The secondary function is to provide a 
physical and chemical barrier (the cervical epithelia produce cytokines and 
antimicrobial peptides) to prevent infection ascending up into the uterus via the 
vagina (Critchley et al., 2004, Timmons et al., 2007, Timmons et al., 2010, Frew and 
Stock, 2011, Miessen et al., 2012).  Towards term, the structure of the cervix softens 
and becomes more distensible through a process known as cervical ripening; this 
subsequently facilitates cervical dilation promoted by myometrial contractions during 
labour.   
Cervical remodelling in both human and mouse, can be divided into four separate 
but overlapping stages defined as softening, ripening, dilation and postpartum repair 
(Leppert, 1995, Word et al., 2007, Timmons et al., 2010) (Figure 1.8).  Hegar (1985) 
was the first to report that the human lower uterine segment felt softer in pregnancy 
at four to six weeks (Hegar, 1985, Read et al., 2007).  However, many years before, 
Harkness & Harkness (1959) documented that distensibility of rat cervical tissue 
increased dramatically starting mid-gestation between days 11 and 12, again 
indicative of a softening to the cervical structure (Harkness and Harkness, 1959).  
Cervical softening is classified as the first measurable decline in the tensile strength 
or tissue compliance compared with non-pregnant. Digital cervical examination in 
women and biomechanical studies in mice have indicated that softening initiates in 
the first trimester of pregnancy in women and by day 12 of a 19 day gestation in 
mice (Leppert, 1995, Read et al., 2007, Timmons et al., 2010).  
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The softening phase is different from the remodelling stages that occur closer to 
term, as it is a relatively slow and incremental process which occurs in a 
progesterone-rich environment.  Despite the progressive increase in compliance, 
tissue competence is preserved.  Changes in tissue compliance during softening are 
proposed to be facilitated by changes in the composition or structure of the 
extracellular matrix (ECM) in humans and rats (Liggins, 1978, Leppert, 1995).  This 
is supported by the observations that cervical incompetence is increased in women 
with inherited defects in collagen and elastin synthesis or assembly such as Ehlers-
Danlos and Marfan syndromes (Meijboom et al., 2006).  In addition, mice deficient in 
the ECM protein, thrombospondin 2, have altered collagen fibril morphology and 
premature cervical softening (Kokenyesi et al., 2004).  
Cervical ripening at the end of gestation is a more accelerated stage defined by 
maximal loss of tissue compliance and integrity.  Ripening is characterised by an 
increase in hyaluronan content, weakening of the collagen matrix, increased 
collagen solubility (Hillier and Wallis, 1982, Granstrom et al., 1989), changes in the 
distribution of inflammatory cells, increased tissue growth and hydration and loss of 
tensile strength (Uldbjerg et al., 1983, Straach et al., 2005, Timmons et al., 2010). 
Ripening takes place within a week or two preceding birth in women, or in the hours 
preceding birth in mice.  Following delivery, the final stage of remodelling, known as 
postpartum repair, allows recovery of tissue integrity and competency.  Each phase 
of remodelling is coordinated within a unique endocrine environment affecting 
epithelial, stromal, immune and endothelial cell function as well as the composition 





1.5.3 Cervical architecture: The extracellular matrix  
The predominant molecules of the cervical extracellular matrix are type 1 (70%) and 
type 3 (30%) collagen (Kleissl et al., 1978), with a small amount of type 4 collagen at 
the basement membrane (Minamoto et al., 1987).  Intercalated among the collagen 
molecules are glycosaminoglycans (Fumagalli et al., 2012), proteoglycans, elastin, 
and various gylcoproteins such as fibronectins.  There is also a cellular portion of 
the extracellular matrix consisting of smooth muscle, epithelium, fibroblasts and 
blood vessels.  The relative ratio of smooth muscle to connective tissue is not 
uniformly distributed throughout the cervix. The upper cervical portion closest to the 
myometrium has lower connective tissue ratio compared to the lower distal portion 
of the cervix (Ludmir and Sehdev, 2000). Cervical remodelling, transitioning from 
non-pregnant to late pregnant cervix, is greatly facilitated by the reorganisation of 
the extracellular matrix. 
 
Collagen 
Collagen is the most important component of the extracellular matrix as it 
determines the tensile strength of the fibrous connective tissue (Read et al., 2007, 
Word et al., 2007, Timmons et al., 2010, Mahendroo, 2012).  In its natural helical 
state, collagen proteins are rigid and essentially non-extensible.  Synthesis of stable 
collagen triple helices requires vast co-translational and post-transitional 
modifications.  Once arranged as a triple helix, the collagen can then be cross-linked 
into fibrils, fibres and bundles.  Collagen fibres must be at least 20 m in length to 
maintain tensile strength, and the process of cross-linking further enhances this 
tensile strength (Aspden, 1988).  When cross-linked, collagen is less accessible to 
collagenases and proteases that act to degrade the collagen fibres.  In the non-
pregnant cervix, collagen bundles are densely and irregularly packed.   
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Throughout pregnancy, collagen is actively synthesised and continuously 
remodelled by collagenases, which are secreted from both cervical cells and 
neutrophils.  Collagen is broken down by collagenases both intracellularly, to 
remove structurally defective pro-collagen to prevent the formation of weak 
structural collagen and extracellularly, to slowly weaken (soften) the collagen matrix 
to allow delivery of the fetus (Junqueira et al., 1980, Uldbjerg et al., 1983, Ludmir 
and Sehdev, 2000).   
Even by the end of the first trimester, the collagen bundles become less compactly 
assembled, resulting in an overall decrease in the collagen concentration. However, 
with smooth muscle cells and elastic tissue, the collagen fibres align in a certain 
direction parallel to each other. Therefore, the cervix feels softer than the non-
pregnant cervix, but is still able to maintain the pregnancy in utero (Ludmir and 
Sehdev, 2000).  As the pregnancy progresses closer to term, there is a further 
decrease in the overall concentration of collagen. Cervical cells secrete decorin, a 
small molecular weight proteoglycan that coats collagen fibrils.  The levels of 
decorin rise both in late pregnancy and in labour.  When the ratio of decorin to 
collagen increases, it is likely to cause a dispersal of collagen fibrils leading to 
disorganisation of the collagen fibres (Rechberger and Woessner, 1993).  The 
concentration of collagen therefore decreases as a consequence of this relative 
―dilution‖ of the collagen as it is dispersed and remodelled into fine fibres.  
Hyaluronic acid, a glycosaminoglycan, is secreted by fibroblasts and has a high 
affinity for water molecules.  As collagen fibres disperse, hyaluronic acid levels 





As summarised above, the properties of collagen are influenced by changes in 
synthesis, posttranslational modifications, assembly of fibres and degradation of 
fibres.  Current understanding confirms that changes in collagen structure precede 
cervical softening and contribute to the progressive decline in the tensile strength of 
the cervix.  Maximal tensile strength diminishment occurs at birth and is rapidly 
regained in the postpartum period (Timmons et al., 2010, Akins et al., 2011).  It is 
believed that the structural reorganisation of collagen by the end of gestation allows 
access of proteases to active sites allowing more effective removal of less mature 
collagen. The upregulation of collagen assembly genes in the postpartum period are 
considered to promptly replenish mature collagen in the matrix resulting in a 
marginal overall change in total collagen content. The relative contribution of 
collagen degradation versus structural reorganisation remains controversial, and 




Elastin fibres provide recoil to tissues that undergo repeated stretch. Along with 
collagen, elastin is another important component of the extracellular matrix of the 
uterine cervix.  These fibres are located in defined regions of the stromal matrix and 
comprise 0.9–2.4% of the total amount of connective tissue, without a substantial 
change in content over the course of pregnancy.  They are organised parallel to and 
between collagen fibres and assemble in bands of 20-30 µm thickness (Leppert et 
al., 1983, Leppert et al., 1986).  These thin sheets are capable of being stretched in 
any direction.  Elastin allows the uterus to retain the fetus during gestation, but with 
mechanical stress, the elastin component can distend to twice its length to allow the 
cervix to dilate for parturition.   
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The importance of elastin fibres in facilitating reversible extensibility or elasticity is 
suggested by the reduction in elastin fibre content in women with cervical 
insufficiency.  In biopsies from patients with clinically evident incompetent cervices, 
histologic evaluation reveals both a decrease in elastin and abnormal architecture 
(Leppert et al., 1987).  The elastin fibres appear broken and fragmented compared 
to samples from women with full-term pregnancies that revealed elastin oriented in a 
band-like manner (Leppert et al., 1987).  
 
Cellular components of the cervix 
Smooth muscle cells and fibroblasts make up the cellular component of the human 
uterine cervix (Leppert, 1995).  Early in gestation, turnover of both smooth muscle 
and fibroblasts is initiated and the cervix undergoes hyperplasia as these cells 
proliferate.  As pregnancy advances, the cells go from a proliferative phase to a 
quiescent phase in which physiologic cell death occurs and decorin becomes up-
regulated. Decorin then further suppresses cell proliferation, which accounts for 
further increases in decorin levels; a process that helps to disperse collagen fibres 
(De Luca et al., 1996, Ludmir and Sehdev, 2000).  This disorganisation of collagen 
then aids in an influx of water and aids in increasing the ability of the cervix to 
distend. Regulation of cell death can be affected in multiple ways, including 
secretion of hormones and cytokines. The pattern of physiologic cell death appears 
to be controlled precisely during the various stages of cervical remodelling. 
Physiologic cell death induces invasion of the cervical stroma by neutrophils and 
macrophages. These cells then induce the release of collagenases and elastase 






Matricellular proteins are not considered to be structural components of the 
extracellular matrix themselves, but they modulate the functions of structural 
proteins such as collagen as well as cell functions through interactions with cell 
surface receptors, proteases, and growth factors.  Matricellular proteins include 
SPARC (secreted protein acidic and rich in cysteine), thrombospondin 1, 
thrombospondin 2 and tenascin C which modulate interactions of cells with the 
extracellular matrix during development, remodelling and wound healing (Midwood 
et al., 2004, Timmons et al., 2010, Akins et al., 2011).  Transcription of tenascin C, 
thrombospondin 1, thrombospondin 2 and fibrillin is increased several-fold in the 
postpartum cervix which validates their described roles in wound healing and tissue 
repair. In summary, matricellular proteins are expressed and regulated during 
cervical remodeling, but their specific function in this process remains to be 












1.5.4 Mechanisms controlling cervical ripening prior to labour onset 
Animal studies have provided a working understanding of cervical remodelling, but 
much of the proposed model remains to be tested experimentally in humans.  In 
summary, cervical remodelling is the result of a series of complex and properly 
timed biochemical processes that consequently lead to the rearrangement and 
realignment of the collagen molecules, decreased collagen fibre strength and 
diminished tensile strength of the ECM.  Softening is characterised by increased 
collagen turnover and reduced collagen crosslinking. As mature, crosslinked 
collagen is depleted from the matrix, it is replenished with the less mature collagen 
resulting in a progressive decline in tissue stiffness (House et al., 2009, Akins et al., 
2011).  Associated with changes in the ECM is the localisation of leukocytes to the 
subepithelial region, along with increased proliferation and an increase in the 
surveillance capability of epithelia via expression of repair and barrier maintenance 
factors. These changes take place in a low oestrogen and high progesterone 
environment (Timmons et al., 2010).  The shift to the accelerated stage of cervical 
ripening is mediated by a decline in progesterone synthesis, increased cervical 
progesterone metabolism and increased synthesis of estradiol and relaxin.  The 
ongoing processes initiated during the softening phase are then joined during 
ripening by increased vascularisation, a change in glycosaminoglycan (GAG) 
composition and alteration in tissue hydration which together result in increased 
tissue volume. The best understood GAG change is an increase in hyaluronan, 
which facilitates further disorganisation of collagen fibres and provides increased 
viscoelasticity to the cervix. The maximal loss of tissue tensile strength might result 
from disruption of stable high MW hyaluronan crosslinked to versican owing to 





Disruption of these crosslinks might culminate in loss of integrity, allowing maximal 
dilation during labour upon initiation of uterine contractions. Changes in barrier 
properties of the cervical epithelia via changes in expression of tight junction, 
aquaporin and gap junction proteins might also accompany this phase of 
remodelling (Timmons et al., 2010, Mahendroo, 2012). 
The structural changes in ECM components have been linked to a cervical stromal 
inflammatory response (Dubicke et al., 2010). During cervical ripening there is an 
influx of neutrophils, eosinophils, mast cells, and macrophages into the cervical 
stroma (Timmons et al., 2010, Word et al., 2007, Read et al., 2007). There is also an 
increase in the enzyme PTGS2 associated with cervical ripening, which leads to a 
local increase of prostaglandin E2 (PGE2) in the cervix. PGE2 in turn stimulates the 
release of interleukin IL–8 increasing chemotaxis for neutrophils, which is 
associated with collagenase activity promoting collagen degradation.  There is an 
increase in the activity of matrix metalloproteinases 2 and 9, enzymes that degrade 
extracellular matrix proteins. Cervical collagenase (also called matrix 
metalloproteinase 1) and elastase also increase (Stygar et al., 2002, Read et al., 
2007, Word et al., 2007, Timmons et al., 2010).  The trigger for these changes to the 
morphology of the cervix is considered to be linked to the increased concentration of 
PTGS2, endogenous cytokine and prostaglandin synthesis, and decrease in 
functional progesterone receptor, which all occur as a result of the activation for the 
onset of labour.  Increasing oestrogen levels also lead to an increased collagenase 
activity, cervical cell apoptosis, and eosinophil infiltration in the cervix (Word et al., 






The nitric oxide synthase (NOS)/nitric oxide (NO) system has been postulated to 
have a regulatory role in the process of cervical ripening (Ledingham et al., 2000, 
Tornblom et al., 2005). Gene expression of endothelial inducible NOS is significantly 
higher in cervical tissues from women in labour compared to unripe cervices 
(Tornblom et al., 2005).  In animal studies increased cervical NO is associated with 
an increase in metalloproteinase activity, cellular apoptosis in the cervix, and 
glycosaminoglycan synthesis in the cervix.  In a rat model, the administration of a 
nitric oxide synthase inhibitor (L-nitro-arginine methylester) was able to block 
cervical ripening, whereas the direct application of a NO donor (sodium 
nitroprusside) to the cervix induced cervical ripening (Calder, 1998, Chwalisz and 
Garfield, 1998, Buhimschi et al., 1996).  
There is much controversy surrounding the theory that activation of immune cells is 
required for physiological cervical ripening at term and some groups who work 
mainly with rodent models, openly oppose the concept (Hirsch et al., 2006, 
Timmons and Mahendroo, 2006, Gonzalez et al., 2009, Timmons et al., 2009, 
Mahendroo, 2012).  These groups suggest that during ripening there is an influx of 
monocytes into the cervix that are dependent on the loss of progesterone function.  
In addition, resident macrophages and neutrophils are present in the cervix at this 
time. Despite the presence of these leukocytes, mRNA expression of 
proinflammatory genes such as IL-1, IL-6, TNF, CXCL1, PTGS1, and PTGS2 are 
believed not to be induced during ripening though some are increased shortly after 
postpartum.  Furthermore, depletion of neutrophils has no effect on timing of 
parturition and myeloperoxidase activity, a marker of functional neutrophils, is not 
measurable until postpartum.  These data suggest that immune cells are present but 
not activated during rodent cervical ripening, thus suggesting that physiological 
ripening is not mediated by an inflammatory cascade (Mahendroo, 2012).    
75 
 
However, some theories still propose a potential role for inflammatory mediators in 
human cervical ripening, particularly in relation to preterm labour; gene expression 
of proinflammatory genes such as IL-1 and IL-1are higher in cervical biopsies 
from women in labour compared to unripe cervical tissues (Dubicke et al., 2010).  
Monocytes which invade the cervical stroma either prior to birth, during labour or 
shortly postpartum are differentiated to produce macrophages with two diverse 
phenotypes, M1 and M2 (Timmons et al., 2010).  M1 macrophages are activated by 
pro-inflammatory mediators such as LPS and IFN and express pro-inflammatory 
cytokines such as IL-6, IL-12, and TNF (Dalton et al., 1993, Gordon, 2003, Mosser, 
2003, Gordon and Martinez, 2010).  M2 macrophages are activated by IL-4 and IL-
13 and produce anti-inflammatory cytokines such as IL-10, IL-1 receptor antagonist 
and TGF(Stein et al., 1992, Doherty et al., 1993, Song et al., 2000, Mosser, 2003). 
The activation of M1 macrophages protect the reproductive tract from the threat of 
microbial invasion, and generate pro-inflammatory molecules which are important 
for the postpartum clearance of cervical extracellular matrix molecules.  
Alternatively, M2 macrophages prevent over-activation of the M1-mediated 
inflammatory process and instead promote repair of the cervix back to the non-
pregnant state (Timmons et al., 2009, Timmons et al., 2010).  Postpartum repair is 
characterised by a significant increase in transcription of genes involved in matrix 
repair (e.g. matricellular proteins, collagen assembly) and epithelial barrier function 








In summary, cervical remodelling (inclusive of softening and ripening) is a dynamic, 
progressive process resulting in realignment of collagen, degradation of collagen 
cross-linking due to proteolytic enzymes and dilation of the cervix resulting from 
these processes plus uterine contractions. This is a complicated series of events in 
which many things occur both simultaneously and sequentially. Cervical repair then 
occurs postpartum so that a successful pregnancy can occur again in the future.  If 
the timing of these complex cervical changes is not tightly controlled, a delay in 
delivery post term or preterm delivery can result, or it can even result in an 





Slow, progressive phase 
 Greater progesterone function 
 Lower oestrogen levels 
 Changes in collagen structure 
- Decreased crosslinking 
- Increased solubility  
 Increased epithelial repair and 
protective factors 
 Lowered tensile strength 
 
Rapid phase 
 Lower progesterone function 
 Greater oestrogen level 
 Greater tissue hydration 
 Increased high MW hyaluronan 
 Increased collagen dispersion 
 Maximal loss of tensile strength 
 Increased monocyte influx 
 Changes in proteoglycans 
 
 
 Lower collagen solubility 
 Greater collagen density 
 Greater leukocyte activation 
 Metabolism of high MW hyaluronan 
to low MW hyaluronan 
 Increased proinflammatory gene 
expression 




Figure 1.8 Representative schematic of the stages of cervical remodelling 
The changes in cervical physiology during human and mouse gestation can be divided into distinct, overlapping phases: softening, 
ripening/dilation, and postpartum repair.  (Information for the mouse was adapted from: Cervical remodelling during pregnancy and 
parturition: molecular characterisation of the softening phase in mice (Read et al., 2007). 
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1.6 The Myometrium in Pregnancy and Labour 
 
1.6.1 Structure of the uterus 
Myometrial function in pregnant ageing mice was investigated as part of this thesis; 
this following section describes the activation of the myometrium for labour.  The 
human uterus is located between the cervix and the fallopian tubes.  It compromises a 
single chamber.  The myometrium, the major tissue component of the uterus, is 
located between the endometrium and the perimetrium (Figure 1.9).  The myometrium 
is composed of predominantly smooth muscle and extracellular matrix.  Knowledge of 
the exact number, or relative proportion, of smooth muscle fibres that exist in normal 
myometrium, is limited (Sweeney et al., 2013).  However, research into the 
microanatomy of the human term-pregnant myometrium has indicated there are clearly 
defined structural elements, which include densely packed sheets and cylindrical 
bundles of myocytes (Young and Hession, 1999).   
The structure of the human myometrium is composed of three layers: the 
supravascular, the vascular and the subvascular.  The outermost supravascular layer 
is predominantly a longitudinal arrangement of smooth muscle cells that are arranged 
in interconnecting bundles of 10 to 50 partially overlapping cells and set in a matrix of 
collagenous connective tissue.  The middle vascular layer is thick and consists of an 
interlacing mesh of muscle fibres interspersed with blood vessels.  The innermost 
subvascular layer is adjacent to the endometrium and is predominantly a circular 
arrangement of muscular fibres running perpendicular to the long axis of the uterus; 
this layer runs clockwise and counter-clockwise in a spiral (Noe et al., 1999, Schünke 





Mice have a duplex uterine structure, consisting of two uterine horns that join together 
at the uterine body (Figure 1.9).  Each uterine horn has a myometrial smooth muscle 
layer.  The mouse myometrial structure is similar to that of human myometrium 
composing of two layers: an outer longitudinal layer of smooth muscle fibres and a 
thicker inner circular muscle layer; the two layers are separated by loose, highly 














Figure 1.9 Schematic frontal section through human and mouse uterine structures 
A: Human uterus; figure from http://medicalterms.info/anatomy/Uterine-Wall/                 
The human uterus compromises of one uterine chamber and cervix. The uterine wall is made 
up of three layers: the endometrium, the myometrium (smooth muscle layer), and the 
perimetrium.  B: Mouse uterine horns; figure from: A study of the uterine cervix of the mouse 
(Leppi, 1964).  1. The mouse reproductive tract compromises of two uterine horns (H) that join 
to form the body of the uterus (B), the cervix (C) and vagina (V) (x 4 magnification). 2. 
Representative diagram showing the lumen of each uterine horn (H) are continuous with those 
of the uterine corpus (B). Each uterine horn is made up of an outer layer of longitudinal muscle 
and a thicker inner layer of circular smooth muscle, as represented by crosshatching.  (V) 
vagina, (F) vaginal fornices, (C) cervix,  (A) cervical and vaginal stroma, (R) stroma of the 





1.6.2 Myometrial function in menstruation and menopause 
The non-pregnant uterus exhibits contractile activity during menstruation and can be 
responsible for the dysmenorrhea. The uterus exhibits two known patterns of 
myometrial contraction during the menstrual cycle.  The first has been termed ―focal 
and sporadic bulging of the myometrium‖ (Togashi, 2007), which frequently involves 
the entire layer of the myometrium.  These contractions are sustained and last for 
several minutes.  The second pattern: ―uterine peristalsis", initiates rhythmic ‗wave-like‘ 
subtle contractions, which are likely to be responsible for the shedding of the 
subendometrial myometrium, and required for the transport of spermatozoa from the 
external os of the cervix into the fallopian tubes (Kunz and Leyendecker, 2002). 
Concentrations of the female steroid hormones alternate during the menstrual cycle 
and influence the pattern of myometrial activity in both human and animal models.  
These hormones also control levels of ATP and other metabolites required for 
contraction and can influence uterine excitability.  Recordings of uterine pressures in 
the non-gravid uterus, as well as MR imaging have shown that the pattern of 
myometrial activity, such as the direction of contraction propagation throughout the 
uterus varies with the different phases of the menstrual cycle.  Antegrade contractions, 
which are contractions propagating from the fundus towards the cervical end of the 
uterus, favour forward emptying or discharge of the uterine content such as menstrual 
blood, whilst cervico-fundal contractions aid in sperm transport (Arrowsmith et al., 







The menopause is marked with a gradual decline in hormonal secretion from the 
ovaries, to the point when the ovaries cease to function, and there is a characteristic 
loss of regular menstruation and eventual permanent cessation of menses (Burger et 
al., 2008). Contrary to the assumption that uterine activity ceases following the 
menopause, rhythmical myometrial contractions have been seen by ultrasound 
examination in postmenopausal women and low levels of spontaneous activity have 
been reported in strips from human post-menopausal myometrium in vitro (de Vries et 
al., 1990, Domali et al., 2001, Arrowsmith et al., 2012).  In conclusion, the uterus is a 
dynamic organ which functions throughout a lifetime, but changes accordingly with 
advancing age. 
1.6.3 Myometrial contraction and activation at labour onset 
For the majority of pregnancy, the uterus demonstrates limited contractile activity 
(quiescence), with sporadic, low amplitude and arrhythmic contractions. During this 
state, the contractile function of the myometrial smooth muscle is considered to be 
suppressed by the down regulation of contractile associated proteins (CAPs) such as 
gap junctions proteins, uterotonin receptors, PTGS2 and elements of calcium 
signalling, and/or the upregualtion of pro-quiescence pathways (Norwitz et al., 1999, 
Bernal, 2001, Lopez Bernal, 2003, Smith et al., 2007, Smith, 2007, Kamel, 2010). 
In the human myometrium, the resting membrane potential has been shown to 
increase as term approaches (Parkington et al., 1999). The reasons for this change 
are not entirely known, but a decrease in specific potassium (K+) channel populations 
is likely to play a key role (Khan et al., 2001). The switch to a more positive potential 
renders the cell closer to the threshold for an action potential, which will be elicited by 
spontaneous and/or agonist-meditated myometrial depolarisation.  Membrane 
depolarisation leads to the opening of voltage dependent L-type calcium channels and 
to a lesser extent, calcium release from intracellular stores. The subsequent rise in 
intracellular calcium mediates formation of calcium-calmodulin complexes and leads to 
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activation of myosin light chain kinase and phosphorylation of the myosin light chain 
allowing cross-bridge cycling and hence contraction (Tribe et al., 2000, Tribe, 2001).  
The uterotonins that lead to contraction are primarily prostaglandins and oxytocin.  In 
humans, augmented expression of IP3-coupled prostaglandin receptors (Slater et al., 
2006, Astle et al., 2007) is seen along with an increase in oxytocin receptor (OXTR) 
numbers. The increase in OXTR expression is also likely to be activated by a rise in 
circulating and local tissue production of oxytocin. Furthermore, the action potentials 
are more effectively propagated throughout the myometrial syncytium close to term, 
via enhanced intercellular connections. This is demonstrated by an increase in 
expression of connexin-43 (Cx43, a component of gap junctions). Expression at term 
of both OXTR and Cx43 are believed to be augmented by uterine stretch (Ou et al., 
1997, Ou et al., 1998). 
Some of these changes, including downregulation of specific potassium channels 
(Knock et al., 2001, Khan et al., 2001) and the expression and formation of gap 
junctions (Di et al., 2001) are considered to be mediated by the rising concentrations of 
circulating oestrogen. Unlike other species where a decrease in progesterone 
precedes labour, levels of circulating progesterone remain elevated in humans, but 
recent research suggests that a switch in the myometrial progesterone receptor A/B 
isoform ratio leads to ‗functional‘ progesterone withdrawal, which may be a trigger in 
the switch from uterine quiescence to active contractions (Mesiano et al., 2002, Tan et 
al., 2012, Mesiano et al., 2011). In addition, suppression of PRB is paralleled with 
increased NF-B activation.  NF-B activity in myometrium is not only important to 
antagonizes the relaxatory effects of progesterone, but is also considered to 
upregulate expression of contraction-associated proteins such as PTGS2, and other 
pro-inflammatory mediators, including TNF, and IL-1 that are associated with the 
onset of labour (Khanjani et al., 2011, Cookson and Chapman, 2010).  An up-
regulation of all these cellular systems prior to labour onset ensures that the uterus is 
primed to respond to uterotonins and contract forcefully at the time of parturition.   
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Uterine Activation via contraction-associated proteins 
The myometrial switch from a quiescent state during pregnancy to a muscle that is 
spontaneously active and sensitive to endogenous uterotonins during labour is termed 
―uterine activation‖.  One of the primary theories for this myometrial activation 
proposes that it is a result of coordinated up-regulation of genes for CAPs, which may 
be regulated by a common mechanism (Cook et al., 2000, Tribe, 2001).  CAPs include 
OXTR, PTGS2, Cx43 prostaglandin F2 (PGF2) receptor and heat shock proteins 70 
and 90.  The evidence for a role for CAPs in parturition originates from both human 
and animal studies reporting that significant increases in CAPs are associated with 
labour at term.  In both humans and rodents, a significant increase in myometrial 
PGF2 receptor mRNA expression is associated with labour at term and myometrial 
OXTR density increases significantly before parturition in every model in which it has 
been studied, including the human.  Expression of OXTR and Cx43 has also been 
shown to increase with labour onset, possibly as a result of steroid hormone changes 
and uterine stretch (Garfield et al., 1977, Ou et al., 1997, Brodt-Eppley and Myatt, 
1998, Brodt-Eppley and Myatt, 1999, Cook et al., 2000).  Once activated, the 
myometrium is able to respond to stimulants such as oxytocin and prostaglandins.  
Prostaglandins have both direct and indirect effects on myometrial contractility; they 
stimulate myometrial contractions, further increase uterine sensitivity to uterotonic 








Uterine Myocyte Excitability 
The development of powerful myometrial contractions requires increased excitability of 
the myocytes, and increased connectivity between them.  The excitability of the 
myometrium is governed by the myocyte resting membrane potential which is 
determined by opposing inward (Na+, Ca2+) and outward (K+, Cl-) ionic fluxes (Tribe, 
2001).  Before the initiation of labour, the myocyte maintains a relatively high interior 
electronegativity, which lowers the likelihood of depolarisation and contraction.  The 
resting membrane potential is created by the ATPase-driven sodium-potassium pump, 
which transports out three sodium ions for every two potassium ions that enter the cell 
(Smith, 2007).  Open potassium channels permit potassium ions to leave the cell along 
the concentration gradient, further increasing the intracellular electronegativity.  The 
myocytes of the uterus are maintained in a relaxed state by a variety of factors that 
increase intracellular cyclic AMP (cAMP).  The increase in cAMP activates protein 
kinase A, which promotes phosphodiesterase activity and dephosphorylation of myosin 
light-chain kinase, required to drive uterine contractions (Sanborn, 2000, Smith, 2007). 
The resting membrane potential gradually becomes more depolarised as term 
approaches.  At onset of labour, depolarisation occurs when PGF2 and oxytocin bind 
to cell-surface receptors, thus promoting the opening of ligand-regulated calcium 
channels.  Activation of these receptors also triggers the release of calcium ions from 
sarcoplasmic reticulum stores.  As the calcium begins to enter the cell, the drop in 
electronegativity stimulates the opening of large numbers of voltage-regulated calcium 
channels, resulting in a rapid movement of calcium ions into the cell and, 





In a detailed study by Parkington et al. (1999), the resting membrane potential was 
shown to increase from around –70 mV at 29 weeks to –55 mV at term and during 
labour.  These changes were associated with an increased frequency of contractions 
in vitro (Parkington et al., 1999, Tribe, 2001, Smith, 2007). This emphasises the 
importance of increased excitability of the myocytes for successful myometrial 
contractions. 
 
The expression of the gap junction protein connexin-43 in the myometrium is 
necessary for parturition  
The development of myocyte synchrony is a critical aspect of myometrial activity at 
labour.  As parturition advances, there is increasing synchronisation of the electrical 
activity of the uterus (Eswaran et al., 2004, Smith, 2007).  At the cellular level, this 
synchrony is achieved by electrical conduction through connecting myofibrils, which 
transmit the electrical activity to nearby muscle fibres.  The activated myocytes 
produce prostaglandins, which act in a paracrine manner to depolarise neighbouring 
myocytes.  This process leads to a wave of activity as multiple myocytes are recruited 
into the contraction (Smith, 2007).  
The connectivity of myocytes that allow them to function together is promoted by gap 
junction connections between adjacent myocytes created by multimers of Cx43. There 
is an increased synthesis of the Cx43 protein that forms gap junctions at term 
parturition (Doring et al., 2006).  Gap junctions are considered to allow the flow of 
current, calcium ions and small molecules (<1000 D molecular weight) between 
adjacent myocytes (Smith et al., 2007, Smith, 2007). The importance of Cx43 to 
synchronise myometrial cells and generate successful uterine contractility for 
parturition has been demonstrated by a study of genetically altered mice, where Cx43 
deficient mice exhibited delayed parturition (Doring et al., 2006, Ratajczak and Muglia, 
2008). 
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Contraction of the Myometrium 
Myometrial contractions in all species arise from spontaneous action potentials due to 
an unstable membrane potential of the myocytes, which is likely to reflect differing ion 
channel expressions or biophysical profiles.  Spontaneous action potentials permit the 
entry of calcium ions from the extracellular space, which are essential for contractile 
activation (Mitchell and Taggart, 2009).  Actin filaments in association with myosin are 
essential for muscle contraction. Serine 19 on the regulatory light chains of myosin 
must be phosphorylated in order to achieve a significant interaction between myosin 
and actin (Wray et al., 2001, Wray, 2007).  Myosin light chain kinase (MLCK), a 
serine/threonine protein kinase, enables this phosphorylation. Myocyte action 
potentials cause a rise in intracellular calcium ions, these bind to calmodulin which 
subsequently activates MLCK.  Activated MLCK promotes the phosphorylation of the 
regulatory 20-kDa myosin light chains (MLC20), which then initiates actin–myosin 
ATPase on the myosin heavy chains.  The ATPase yields energy to drive the sliding of 
myosin over the actin filaments (cross-bridge cycling) creating the movement that 
establishes myometrial contraction (Moore and Bernal, 2001, Wray, 2007).   
There are two key sources for the increase in intracellular calcium ions: entry across 
the surface membrane through voltage-gated L-type Ca2+ channels and/or release 
from the sarcoplasmic reticulum (SR).  The primary source of calcium ions for 
contraction in the myometrium are from the action potential-mediated depolarisation 
and consequent opening of L-type Ca2+ channels (Matthew et al., 2004).  If L-type 
channels are blocked or MLCK is inhibited, contractions are obliterated, underlining the 
importance of the Ca2+–calmodulin–MLCK pathway for uterine contractility (Wray, 
2007).  There is considered to be minimal contribution of calcium ions released from 
uterine SR calcium stores consequent to G protein-mediated phospholipase C (PLC) 
hydrolysis of membrane phosphatidylinositol 4,5- bisphosphate (PIP2), inositol 1,4,5-
trisphosphate (IP3) generation and binding to IP3 receptors to release stored calcium 
ions into the cytoplasm (Wray, 2007).   
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However, there are mixed opinions regarding the contribution of the calcium ions 
released from these stores to the activation of myometrial contraction (Taggart and 
Wray, 1998, Tribe et al., 2000, Noble et al., 2009).  Muscle relaxation occurs when the 
action potential ceases, intracellular calcium concentrations fall back to basal levels, 
and the myosin light chain is dephosphorylated by myosin light chain phosphatase 
(MLCP) (Sanborn et al., 2005).   
 
1.7 Current Understanding of Maternal Age in Relation to Parturition 
 
1.7.1 Timing of birth 
Overall, this topic has been poorly researched. There has been very little detailed 
research into the impact of maternal age and delayed parturition; although clinical 
studies suggest they are risk factors for induction (an indication of failure to go into 
labour) and post-date pregnancies as mentioned in section 1.2. Assessment of the 
fetal HPA and hormonal cascades during human pregnancy would be technically 
challenging as it is difficult to investigate pregnancy experimentally in humans.  As a 
first step, the influence of maternal age on pregnancy duration and maternal and fetal 
hormonal profiles could be investigated in pregnant animals.  
To my knowledge, the only work to have been published investigating reproductive 
ageing in female C57BL/6J mice was carried out by Holinka et al., between 1977- 
1979 (Holinka and Finch, 1977, Holinka et al., 1978, Holinka et al., 1979).  They 
reported that gestation was extended during ageing in previously parous C57BL/6J 
mice from 18.6 days at 3-7 months (age at which authors defined as reproductively 
fertile) to 20.8 days at 11-12 months (age at which authors defined as reproductively 
aged) (Holinka et al., 1978). They also found that plasma progesterone, measured by 
radioimmunoassay, decreased sharply after day 16 of gestation in 3-7 month old mice, 
whereas the rate of decrease in 11-12 month old mice was 55% less than in the 
younger group.  In 3-7 months old mice, pre-parturitional progesterone levels were 
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inversely correlated (p<0.05) with the number of viable pups on day 18, whereas such 
a correlation (p<0.05) persisted from days 19-22 in the older mice. In 11-12 month old 
mice, gestation length was inversely correlated with litter size; no significant correlation 
was found in the younger group. They concluded that a decline of progesterone is 
generally considered necessary for parturition in rodents; therefore the retarded 
decrease of progesterone in 11-12-month-old mice is likely to be a major factor in their 
prolonged gestation (Holinka et al., 1978). Holinka et al., also found average litter size 
decreased with age in previously parous mice from 7.8 pups in 3-7 month old mothers 
to 4.6 pups in 11-12 month old mothers; as well as mortality at birth being increased 
with gestation length in 11-12 month old mice (Holinka et al., 1978). 
Holinka et al. (1979) went on to examine the relationships between plasma 
progesterone and the number of viable embryos and resorptions in aged C57BL/6J 
mice to elucidate the possible mechanisms contributing to the loss of fertility during 
ageing.  In mice aged 3-7 months and 11-12 months, the older mice had 12% fewer 
implantation sites on days 6-10, p<0.001. Major losses of viable embryos occurred 
after day 13 in older mice, primarily because the average resorption frequency doubled 
(p<0.001). In 6% of the older mice, all conceptuses underwent resorption, which was 
rarely found in younger mice.  They also reported that total uterine weight was less 
throughout pregnancy in the older mice.  However, when uterine weight was 
normalized to viable fetuses, there were no differences between the age groups from 
day 10 to term. The increase in plasma progesterone values between days 1-6 were 
less in older mice with a significant deficit of 40% on day 4, p<0.05.  However, no 
correlation was found between plasma progesterone and the number of viable fetuses 
or resorption sites during days 11-15 (Holinka et al., 1979). 
These studies by Holinka and colleagues give some background to the impact of 
maternal age on the timing and success of parturition in previously parous mice at their 
very extreme limit of reproductive viability; however, it still remains unclear how 
maternal age impacts on nulliparous mice at initial stages of reproductive ageing.  
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1.7.2 Cervical ripening  
Similarly, there is limited data relating to the disruption of cervical ripening as a 
consequence of advanced maternal age, particularly in rodents under controlled 
experimental conditions. A retrospective, cohort study carried out by Malamed et al. 
(2010) compared all women admitted for pre-induction cervical ripening and failed to 
respond to PGE2 with a randomly selected control group of women who underwent 
successful pre-induction cervical ripening with PGE2.  They looked at 122 women in 
the study group and 366 in the control group.  A comparison between the two groups 
revealed that maternal age above 30 years (OR = 2.7, 95% CI: 1.3 to 5.6) was an 
independent and significant predictor of cervical ripening failure with PGE2 (Melamed 
et al., 2010).  This study suggests that there may be an abnormal regulation in the 
timing of the cervical ripening, or may result from unique molecular mechanisms in 
advanced maternal age mothers, which means that they were unable to ripen even 
with PGE2 administration.  Similar findings are highlighted by a study which aimed to 
determine risk factors for failure of labour to progress.  Sheiner et al. (2002), published 
that maternal age greater than 35 years was one of the independent risk factors for 
failure of labour to progress during the first stage (OR = 3.0, 95% CI: 2.6 to 3.6), 
indicating that mothers of advanced maternal age experience a greater risk of failed 









1.7.3 Myometrial contractility 
Advanced maternal age women have significantly more complications of pregnancy 
and parturition and have an increased risk of Caesarean section as previously 
discussed in section 1.2; however, the reason behind this remains unclear.  The 
association of the increased incidence of clinical complications observed as maternal 
age increases is paralleled by evidence that ageing adversely effects uterine function.  
At present, there are no animal data published investigating the effect of ageing on 
myometrial activity, but to my knowledge, there are two human studies.  Smith et al. 
(2008) have shown that there is a linear relationship between the age of the mother 
and the risk of Caesarean delivery, operative vaginal birth and long duration of labour.  
Older age in first pregnancy was associated with both an increased risk of Caesarean 
section and increased duration of labour. Moreover, the need for operative vaginal 
deliveries was also higher in women of advanced age and these findings were shown 
not to be explained by comorbidities such as obesity or gestational diabetes.  In this 
study, they measured the function of human myometrium in relation to age by using a 
standard organ bath system.  Spontaneous contractile activity was quantified and also 
assessed for coupling as can be seen in Figure 1.10. Coupling was defined as the 
presence of two or more distinct peaks before the return to baseline, which is generally 
associated with dysfunctional labour in vivo (Smith et al., 2008). They found that 
spontaneous contraction of isolated myometrium strips declined with advancing 
maternal age, and that there was a 93% increase in the chance of developing coupling 
with a five year increase in age. Both clinical and scientific data would indicate a 
decline in myometrium function with advancing maternal age (Smith et al., 2008).  
However, the data for spontaneous contractile activity in this study is presenting only 
as the ratio of the mean integral tension during spontaneous contractile activity and the 
mean integral tension under in the presence of 50 mM potassium, making the data 
difficult to compare to other uterine contraction studies where more information such 
as force and frequency of spontaneous contractions, as well as the mean integral 









Figure 1.10 Ex vivo human myometrial contractility in relation to maternal age 
A: Mean spontaneous contractile activity (quantified as contraction units) of isolated strips of 
myometrium obtained from women (n=62) at the time of planned Caesarean section in relation 
to the age of the donor. B: The proportion of spontaneous contractions that were multiphasic in 
relation to maternal age (n=62, 181 samples).  Figure from: The effect of delaying childbirth on 










It has been proposed that the myometrium is less effective or less responsive to 
uterotonic agents such as oxytocin or prostaglandins with increasing maternal age 
(Greenberg et al., 2007). This theory is supported by Main et al. (2000), who indicated 
an increasing need for oxytocin-augmentation in women of older age and suggested 
that this effect of ageing was a gradual and continuous process (Main et al., 2000).  In 
a recent study published by Arrowsmith et al. (2012), they examined myometrial 
contractility in over 100 women, aged 25–72 (both pregnant and non-pregnant).  
Myometrial function in relation to age was measured using a standard organ bath 
system; myometrial tissues were examined within 12 hours of biopsy excision, and 
allowed to equilibrate for two hours to generate stable spontaneous contractions.  
Spontaneous contractile activity was quantified in the presence and absence of 
oxytocin, to provide evidence to support the theory described by Main et al. (2000) and 
Greenberg et al. (2007). Arrowsmith et al. (2012) reported a significant decrease in 
spontaneous contractility seen with increase in age; however this is reported only for 
myometrium in non-pregnant state.   
In pregnant myometrium, they found a wide range of contractile ability between 
pregnant women and little evidence for decreased spontaneous activity between the 
ages of 25–40, as shown in Figure 1.11.  It is important to note here that the age range 
included for the non-pregnant myometrial samples is much wider (25–72 years) than 
for the pregnant myometrial samples, so a direct comparison cannot be drawn 
between the two cohorts.  Authors also report a decline in responses to oxytocin (10 
nM; expressed as a percentage increase in integral of force compared to control) with 
increasing maternal age (Arrowsmith et al., 2012).  However, statistical analyses 
provided do not support this statement. 
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Figure 1.11 Myometrial contractility in relation to maternal age 
A: Representative traces of isometric recordings of spontaneously contracting myometrial strips 
obtained from a (i) 32-year old, (ii) 48-year old and (iii) 62-year old woman undergoing 
hysterectomy. B: Plots of spontaneous contractile activity [quantified as area under the 
contraction curve, (AUC, in arbitary units, au)] of strips of pregnant and/or non-pregnant 
myometrium obtained from women undergoing planned Caesarean section delivery or 
hysterectomy respectively, against age.  Spearman‘s rank test found a significant negative 
correlation between integral of force and age (i; combined data, r = -0.379, p< 0.01, n = 104). 
(ii, iii) Plots of non-pregnant and preg-nant women separately. A significant negative correlation 
between integral of force and age was found for non-pregnant women alone (ii; r = -0.529, p = 
0.008, n = 24). In contrast, no significant correlation was found for pregnant women (iii; n = 80). 
Pregnant women are denoted by blue circles, non-pregnant women are denoted by red 
squares. Figure from: What do we know about what happens to myometrial function as women 




1.8 Study Hypotheses and Objectives 
 
In summary, review of the literature indicates there is a need to investigate the reasons 
why older women aged 35 years and above, exhibit a higher incidence of 
complications in pregnancy and labour.  Experimental evidence is sparse and there is 
no clear understanding of how physiological processes are impaired as women age.  A 
more detailed understanding of the mechanistic impacts of ageing on labour could 
ultimately influence the clinical management of these women. 
The overarching goal of this study was to determine whether advanced maternal age 
has a detrimental impact on uterine and/or cervical function at the end of gestation.  
There are several hypotheses to be explored due to the complexity of the hormonal 
processes of the timing of parturition that trigger the initiation of cervical ripening and 
myometrial activation. It is technically and ethically difficult to fully explore these 
mechanisms in pregnant women, and as a result a mouse model of maternal ageing in 
pregnancy was used in an attempt to dissect out the contribution of each factor on 
parturition independently and in combination.   
Hypotheses 
1. The timing/initiation of labour will be disrupted and prolonged in older mothers, 
as a consequence of delayed parturition signals. 
2. The physiological preparation and consequent ripening of the cervix will be 
delayed in older mothers, contributing to the possible delay in parturition. 
3. The physiological activation of myometrium at term will be delayed in older 
mothers, contributing to the possible delay in parturition. 
4. The ability of the myometrium to contract at term will deteriorate in older 
mothers as a result of a reduction in the number of functional myometrial 
mitochondria, resulting in reduced ATP generation and energy availability for 




1. To validate the methodology used within this thesis. 
2. To demonstrate that advanced maternal age in mice impacts on gestation 
length and parturition duration. 
3. To assess the impact of maternal age on gene/protein expression in 
myometrium and cervix from non-pregnant and pregnant mice.  
4. To determine whether age induced alterations in the gene/protein expression in 
the myometrium/cervix or mitochondrial function translate into disruptions in 
spontaneous and agonist-induced myometrial contractility and cervical tensile 
strength (a measure of cervical softening) in vitro. 
5. To determine mitochondrial copy number and function in myometrium from 








Chapter 2 :  Materials and Methods 
2.1 Animals 
2.1.1 Mouse model of advanced maternal age 
The ―Breeding Strategies for Maintaining Colonies of Laboratory Mice‖ manual 
compiled by the Jackson Laboratory (USA), states that female laboratory mice typically 
become sexually mature between five and eight weeks of age.  When referring to 
reproductive life span, this manual states that a female laboratory mouse can breed up 
to approximately seven to eight months post sexual maturity (Lambert, 2009).  Nelson 
and colleagues (1982, 1984) published some fundamental work on the oestrous cycle 
in ageing C57BL/6J mice.  They confirmed that cycle frequency was initially low 
(Phase I) in mice under the age of three months, due to prolonged cycle durations and 
late-starting cycles.  Phase II, when mice were three to five months old, was when 
cycle frequency peaked; this typically lasted between seven to ten months.  
Thereafter cycle frequency declined steadily, known as Phase III.  They found that the 
average age of cessation of cycling was varied, but usually occurred between eleven 
and sixteen months of age.  During the peak cycling period in phase II, the average 
cycle lengths were four days, but these became progressively longer by nine months 
of age.  (Nelson et al., 1982, Felicio et al., 1984).  This evidence suggest that peak 
reproductive ability begins to decline after nine months of age and can completely 
cease as early as eleven months of age in C57BL/6J mice.   
Considering the work by Nelson and colleagues, and in collaboration with Charles 
River (Charles River Laboratories, UK), it was decided that virgin C57BL/6J mice at 
eight months of age would suitably model nulliparous advanced maternal age 
(definition of advanced maternal age in women indicates pregnancy at any age above 
thirty five years (Bewley et al., 2009)).  In this strain of mouse, it was evident that 
pregnancy success was already lowered at this age, since a total number of fifty 
females would need to be mated in order to achieve ten estimated pregnancies in the 
mice.  This is a considerably lower pregnancy success rate than that seen with 
younger C57BL/6J females.   A control group, at three months of age was used to 
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model when cycle frequency firsts peaks (Nelson et al., 1982, Felicio et al., 1984) 
assuming this to be a period when reproduction ability would be at a maximum.  
Finally, to determine the degree to reproductive decline seen with age in this particular 
strain, a mid-group at five months of age was also used for some experimental 
techniques (stated within individual results chapters where applicable).  The age three, 
five and eight months are indicative of the age when mice were mated rather than age 
at the end of gestation.  All mice were maintained under controlled conditions (25°C, 
12-hour light/dark cycle), and fed a standard chow diet.  Females (all ages) were 
mated with C57BL/6J males approximately three to four months of age (Charles River 
Laboratories, UK). Conception was determined by the presence of a vaginal plug (day 
0 of gestation).  All animals were treated in accordance with The Animals (Scientific 
Procedures) Act 1986 guidelines.  
 
2.1.2 Age matched non- pregnant controls 
Where appropriate, experimental techniques were repeated with age matched (three, 
five and eight month old) non-pregnant female mice.  To control for changes to uterine 
smooth muscle during the mouse oestrous cycle, all tissue was collected when mice 









Determination of non-pregnant mouse oestrous cycle: 
All C57BL/6J mice were sourced from Charles River, and allowed to acclimatise to 
their new environment for one week after which daily vaginal smearing commenced.  
Vaginal smearing was carried out at the same time every day (between the hours of 
10.00-11.30AM).  Each mouse was held securely using the scruffing technique, while 
the vagina was flushed with H2O using a thin-ended Pasteur pipette (SLS, UK).  The 
flushed fluid droplet was expelled onto a microscope slide and examined under a light 
microscope (Olympus, UK), so that the cells could be characterised.  The oestrous 
stage was confirmed by the presence of large cornified epithelial cells with very few or 
no visible nuclei; an example is shown in Figure 2.1.   
 
  
Figure 2.1 Unstained vaginal secretion from mouse (oestrus stage), with anucleated 
cornified epithelial cells 






2.1.3 Mouse serum and tissue collection 
On day 18 of gestation, time mated pregnant mice were killed by cervical dislocation, 
in accordance with Schedule 1 of UK Home Office guidelines.  Immediately after mice 
were confirmed dead, approximately 500 l of blood was collected into a 2 ml round 
bottomed microcentrifuge tube (Eppendorf, Germany) from each mouse by cardiac 
puncture.  Each microcentrifuge tube was incubated in an upright position at room 
temperature for 30 minutes to allow clotting, after which it was spun in a centrifuge for 
10 minutes at 13000 x g to separate serum. The supernatant (serum) was carefully 
aspirated at room temperature, aliquote into a cryogenic vial (Sigma-Aldrich, UK) and 
stored at −80°C until required for serum progesterone measurements. 
Once blood had been collected, uterine horns, cervices and bladders were carefully 
dissected from each mousse.  Placenta and fetuses were removed from uterine tissue, 
and fetuses were immersed in ice-cold PBS.  After dissection, uterine, cervical and 
bladder tissues were either immediately snap frozen in liquid nitrogen for 
deoxyribonucleic acid (DNA) extraction and protein isolation, placed into RNAlater 
(Ambion, Warrington, UK) according to manufacturer‘s recommendations for 
ribonucleic acid (RNA) extraction and then stored at −80°C (RNAlater is an aqueous, 
non-toxic tissue storage reagent that rapidly permeates tissue inactivating RNAase 
activity to prevent breakdown of RNA, its composition and formulation is proprietary 
information), or placed straight into ice-cold, phosphate-buffered saline (PBS; Sigma-
Aldrich, UK) for isometric tension recording.  Cervical biopsies taken for histological 
analysis were fixed by overnight immersion in 10% (v/v) formal saline solution 
(Formaldehyde solution 10% v/v in 0.9% NaCl solution; Fisher Scientific, UK), after 
which they were embedded in paraffin (see section 2.8.1 for further details).  Non-
pregnant mice were confirmed to be at oestrous stage of their cycle, after which 
uterine and cervical tissue were collected in the same way as described above for 
pregnant mice.  
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For all planned experiments, tissue were collected from aged late pregnant and non-
pregnant mice (eight month old, n = 6-10), compared to young late pregnant and non-
pregnant mice (three month old, n = 6-10), and where applicable mid-age late pregnant 
and non-pregnant mice (five month old, n = 6-10). 
 
2.2 RNA and DNA Extraction  
 
2.2.1 RNA extraction from mouse uterine and bladder tissue 
Total RNA was extracted from uterine and bladder tissues (bladder tissues for 
microarray studies-section 2.4) using the RNeasy Kit from Qiagen (Qiagen, UK).  The 
use of guanidinium isothiocyanate in RNA extraction was first mentioned by Ullrich et 
al. in 1977 (Ullrich et al., 1977). This method was laborious, so it was modified to a 
single step technique, known as guanidinium thiocyanate-phenol-chloroform extraction 
as described by Chomczynski and Sacchi in 1987 (Chomczynski and Sacchi, 1987).  
These conventional methods have since been modified further, to use solid-phase 
nucleic acid purification.  Most commercial extraction kits such as the RNeasy kit use 
solid-phase nucleic acid purification (Tan and Yiap, 2009).  This technique allows 
rapid, efficient RNA isolation compared to conventional methods, and also prevents 
problems that are associated with liquid-liquid extraction such as incomplete phase 
separation (Esser et al., 2005).  
Solid-phase purification is normally performed by using a spin column, operated under 
centrifugal force, and use either silica matrices, glass particles, diatomaceous earth, or 
anion-exchange carriers as the solid support.  Four key steps involved in solid-phase 
extraction are cell lysis, nucleic acids adsorption, washing, and elution (Tan and Yiap, 
2009).  With the silica matrix RNeasy kit, samples are first lysed and homogenized in 
the presence of a highly denaturing guanidine-thiocyanate–containing buffer in the 
presence of beta-mercaptoethanol, which separates rRNA from ribosomal proteins and 
immediately inactivates RNases by reducing disulphide bonds and destroying the 
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native conformation required for enzyme functionality; this ensures purification of intact 
RNA.  Ethanol is then added to the lysate to create conditions that promote selective 
binding of RNA to the RNeasy membrane, since such solid phase systems will absorb 
nucleic acid in the extraction process dependent on the high salt content and pH of the 
binding buffer.  The sample is then applied to the RNeasy Mini spin column.  Total 
RNA binds to the membrane, and contaminant biomolecules such as carbohydrates, 
proteins, and fatty acids are efficiently washed away in the presence of a stringent 
washing buffer containing a guanidine salt and ethanol.  Finally, a mild washing buffer 
(composition of which is proprietary) removes traces of salts which are still on the 
column due to buffers used earlier in the protocol, allowing elution of high-quality RNA 
in RNase-free water.  The absorption process is based on the following principle: 
hydrogen-binding interaction with a hydrophilic matrix under chaotropic conditions; 
other solid-phase purification techniques rely on ionic exchange under aqueous 
conditions by means of an anion exchanger and affinity and size exclusion 
mechanisms (Tan and Yiap, 2009). 
Once extracted, the integrity of the RNA is determined by two methods.  The first is 
calculated by spectrophotometric absorbance at 260 nm.  This reflects nucleic acid 
concentration so that one unit of optical density reflects 40 µg RNA/ml sample 
analysed (Wilson and Walker, 2010).  In addition to this, the 260/280 nm ratio is also 
calculated; this value indicates any contamination from DNA/protein that may be 
present.  A typical value for good quality RNA is usually ≥1.8 (Wilson and Walker, 
2010, Wilkinson, 2000), considering a ratio of ~2 is generally accepted as ―pure‖ RNA 
(Manchester, 1996).  This method remains the most economical and commercial 
method of RNA quality analysis.  However, it is important to note that the accuracy of 
the 260/280 nm absorbance method has been questioned, as a value of 1.8 could 
correspond to only 40 % RNA, with the remainder accounted for by protein (Bustin and 
Nolan, 2004). 
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The second technique uses gel electrophoresis to determine the integrity of ribosomal 
RNA (18S and 28S) (Fleige and Pfaffl, 2006).  It measures ribosomal RNA bands on a 
partial denaturing agarose gel.  The RNA is heated prior to loading as this disrupts the 
secondary structures, allowing RNA migration (Wilson and Walker, 2010).  Migration of 
RNA along an agarose gel in an electric field is a result of the negative charge on 
competent nucleic acids from their negatively charged phosphate groups (Wilkinson, 
2000).  The magnitude of the overall negative charge of each RNA is proportional to its 
size.  The RNA is separated on the gel moving towards the anode at a rate inversely 
proportional to its size.  A solution of RNA of known molecular masses is included on 
each occasion in order to allow the molecular weights of RNA subsequently detected 
to be determined by comparison.  Once the RNA has been separated, they can be 
visualised using UV light as long as the gel has been prior stained with SYBR Safe 
stain (Invitrogen, UK), which attaches onto the RNA and is excited by the light. 
RNA is unstable due to the ubiquitous presence of RNases which are enzymes 
present in blood, all tissues, as well as most bacteria and fungi in the environment; 
therefore, RNA extraction relies on good laboratory technique and RNase-free 
technique (Tan and Yiap, 2009).  In order to minimise the risks of contamination and 
degradation of RNA, the environment and reagents had to be ribonuclease-free; all 
solutions and equipment were autoclaved.  Several measures were taken to achieve 
and maintain this including the use of Milli-Q treated water, treatment of tips and 
eppendorff tubes while wearing gloves and the use of the laminar flow cabinet to set 
up reactions.  Moreover, all samples are maintained on ice throughout and aliquots of 
RNA containing solutions are prepared at the time of extraction to minimise the 
requirement of repeated freezing and thawing, which is known to lead to RNA 
degradation (Wilson and Walker, 2010). 
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2.2.2 RNA extraction protocol 
Total RNA was extracted from ~ 30 mg of tissue, which was added to 600 l of 
guanidine-thiocyanate–containing RLT lysis buffer (RNeasy mini kit, Qiagen, UK) in a 2 
ml RNAse-free round bottomed microcentrifuge tube (Eppendorf, Germany).  The 
sample was then homogenised using a TissueLyser (Qiagen, UK; 2 minutes at 25 Hz 
using two 5 mm steal beads) until the tissue had been visibly broken down.  RNA was 
extracted from the lysate using the RNeasy mini kit (Qiagen, UK) as per 
manufacturer‘s recommendations.  Since RNA is susceptible to degradation by 
enzyme-induced hydrolysis, gloves were worn. Both gloves and work spaces were 
sprayed with TriGene disinfectant (Medichem International, UK).  At the end of RNeasy 
protocol, the extracted RNA was eluted in 30 l of RNase/DNase free water (Qiagen, 
UK).   
The RNA concentrations from these extractions were determined by 
spectrophotometric analysis (Wilson and Walker, 2010).  Aliquots of each sample (1.5 
µl) were used and spectrophotometric absorbance measured using a NanoDrop® 
spectrophotometer (NanoDrop® ND-1000 Spectrophotometer, Nanodrop 
Technologies, Labtech, UK).  The absorbance at 260 nm relative to Milli-Q water alone 
was measured.  In addition, the absorbance of each sample at 280 nm was measured.  
This allowed the calculation of the ratio of optical density of the samples at 260:280 
nm.  Spectrophotometric absorbencies at 260 nm reflect nucleic acids, whereas that at 
280 nm reflects protein contaminants.  A ratio ≥ 1.8 is regarded as satisfactory (Wilson 
and Walker, 2010).  RNA concentrations are automatically calculated using the 
absorbance at 260 nm using the software (Nano D2000) with the spectrophotometer, 





RNA concentration of the stock extraction (µg/µl) = 
   (Optical density at 260 nm x 40 µg/ml) x (mls of sample) 
     Original stock volume added (µl) 
 
Once quantified, each RNA sample was stored at - 80°C until required. 
 
2.2.3 Agarose gel electrophoresis of RNA 
A 2% agarose gel was made and used to run the RNA samples, as a test of integrity.   
High resolution agarose (2 g; Sigma-Aldrich, UK) was dissolved in 100 ml 0.5 × tris-
borate EDTA/H2O (TBE) (diluted from 10 x TBE stock; Sigma-Aldrich, UK) by melting 
at 80- 100oC for about two minutes until the agarose was fully dissolved.  SYBR safe 
DNA gel stain (10 µl; Invitrogen, UK) was added to the 100 ml of melted agarose and 
then quickly poured into a level horizontal gel tank containing an appropriate size comb 
inserted, allowing wells to form.  After around 45 minutes, once the gel had set, the 
comb was removed and the gel covered with 1 x TBE. Prior to loading, 1-3 µg of the 
RNA samples were mixed together with 8 µl of RNA loading dye (2 x RNA loading dye 
supplied with RNA ladder, Fermentas, UK) and heated at 65oC for 10 minutes to 
disrupt the secondary structures.  These samples were then loaded alongside a RNA 
marker (RiboRuler High Range RNA Ladder Ready-to-Use, 200 to 6000 bases, 
Fermentas, UK) to be used as a size comparison.  Electrophoresis was then 
performed at a constant 100 V for approximately 2 hours.  RNA was then visualised 
using the Gel Logic 2200 Pro Imaging System and Carestream Molecular Imaging 
software (Carestream Health, USA).  The size and quality of RNA (28S and 18S) was 
then estimated by comparison to the RNA ladder.  
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2.2.4 cDNA Synthesis  
Extracted RNA, 1 μg  was added to a tube containing 1 μl (250 ng) random primers 
(Promega, UK), 1 μl 10 mM dNTP mix (Promega, UK) and RNase/DNase free water 
(Qiagen, UK) was added to give a final volume of 13 μl. Contents were briefly 
centrifuged (30 seconds at 13000 x g) after which the mixture was heated to 65oC for 
five minutes before standing for one minute on ice.  Contents were briefly centrifuged 
(30 seconds at 13000 x g) again and then 4 μl of First-strand buffer (Invitrogen, UK), 1 
μl of 0.1M DTT (Invitrogen, UK), 1 μl (20 international units) of RNAsin, an RNase 
inhibitor (Promega, UK) and 200 international units SuperScript III (Invitrogen, UK) 
were added.  
The contents of the tube were mixed by gentle pipetting after which, the tube was 
incubated for 5 minutes at 25oC to enhance binding of the random hexamers to the 
template RNA, then heated to 50oC for 60 minutes  to allow cDNA synthesis and finally 
to 70oC for 15 minutes to inactivate the reaction. RNase/DNase free water was added 
to give a final volume of 80μl.  cDNA concentration (ng/l) for each sample was 
quantified using the NanoDrop ND-1000 spectrophotometer (Nanodrop Technologies, 
Labtech, UK), and then each sample was diluted to 100 ng/l using RNase/DNase free 
water (Qiagen, UK) if necessary.  All cDNA samples were stored at -80oC until required 







2.2.5 DNA extraction from mouse uterine tissue 
Total genomic DNA was extracted from uterine tissues using the ReliaPrep gDNA 
Purification kit (Promega, UK).  The very first DNA isolation was performed by a Swiss 
physician, Friedrich Miescher in 1869 (Dahm, 2005).  Since then, numerous methods 
have been developed; currently, they are divided into solution-based or column-based 
protocols.  Most of these protocols have been developed into commercial kits that 
ease the DNA extraction process (Tan and Yiap, 2009).  The ReliaPrep gDNA 
Purification kit used for this thesis employs a column-based protocol, following a four-
step method: 
1. Effectively disrupting or homogenizing the starting material to release the DNA. 
2. Binding the DNA to the ReliaPrep™ Binding Column. 
3. Removing impurities with wash solution. 
4. Eluting the purified DNA. 
No ethanol is used in the purification protocol, eliminating downstream problems 
caused by ethanol carryover. 
The principle of such silica/cellulose column based purification is based on the high 
affinity of the negatively charged DNA backbone towards the positively charged silica 
particles (Esser et al., 2006). Sodium plays a role as a cation bridge that attracts the 
negatively charged oxygen in the phosphate backbone of nucleic acid. Sodium cations 
break the hydrogen bonds between the hydrogen in water and the negatively charged 
oxygen ions in silica under high salt conditions (pH ≤ 7) (Tan and Yiap, 2009).  The 
DNA is tightly bound, and extensive washing removes all contamination. The purified 
DNA molecules can be eluted under low ionic strength (pH ≥ 7) by using ultra-pure 18 
MOhm RNase/DNase water. 
Once extracted, the DNA yield can be assessed using similar methods to that used for 
RNA yield analysis: absorbance (optical density), and agarose gel electrophoresis.  
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The most common technique to determine DNA yield and purity is absorbance, using a 
NanoDrop® spectrophotometer.  Absorbance readings are performed at 260 nm 
(A260) where DNA absorbs light most strongly, and the number generated allows one 
to estimate the concentration of the solution. To ensure the numbers are useful, the 
A260 reading should be between 0.1–1.0 (Adams, 2003).  However, DNA is not the 
only molecule that can absorb UV light at 260 nm. RNA also has a great absorbance at 
260 nm, and the aromatic amino acids present in protein absorb at 280 nm, therefore if 
both contaminants are present in the DNA solution, they will contribute to the total 
measurement at 260 nm, meaning that the DNA quantity may be overestimated 
(Adams, 2003). 
To evaluate DNA purity by spectrophotometry, the most common purity calculation is 
determining the ratio of the absorbance at 260 nm divided by the reading at 280 nm. 
Good-quality DNA will have an A260/A280 ratio of 1.7–2.0 (Teare et al., 1997).  Strong 
absorbance around 230 nm can indicate that organic compounds or chaotropic salts 
are present in the purified DNA.  A ratio of 260 nm to 230nm can help evaluate the 
level of salt residue in the purified DNA; the lower the ratio, the greater the amount of 
thiocyanate salt present.  A reading at 320nm will indicate if there is turbidity in the 
DNA solution, indicating possible contamination. Therefore, taking a spectrum of 
readings from 230nm to 320nm is most informative (Wilfinger et al., 1997). 
DNA concentration can be estimated by adjusting the A260 measurement for turbidity 
(measured by absorbance at 320 nm; A320), multiplying by the dilution factor, and 






DNA concentration of the stock extraction (µg/µl) = 
    (A260 reading – A320 reading) × dilution factor × 50 µg/ml 
 
Agarose gel electrophoresis of the purified DNA reduces the issues associated with 
absorbance readings. As already described for RNA extraction in section 2.2.3, DNA 
samples intercalating with a DNA dye (6x DNA loading dye; Fermentas, UK) along with 
appropriately sized DNA ladder (50 bp ladder, Invitrogen, UK) can be run on a partial 
denaturing agarose gel stained with SYBR Safe stain (Invitrogen, UK).  The negatively 
charged DNA backbone migrates toward the anode. Since small DNA fragments 
migrate faster, the DNA is separated by size.  Any RNA, nucleotides and protein in the 
sample migrate at different rates compared to the DNA so the band(s) containing the 
DNA will be distinct (Wilson and Walker, 2010).  Concentration and yield can be 
determined after gel electrophoresis is completed by comparing the sample DNA 










2.2.6 DNA extraction protocol 
Total genomic DNA was extracted from ~ 25 mg of tissue.  Tissue was minced using a 
sterile scalpel (Swann Morton, UK) and added to 160 µl of PBS (Sigma-Aldrich, UK) in 
a 2 ml RNAse-free round bottomed microcentrifuge tube (Eppendorf, Germany), both 
were briefly mixed by vortex.  The sample was then homogenised using a TissueLyser 
(Qiagen, UK; two minutes at 25 Hz using two 5 mm steal beads) until the tissue had 
been visibly broken down.  DNA was extracted from the lysate using the ReliaPrep 
gDNA Purification kit (Promega, UK) as per manufacturer‘s recommendations. At the 
end of ReliaPrep gDNA Purification protocol, the extracted DNA was eluted in 100 l of 
RNase/DNase free water (Qiagen, UK). Samples were quantified to give a DNA 
concentration in ng/l and were checked for DNA integrity, using the NanoDrop ND-
1000 spectrophotometer (Nanodrop Technologies, Labtech, UK).  The absorbance of 
each sample at 260 nm and 280 nm relative to RNase/DNase free water alone was 
measured.  This allowed the calculation of a ratio of optical density of samples at 
260:280 nm.  A ratio between 1.7-2.0 was regarded as satisfactory.  Once quantified, 
each DNA sample was diluted to 50 ng/l in a total volume of 100 l using 
RNase/DNase free water (Qiagen, UK), and then placed in a bath sonicator (Pulsatron 
55; Kerry Ultrasonics Ltd., UK) for ten minutes to shear the DNA and minimise dilution 
bias.  Samples were then stored at - 20°C until required for quantitative real time PCR 








2.3 Polymerase Chain Reaction (PCR) 
 
Absolute quantification of unknown samples using qPCR requires a standard curve 
generated from serial dilutions of cDNA (of known quantities) amplified using the 
primers for the gene of interest.   
2.3.1 Oligonucleotide primers  
Primers required qPCR were designed using Universal Probe Library Assay Design 
Centre, Roche Applied Science (https:// www.roche-applied-science.com). Where 
possible, primers were designed ensuring that the sequences were overlapping exon-
intron boundaries and amplified a product of ~ 100 base pairs (bp) in size.  All 
oligonucleotides were purchased from Eurofins MWG Operon, Germany.  Once 
delivered, primers were re-suspended with the appropriate volume of RNase/DNase 
free water (Qiagen, UK) as directed by manufacturer to give a stock concentration of 
100 M.  Table 2.1 shows the forward and reverse primer sequences for all primers 












Table 2.1 Oligonucleotide primer sequences 








Forward  primer:  
5‘-TTGATGGCAACAATCTCCAC-3‘ 
Reverse primer:  
5‘-CGTCCCGTAGACAAAATGGT-3 
 








Reverse primer:  
5‘-TGGTGCTTGTCTCACTGACC-3‘ 
 




Forward primer:  
5‘-ATGGAGGGGAATACAGCCC-3 ‘     
Reverse primer:  
5‘-TTCTTTGCAGCTCCTTCGTT-3‘ 
 





Forward primer:  
5‘-GTGCAGATGTGGAGCGTCT-3‘ 
Reverse primer:  
5‘-GTTGAGGCTGGCCAAGAG-3‘ 
 





Forward primer:  
5‘-GTGCCGGCTTCACTTTCA-3‘ 










Forward primer:  
5‘-GGGAGTCTGGAACATTGTGAA-3‘ 
Reverse primer:  
5‘-GTGCACATTGTAAGTAGGTGGACT-3‘ 






2.3.2 Reverse-transcriptase polymerase chain reaction (RT-PCR)  
Polymerase Chain Reaction (PCR) is a technique used to amplify a single or a few 
copies of a selected region of DNA and multiply it across several orders of magnitude, 
generating thousands to millions of copies of that particular DNA sequence. Since its 
development in 1983 by Kary B. Mullis, PCR has revolutionised molecular biology.  
PCR has widespread medical and biological applications in many diverse fields 
including forensic science, histopathology, epidemiology, prenatal diagnostics 
(Baumforth et al., 1999), genetics, and gene cloning (Saiki et al., 1988). 
Any region of any DNA molecule can be selected for PCR amplification provided the 
sequences at the borders of the selected regions are known.  PCR involves two 
primers (single-stranded DNAs), which are complementary to opposite strands of the 
double stranded DNA sequence to be amplified.  The use of thermostable DNA 
polymerase I allows the double stranded DNA to be separated and subsequently 
permits the primers to anneal to their respective sequences with minimal loss of 
enzymatic activity.  The basic process of PCR is carried out over several cycles 
(typically 30- 35 cycles) of denaturation, hybridisation and synthesis resulting in the 
eventual synthesis of several hundred million copies of the desired DNA fragment.    
Since many cellular decisions concerning survival, growth and differentiation are 
reflected in altered patterns of gene expression, the ability to quantitate transcription 
levels of specific genes is essential to any research into gene function.  PCR is often 
coupled with reverse-transcription PCR.  Reverse transcription polymerase chain 
reaction (RT-PCR) is currently the most sensitive method for the detection of low-
abundance mRNA, which has often been obtained from limited tissue samples (Bustin, 
2000, Bustin et al., 2005).  The procedure, allows generation of complementary DNAs 
(cDNAs) for cloning using a reverse transcriptase enzyme; the cDNA can then be 
amplified by PCR.  Most commonly used transcriptases are derived from avian 
myeloblastosis virus (AMV) or Moloney murine leukaemia virus (MMLV).  Although 
both enzymes are routinely used, AMV reverse transcriptase has an advantage of 
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having its optimum temperature for reverse transcription of 42oC, which appears to be 
of benefit if the RNA template has a high degree of secondary structure (Baumforth et 
al., 1999). 
 
2.3.3 Reverse-transcriptase polymerase chain reaction (RT-PCR) optimisation 
Primer concentration optimisation:  
The thermodynamic stability of a duplexed primer/target structure differs for different 
primers and varies with primer concentrations (Nolan et al., 2006).  Therefore, it is 
important to determine the concentration of both 5‘ and 3‘ primers that would result in 
optimal hybridization and priming.  Real time quantitative PCR (qPCR) assays as 
detailed in section 2.3.8 were performed using differing combinations of concentrations 
of forward and reverse primers, as shown in Table 2.2 to determine optimum primer 
concentrations.  
 
Table 2.2 Primer concentration combinations tested to determine optimal primer 
concentrations 



















All forward and reverse primer sets were optimised to be used at 300 nM F, 300 nM R 
working concentrations, in a total reaction volume of 10 l. The best primer 
concentrations were those that gave the lowest Ct value, the highest fold fluorescence 
change, and no primer dimer or non-specific amplification, as defined by Nolan et al., 
(Nolan et al., 2006).  Melt curve analyses were performed to confirm the presence of 
one single product, and non-template controls were run to assess contamination. For 
each primer set, it was confirmed that unknowns sample quantification values fell 
within the dynamic range of the standard curve.  
Figures 2.2 and 2.3 illustrate examples of primer validation for two of the genes 
examined using qPCR in this study: mouse glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH) and mouse β2 microglobulin (2M).  Cut off values for 
efficiency and R2 were 80% and 0.99 respectively (Bustin et al., 2005).  The qPCR 
products for all genes were sequence verified and run on a gel to confirm product band 
size.   
2.3.4 Reverse-transcriptase polymerase chain reaction (RT-PCR) protocol 
RT-PCR amplifications were performed for all of the genes shown in Table 2.1.  Each 
RT-PCR reaction volume contained the following: 3.5 µl of cDNA (100ng; from uterine 
muscle), and 0.75 µl (10 µM, 300nM final conc.) of each primer (forward and reverse; 
Eurofin MWG Operon, Germany), these were made up to a final reaction volume of 25 
µl using 12.5 µl HotStarTaq master mix (Qiagen, UK) and 7.5 µl RNase/DNase free 
water (Qiagen, UK).  All RT-PCR reactions were performed in a Px2 Thermal Cycler 
(Thermo Electron Corporation, UK).  Cycling conditions used: initial activation step: 
95˚C for 15 minutes; followed by 3 step cycling: denaturation 94˚C for 1 minute, 
annealing 60˚C for 1 minute, extension 72˚C for 2 minutes for a total of 40 cycles with 
a final extension at 72˚C for 10 minutes. RT-PCR products were stored at -20 ˚C until 




Figure 2.2 QPCR validation data for mouse GAPDH gene 
A: raw fluorescence values for all samples, B: melt curve for all samples, C: generated 
standard curve, D: GAPDH qPCR amplification product shown on 2 % agarose gel; size of 
product is 110 bp.  Pink lines shown in A and B correspond to the unknown samples isolated 
from myometrium from late pregnant mice (three months old, day 18 gestation), grey lines 




Sequence ID: NM_008084 Product size: 110bp   
Forward primer: 5‘-TTGATGGCAACAATCTCCAC-3‘ Reverse primer: 5‘-CGTCCCGTAGACAAAATGGT-3
Product sequence: TTGATGGCAACAATCTCCACtttgccactgcaaatggcagccctggtgac caggcgcccaatacggccaaatccgttcacaccgaccttcACCATTTTGT
CTACGGGACG 
Assay conditions: Rotorgene 6000, Corbett Research
Activation: 95 °c for 5 min
Cycling: (melting 95 °c for 10 secs; combined annealing/extension 60 °c for 30 secs) x 40





















Figure 2.3 QPCR validation data for mouse 2M gene 
A: raw fluorescence values for all samples, B: melt curve for all samples, C: generated 
standard curve, D: 2M qPCR amplification product shown on 2 % agarose gel; size of product 
is 103 bp.  Red lines shown in A and B correspond to the unknown samples isolated from 
myometrium from non-pregnant mice (three months old, oestrous), green lines correspond to 







Sequence ID: NM_009735 Product size: 103 bp
Forward primer: 5‘-TTCAGTATGTTCGGCTTCCC-3‘ Reverse primer: 5‘-TGGTGCTTGTCTCACTGACC-3‘
Product sequence: TTCAGTATGTTCGGCTTCCCattctccggtgggtggcgtgagtatacttg aatttgaggggttttctggatagcatacaggccGGTCAGTGAGACAAGCA
CCA 
Assay conditions: Rotorgene 6000, Corbett Research
Activation: 95 °c for 5 min
Cycling: (melting 95 °c for 10 secs; combined annealing/extension 60 °c for 30 secs) x 40
Melt: 67-95oC in 1oC increments














2.3.5 DNA extraction from gel 
The purification of DNA from agarose was first reported by Vogelstein & Gillespie 
(Vogelstein and Gillespie, 1979).  Since then many different modifications of this 
original methods have been established and at present many kits are available for fast 
and efficient purification of DNA from agarose gels.  The QIAquick gel extraction kit 
used for the present study combines spin-column technology with the selective binding 
properties of a silica membrane which absorbs the DNA in the presence of high 
concentrations of salt, whilst allowing contaminants to pass through; after further 
purification steps, DNA can then be eluted.  
2.3.6 DNA extraction from gel protocol 
RT-PCR products were run on a 2 % agarose gel in duplicates to ensure that they 
were of the desired size, to check for integrity, and to allow for DNA extraction from 
gel.  High resolution agarose (2 g, Sigma-Aldrich, UK) was dissolved in 100 ml 0.5 × 
tris-borate EDTA/H2O (TBE) (diluted from 10 x TBE stock; Sigma-Aldrich, UK) and 
heated until melted; 10 µl of SYBR safe DNA gel stain (Invitrogen, UK) was added to 
the 100 ml of melted agarose and then quickly poured into a level horizontal gel tank 
containing well combs and allowed to set for 45 minutes.  The samples to be run were 
prepared by mixing 10 µl of PCR product with 2 µl of loading buffer (6x DNA loading 
dye; Fermentas, UK). Once set, the well comb was removed, and the gel was 
submerged in 1 × TBE and loaded with the 12 µl of sample into each well.  A 50 bp 
ladder (5 µl; Invitrogen, UK) was run at each end of the comb. The gel was then run at 
a constant 100 V for 1.5 hours before being imaged using the Gel Logic 2200 Pro 





The bands of appropriate size (according to the size of the expected PCR product for 
each gene) were excised using a clean sharp blade on a UV transilluminator (UVP, 
UK).  Each excised band was weighed and DNA was extracted using the QIAquick 
DNA extraction kit (Qiagen, UK) as per manufacturer‘s recommendations.  The 
extracted DNA was eluted in 20 l buffer EB (Elution Buffer, Qiagen, UK) and 
subsequently stored at -20 ˚C until required for densitometry. 
2.3.7 Densitometry 
Gel extracted DNA samples were loaded (10 µl of sample + 2 µl of loading buffer (6x 
DNA loading dye; Fermentas, UK) on a 2% agarose gel along with a known 
concentration DNA fragment ladder (MassRuler Low Range DNA ladder mix; Thermo 
Scientific, Germany).  The samples were then size separated by running the gel at a 
constant 100 V for approximately one and a half hours.  Once run, the gel was imaged 
using the Gel Logic 2200 Pro Imaging System (Carestream Health Inc., USA) and the 
density of each band was assessed using the Carestream Molecular Imaging software 
(Carestream Health, USA).  The concentrations of the unknown DNA samples were 
calculated using their raw volume density values and comparing back to the known 
concentration DNA ladder.  Once the DNA concentrations were calculated for each 
gene, serial dilutions from 1 x 1010 - 101 copies were made as standards and stored at 










a) For a particular gene of interest, with a PCR product size of 105 bp.  During 
densitometry, the gene of interest DNA band is closest in size to a standard of 
100 bp on the DNA ladder, which is known to contain 15 ng of DNA. 
 
For the known standard (100 bp, 15 ng DNA): the mean density of the band is 
measured as 33, 455 mean density units. 
For the gene of interest product (105 bp, unknown DNA quantity): the mean 
density of the band is measured as 75, 967 mean density units. 
To calculate the DNA quantity of the gene of interest band =  
 
 100 x 75,967 x 15 = 32.4 ng/ 12 l loaded volume 
105        33,455     
       = 2.7 ng/l 
b) The average molecular weight of a dNTP (assuming equal numbers of all 
bases A, T, G, C) = 330 Da 
Since the PCR product is double stranded = 330 x 2  
                = 660 Da 
The gene of interest PCR product is 105 bp, therefore the weight of the product  
= 105 x 660 
                                                                                                                                        






c) Avogadro‘s Constant = 6.02 x 1023 molecules in 1 mole 
1 mole = Molecular weight in grams 
69, 300 g of the gene of interest PCR product = 6.02 x 1023 molecules 
Therefore, in 1ng of the gene of interest PCR product =   6.02 x 1023    
                  69, 300 x 109  
                                                                                       
                                                                                                  = 8.69 x 109 copies/ ng  
 
From part a), there is 2.7 ng/l PCR product in the band of interest, therefore the 
number of copies in 1l of eluted PCR product from this band will be = 2.7 ng x 8.69 x 
109 copies 
                                                                                                   = 2.35 x 1010 copies/ l 











2.3.8 Real time quantitative PCR (qPCR) 
Real time PCR uses a signal, normally fluorescence, which increases with the 
increased amount of DNA formed by PCR (Bustin and Nolan, 2004).  When the signal 
rises above a set background, it is detected.  The signal normally rises in a sigmoidal 
way, until it reaches its plateau (Figure 2.4).  During the linear increase, the signal can 
be compared with the signal from other samples.  A standard curve with known DNA 
concentrations (Figure 2.5) is usually run on the same 72/100 well rotar, to compare 
the signal of the samples and to calculate the DNA concentrations of the unknown.  
The signal is normally measured at a threshold level called, cycle threshold (CT).  The 
cycle number at which the signal crosses the CT is correlated to the initial 
concentration of DNA in the template (Higuchi et al., 1993). 
 
 
Figure 2.4 Typical real-time PCR result showing raw fluorescence for each sample 
The cycle points (CP) is the point where the instrument (RotorGene 6000) first detects 
fluorescence above background noise.  Green lines correspond to standards of known 
concentrations for the gene of interest (represented in sequential order from highest 
concentration of 10
7
 copies on the furthest left to lowest concentration of 10
1
 copies on the 




Figure 2.5 Typical standard curve from real-time PCR 
Standard curve generated from fluorescence data, indicating the appropriate R
2
, and efficiency 
(E) values (Bustin and Nolan, 2004). 
 
DNA binding agents, like SYBR green, bind specifically to double stranded DNA; they 
emit a fluorescent signal when they bind to double stranded DNA.  During each cycle 
of PCR, the amount of double stranded DNA increases with the fluorescent signal.  
Like with conventional PCR, the specificity of the reaction is determined entirely by its 
primers; however the PCR can be verified by a melting curve (Al-Robaiy et al., 2001, 
Ririe et al., 1997) that allows a comparison of the melting temperatures of the specific 
product and any suspected non-specific products (Lekanne Deprez et al., 2002).  The 
reason for this is that different length products and products of different sequences will 
melt at different temperatures and will be observed as distinct peaks (Figure 2.6); 
therefore, a single peak should be present to confirm specificity (Bustin, 2000, Bustin 




Figure 2.6 Typical melt cure from real-time PCR 
The single peak of the melt curve indicates the specificity of the product amplified.   
 
 
When comparing samples, a housekeeping gene is also used to rule out any pipetting 
errors and to normalise for any variation in RNA abundance between samples (Bustin, 
2000).  A good housekeeping gene is one that should not vary in its expression level 








2.3.9 Real time quantitative PCR (qPCR) protocol 
Real Time qPCR was performed for the optimised primers listed in Table 2.1.  A 
volume of 2 l of cDNA/DNA (sections 2.2.4 or 2.2.6) was used to carry out qPCR 
amplifications alongside previously prepared standards from 108 to 101 copies using 
SYBR Green chemistry (QuantiFAST SYBR green; Qiagen, UK) on a RotorGene 6000 
(Corbett Research, Australia).  Forward and reverse primers were optimised to be 
used at 300 nM working concentrations, in a total reaction volume of 10 l.   
A pre-PCR cycle was run for 5 minute at 95°C followed by 42 cycles of 95°C for 10 s 
denaturation step, followed by 60°C for 30 s combined annealing/extension step. Melt 
curve analysis was performed to confirm the presence of one single product, and non-
template controls were run to assess contamination. CT values and a standard curve 
were generated using the RotorGene software. All unknowns sample quantification 
values should fall within the dynamic range of the standard curve. Cut off values for 
efficiency and R2 were 80% and 0.99 respectively.  All gene qPCR products were 
sequence verified and run on a gel to confirm product band size.   
For normalising data for the genes of interest, unknown samples were also run using 
reference/housekeeping genes.  Quantification data for the genes of interest were 
expressed relative to the geometric mean of 2 or more housekeeping genes (where 








2.4 Microarray Studies of Mouse Myometrium 
As described in section 2.2.2, total RNA was extracted from ~ 30 mg of myometrium 
and paired bladder samples collected from late pregnant (day 18 of gestation) mice.  
Once quantified using the NanoDrop ND-1000 spectrophotometer (Nanodrop 
Technologies, Labtech, UK), RNA samples were diluted to 45 ng/l using 
RNase/DNase free water (Qiagen, UK).  RNA samples were then passed over to the 
NIHR Comprehensive Biomedical Research Centre Genomics Facility (Guy‘s hospital, 
London).  The Genomics Facility used the RNA samples to complete the Illumina 
TotalPrepTM RNA Amplification Kit (Invitrogen, UK) protocol, as per manufacturer‘s 
recommendations to make labelled cDNA.  The mouseWG-6 v2.0 Expression 
BeadChip Kit (Illumina, UK), was then used to run the microarray.  Labelled cDNA 
samples were detected by hybridization to 50-mer probes on the BeadChip.  After 
washing and staining steps as per manufacturer‘s recommendations, BeadChips were 
scanned on an iScan reader (Illumina, UK). 
Differential expression analysis was performed by the Genomics Facility.  
Comparisons were made between two ages (three month versus eight month old) of 
myometrial tissues.  Myometrial expression was normalised against expression in age-
matched bladder tissues.  A threshold P-value of 0.05 (Diff score +/- 13) was applied to 








2.5 Infra-red Video Camera Recording of Mouse Parturition 
 
Late pregnant (day 17 of gestation onwards) females were singly housed in cages 
containing bedding of white pine shavings, and minimal nesting bedding (Enviro-dri; 
Shepherd Speciality Papers, USA), so the view of the cameras were not obscured.  
Mice had access to standard chow and bottled water ad libitum.  The light-dark cycle 
was maintained 12L: 12D (light 0700-1900 h).   Females were monitored continuously, 
using infrared video cameras (600TVL Eyeball Dome; Qvis, USA) in order to 
accurately record from the appearance of the first pup until the completion of 
parturition.  Cameras were connected to a Zeus Lite HDMI LX 4 Channel Full D1 
Networked CCTV Recorder DVR 1TB Hard Drive (Qvis, USA), which recorded 
continuously for the duration of the experiment with correct time and date associated 
with video footage. 
Following delivery, the litter size delivered per mouse was recorded and the weights of 
each live pup were also determined.  Any pup mortality seen was also noted.  Each 
video was examined for the precise time of birth, which was determined by the 
appearance and complete delivery of the first pup, this was used to determine 
gestation length (days).  Total parturition duration (hours) was determined as the exact 
time between the complete delivery of the first pup to the complete delivery of the final 
pup. 







2.6 Ex Vivo Isometric Tension Measurements of Mouse Myometrium 
 
Isolated tissue and organ preparations have been in use for over one hundred years, 
providing researchers with convenient biological models that exist without the systemic 
influences of the intact animal  (Csapo and Goodall, 1954, Hill, 1953, Ringer, 1883, 
ADInstruments, 2013). Furthermore, isolated tissue preparations can generally be run 
in groups of two, four, or eight, and can be easily subjected to controlled changes in 
perfusion solution, oxygen, drugs and other factors that may affect organ function.  
Traditionally, such experiments have been carried out in tissue-organ baths to study in 
vitro dose response changes on isolated tissue preparations to investigate the 
physiology and/or pharmacology of that tissue.  Tissue-organ baths are used to 
maintain the integrity of the tissue for several hours, in a temperature-controlled 
environment, while physiological measurements are performed. Typical experiments 
involve the addition of drugs to the organ bath, where the tissue reacts by 
contracting/relaxing and an isometric transducer is used to measure force generated 
by the tissue  (Radnoti, 2010, ADInstruments, 2013).  
To measure muscular activity, the organ, muscle strip or ring is attached by wire, silk 
or cotton suture to a force transducer which converts the force generated by the 
muscle into an electrical signal that can then be detected on a chart recorder or a 
computer based data acquisition system.  The muscle is usually pre-loaded with a 
weight or pre-stretched using a tissue tensioner or micrometer.  The suture attaching 
the muscle to the transducer should not touch the bath walls and should be in line with 
the transducer. The force transducer makes an isometric measurement, where the 
muscle length remains constant as force changes.  Isometric measurements are 
measured as grams (g) or millinewtons (mN) (Dillon and Murphy, 1982, Radnoti, 
2010); these force measurements can be converted to stress measurements, allowing 
the researcher to control for the differences caused by the size of the preparation and 
its effect on force output (Radnoti, 2010, Herlihy and Murphy, 1973). 
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Muscles have an optimal length where contraction produces a maximum active force.  
Maximum force usually occurs at the natural length of the muscle and is termed 
optimal length.  The length-tension relation was first studied in uterine muscle by 
Csapo & Goodall in 1954 (Csapo and Goodall, 1954). They confirmed that that 
maximum force was developed at the 'resting length', a length determined by applying 
a series of slight stretches to the isolated muscle and taking as the resting length the 
last length before any significant resting tension was developed.   
 
2.6.1 Ex vivo isometric tension optimisation 
Measurement of length-tension properties of non-pregnant mouse myometrium  
An adapted method as published by (Wu et al., 2008) was used. 
Mouse uterine horns were cut longitudinally down the midline, and the endometrium 
gently removed with a cotton bud.  Small myometrial muscle strips (4-5 mm in length) 
were dissected from each of the horns and tied at each end with thread and mounted 
in a standard 10 ml organ bath chamber (ADInstruments, UK). One tissue end was tied 
to a fixed hook, and the other to a tension transducer linked to a micrometer allowing 
for manual stretch of the tissue. The tissue bath contained physiological saline solution 
(PSS; 119 mM NaCl, 4.7 mM KCl, 1.17 mM MgSO4, 25 mM NaHCO3, 1.18 mM 
KH2PO4, 0.025 mM ethylenediaminetetraacetic acid (EDTA), 6.0 mM glucose, 2.5 M 
CaCl2; pH 7.4) at 37°C that was bubbled with a 95% air-5% CO2 mixture (BOC Gases, 
UK). Myometrium strips were initially held at slack length (the length at which any 
further 0.25 mm incremental stretch of the tissue noticeably changed passive tension), 
equilibrated for 30 minutes at this initial length and then stimulated with high 
K+ solution (PSS with 60 mmM KCl substituted for NaCl) for five minutes. After 
washout and a further ten minutes equilibration in PSS, the tissues were stretched by 
1mm (approximately 1.20–1.25-fold beyond initial length). After ten minutes 
equilibration at this new length, the tissues were again stimulated with high K+ solution 
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for five minutes and subsequently returned to PSS. The active tension in response to 
the high K+ was noted just before returning to PSS. This procedure was repeated at 
several tissue lengths to allow construction of an active length–tension curve. All data 
were recorded and analysed using LabChart 6 software (ADInstruments Limited, UK).  
Data for each strip was expressed as a percentage of the maximum active tension 
recorded; collated data was then averaged to construct the length-tension curve, as 
can be seen in Figure 2.7. 
This experiment was repeated without the stimulation with high K+ solution, but with 
stretching of the myometrium strips alone.  The passive tension was noted just before 
stretching of the tissue by a further 1mm increment. This procedure was repeated at 
several tissue lengths to allow construction of a passive length–tension curve. Data 
were expressed as absolute force per cross sectional area (mN/cm2), as can be seen 













































Figure 2.7 The active (high K
+
PSS stimulation) length-tension curve for myometrium 
from three month old non-pregnant mice 
Mean active tension (±SD) was normalised to the peak in active tension (100%) and the stretch 
was normalised to a slack length of 1.0 (n = 16 tissue strips from n = 4 mice).  Where error bars 










































Figure 2.8 The passive length-tension curve for myometrium from three month old non-
pregnant mice 
Mean passive tension (±SD) was expressed as absolute force per cross sectional area 
(mM/cm
2








Figure 2.7 shows the mean maximum active tension was generated when myometrial 
strips were stretched to 2-fold of their original/slack length.  Figure 2.8 shows that at a 
2- fold stretch beyond initial length, the myometrial strips are held under a mean 
passive force of approximately 1600 mN/cm2.  Taking this into consideration, it was 
calculated that ideal resting tension for myometrial tissue strips (5 x 2 x 2 mm 
dimensions) in future experiments should be 32 mN (3.26 g).  However, the software 
(LabChart 6, ADInstruments Limited, UK) used to record data, was pre-set to grams 
rather than millinewtons settings, therefore a resting tension of 3 grams/29.4 mN was 
used for all subsequent myometrial isometric tension experiments. 
 
2.6.2 Ex vivo isometric tension protocol 
Mouse uterine horns from non-pregnant females in oestrous or late pregnant (day 18) 
(section 2.1.3) were cut longitudinally down the midline in non-pregnant uterine horns 
or along the axis of placental attachment in pregnant horns, and the endometrium 
gently removed with a cotton bud.  Small myometrial muscle strips (5 x 2 x 2 mm 
dimensions) were dissected from each of the horns and tied at each end with cotton 
thread and mounted in a standard 10 ml organ bath chamber (Panlab 8 Chamber 
Organ Bath System; ADInstruments, UK). One tissue end was tied to a fixed hook, and 
the other to a tension transducer linked to a micrometer allowing for manual stretch of 
the tissue. The tissue bath contained PSS (section 2.6.1) at 37°C that was bubbled 
with a 95% air-5% CO2 mixture (BOC Gases, UK). Myometrium strips were put under 
29 mN (x2 slack length; as determined by optimisation studies) of resting tension and 
left to equilibrate for 45 minutes to allow spontaneous contractions with a stable 
baseline to develop. Contractions were recorded for a 10 minute baseline period, prior 
to recording spontaneous contractile activity (one hour minimum duration of recording), 
and response to the contractile agonists oxytocin (10-12-10-7 M oxytocin concentration 
response curve; Syntocinon; Alliance Pharmaceuticals, UK).   
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Maximal contractile capacity of each myometrial tissue strip in response to high 
K+ solution (section 2.6.1; duration of 5 minutes) was measured at the end of 
spontaneous contractile activity experiments. 
All data were recorded and analysed using LabChart 6 software (ADInstruments 
Limited, UK). Contractile periods were assessed using mean integral tension (MIT), 
which is the sum of the contraction integrals divided by the duration of the period 
assessed.  Contraction force was measured as the mean height of contractions in the 
period assessed.  To confirm that any observed differences in contractile activity were 
not due bias in dissecting the myometrial strips or their relative weights, measurements 
were normalised to cross sectional area of strips.  The frequency of contractions were 
calculated as number of contractions per second, and the duration of contraction was 
calculated as the time in seconds between the start and end of an individual 













2.7 Ex Vivo Tensile Strength Measurements of Mouse Cervix 
 
The cervix is a metabolically active organ in pregnancy composed primarily of 
fibroblasts and to a lesser extent smooth muscle cells.  These cells secrete an 
extracellular matrix (ECM) rich in fibrillar collagen, elastin, proteoglycans, and 
hyaluronan (Leppert, 1995).  During pregnancy, the cervix remains closed and firm in 
order to prevent passage of an immature infant through the birth canal (Mahendroo, 
2012).  However, near term, the cervix is extensively remodelled, making it more 
distensible in order to open sufficiently facilitating safe passage of the fetus at 
parturition. In 1895, Hegar first described ‗softening‘ of the lower uterine segment in 
association with human pregnancy at four to six weeks (Read et al., 2007).  
Cervical softening can be defined as a change in the biomechanical properties of the 
cervix when compared with the non-pregnant cervix and is characterized by a 
progressive decrease in tissue stiffness without loss of tensile strength (Leppert and 
Yu, 1994).  Physiologic softening of the rat cervix was first shown by Harkness & 
Harkness in 1959 who noted that distensibility of cervical tissue increased dramatically 
starting mid-gestation between days 11 and 12 (Harkness and Harkness, 1959).  
Harkness and Harkness isolated cervices from pregnant rats and the tissues were 
distended between two cylindrical steel rods, both of which were inserted through the 
cervical canal. The apparatus used is summarised in Figure 2.9.  The rods were 
arranged parallel one above the other, going through the cervical canal (X).  The lower 
rod (r1) was fixed and immovable and the other rod (r2) was fixed to a movable stirrup 
on which force could be exerted to pull the two rods apart.  The stirrup (S) holding the 
upper rod (r2), was attached above to a stainless-steel rod (r3), which went vertically 
upwards through a cylindrical channel (c) 5 cm long, in a sheet of Perspex. Two cotton 
threads (a, b) were attached to the upper end of the rod, one (b) going over a Perspex 
wheel (w) to a pan (p) on which weights could be placed, the other (a) going up 
vertically to the short arm of a light spring-loaded lever (e) which gave a magnification 
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of x 3.0 or x 4.5.  Lever (e) had a writing point on a drum, to enable recordings of 
relative force. 
The excised cervix was placed in position, immersed in Ringer-Locke's solution.  With 
the two rods as close together as their mountings would allow, a zero line was marked 
round the drum. The apparatus was then released with no load on the pan. Under 
these conditions a small constant force of approximately 2 g was exerted on the upper 
rod, this force representing the effect caused by the upper rod and its mounting being 
immersed in an aqueous medium. This small force was applied for approximately one 
minute. Subsequently, a load was placed on the pan and left there, the effect on the 
tissue was recorded on the drum. The load was increased in steps of 25 g every 15 



















Figure 2.9 Diagram of the apparatus used by Harkness and Harkness for stretching of 
pregnant rat cervical tissues 
Figure from: Changes in the physical properties of the uterine cervix of the rat during pregnancy 







Following on from these initial cervical tissue biomechanics studies, the methodology 
has been adapted further by Read et al., 2007 (Read et al., 2007), these authors 
carried out tensile distensibility and maximum stretch of isolated mouse cervical 
tissues.  Instead of rods, they have mounted the excised cervix by means of two pins 
inserted through the cervical canal.  One pin was attached to a calibrated mechanical 
drive and the other pin to a force transducer. Tissues were incubated in a water-
jacketed bath containing PSS (NaCl (120.5 mM), KCl (4.8 mM), MgCl2 (1.2 mM), CaCl2 
(1.6 mM), NaH2PO4 (1.2 mM), NaHCO3 (20.4 mM), dextrose (10 mM), and pyruvate 
(1.0 mM), pH 7.4 at 37 oC) bubbled with 95% O2/5% CO2. Baseline cervical dilatation 
(resting diameter of cervical canal) was quantified by determining the difference in 
cervical diameter at 0 (pins juxtaposed with no tension) and the inner cervical diameter 
at the initiation of tension as the pins were separated. Thereafter, the inner diameter of 
the cervix was increased isometrically in 0.5 mm increments at two minute intervals. 
The amount of force required to distend the cervix and the tension exerted by the 
stretched tissue were recorded. The diameter was increased until either forces exerted 











2.7.1 Ex vivo tensile strength measurements of mouse cervix protocol 
The method used was adapted from a previous report (Read et al., 2007).  Whole 
intact mouse cervices from non-pregnant females in oestrous or late pregnant (day 18) 
(section 2.1.3) were isolated and dissected at the utero-cervical junction (beneath the 
uterine bifurcation). Each cervix was further dissected ex vivo to remove all vaginal 
tissue.  Two pieces of cotton thread were passed through the cervical canal/lumen of 
the isolated cervix using a clean needle and a loop was tied for each piece of thread 
around the cervix (Figure 2.10).  Each cervical preparation was mounted in a standard 
10 ml organ bath chamber (Panlab 8 Chamber Organ Bath System; ADInstruments, 
UK). One thread loop was tied to a fixed hook, and the other to a tension transducer 
linked to a micrometer allowing for manual stretch of the tissue.  The tissue bath 
contained PSS (section 2.6.1) at 37°C that was bubbled with a 95% air-5% 
CO2 mixture (BOC Gases, UK).  Cervical tissues were initially held at slack length (at 
which any further 0.25 mm incremental stretch of the tissue noticeably changed 
passive tension), and were allowed to equilibrate for 15 minutes.  During this 
equilibration period, the inner diameter of each cervix (resting diameter of cervical os/ 
the baseline cervical dilatation) was taken to be at 0 mm stretch.  Thereafter, the inner 
diameter of the cervix was stretched isometrically in 1 mm increments at two minute 
intervals. This increase in cervical diameter stretch was continued until either the 
forces exerted by the tissue reached a plateau or in very rare cases where the tissue 
snapped or tore.  The amount of force required to distend the cervix and the tension 
exerted by the stretched tissue were acquired and analysed using Lab Chart 6 
software (ADInstruments Limited, UK). Force was plotted as a function of cervical 
diameter.  The slope of the linear portion of these force–strain curves were measured 
as an index of tissue stiffness and elasticity. 
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Figure 2.10 Images to show how cervical tissues were mounted into in a standard 10 ml organ bath chamber 
A: Two pieces of cotton thread were passed through the cervical canal/lumen of the isolated cervix using a clean needle, B: a loose loop was tied for each piece 
of thread around the cervix, C: loops of thread were used to mount cervical preparation in a standard 10 ml organ bath chamber. 
A B C 
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2.8 Histological Studies in Mouse Cervix 
 
2.8.1 Tissue processing  
Tissue processing is central to successful immunohistochemistry; fixatives are used to 
ensure preservation of tissue architecture and cell morphology.  Prompt and adequate 
fixation is essential, especially in immunological studies, where fixation is imperative to 
ensure the adequacy of the specimen and target antigens.  Inappropriate or prolonged 
fixation may significantly diminish the antibody binding capability. 
The most common combination used for successful antigen retrieval is formalin-fixed 
paraffin-embedded tissue sections, as these have been shown to provide excellent 
morphological detail and resolution (MacIntyre, 2001, Montero, 2003, Werner et al., 
2000).  Formaldehyde is usually a 10% solution, usually in neutral phosphate buffer or 
saline (Montero, 2003).  It has been demonstrated in a kinetic study of formaldehyde 
binding to tissue, that if the dimension of the tissue specimen is under the 2-3 mm 
prescribed, at least for one of the dimensions, 24 hours will be enough for good fixation 
(Helander, 1994).   
2.8.2 Tissue processing protocol 
Each whole intact cervical sample was fixed after overnight immersion in 10% (v/v) 
formal saline solution (Formaldehyde solution 10% v/v in 0.9% NaCl solution; Fisher 
Scientific, UK), as stated in section 2.1.3.  The samples were then placed into plastic 
cassettes (Histosette cassettes; VWR International Ltd, UK) in a longitudinal 
orientation.  The sample cassettes were washed in three consecutive 45 minutes 
washes in PBS (Sigma-Aldrich, UK), after which they were transferred to 70% ethanol 
ready to be processed.  Processing was completed overnight using an automated 
tissue processor (TP1020 tissue processor; Leica Biosystems, UK).  Table 2.3 outlines 




Table 2.3 Protocol used to process mouse cervical tissues in the automated tissue 
processor  
(TP1020 tissue processor; Leica Biosystems) 
Reagent Time (minutes) 
70% Ethanol 120 
80% Ethanol 120 
90% Ethanol 120 
100% Ethanol 120 







Immediately after processing, the samples were was embedded using a wax 
embedding console system (EG1150 heated paraffin embedding module; Leica 
Biosystems, UK).  Individual cervical sample wax blocks were allowed to set, and then 
stored in a cool environment until required for sectioning.  A sledge rotary microtome 
(RM2135 rotary microtome; Leica Biosystems, UK) was used to cut 5-10 m 
longitudinal sections of the cervical sample wax blocks; sections were allowed to dry 
onto SuperFrost Plus slides (VWR International Ltd, UK) using a slide drying bench set 
to 30°C (MH6616; Electrothermal, UK).  Slides were then kept overnight in an oven set 





2.8.3 Masson’s trichrome staining 
Trichrome stains are primarily used for distinguishing collagen in connective and 
muscle tissues (Williams and Wilkins, 1977).  Historically, the first trichrome system 
has been credited to Mallory (Lillie, 1940, Sheehan and Hrapchak, 1980).  Subsequent 
modifications to this staining system were introduced by Masson and Gomori (Lillie, 
1940, Gomori, 1950).  In general, trichrome stains consist of nuclear, collagenous and 
cytoplasmic dyes.  For the purpose of this study, a Masson‘s trichrome Kit (Sigma 
Aldrich, UK) was used, for which the procedure is based on the work of Masson as 
modified by Lillie (Williams and Wilkins, 1973) using aniline blue as a collagen stain 
instead of a green dye. Tissue sections were treated with Bouin‘s solution to intensify 
the final collagen stain colouration. Nuclei were stained with Weigert‘s iron 
hematoxylin, and cytoplasm and muscle stained with Beibrich scarlet-acid fuchsin.  
Rinsing in acetic acid after staining reduces the shades of colour making them more 
delicate and transparent (Gomori, 1950). 
 
2.8.4 Masson’s trichrome staining protocol 
Cervical sections were stained using a Masson‘s Trichrome Kit (Accustain® Trichrome 
stains (Masson); Sigma-Aldrich, UK), to allow identification of structures and detect 
presence of collagen.  Tissue section slides, including a positive control slide 
(Trichrome TISSUE-TROL, Sigma Aldrich, UK) were de-waxed by following the series 
of washes shown in table 2.4 (xylene; Sigma Aldrich, UK), after which they were 
penetrated in Bouin‘s Solution (Sigma Aldrich, UK) at room temperature overnight.  
Slides were washed in running tap water to remove yellow colour from sections, and 
then stained in Working Weigert‘s Iron Hematoxylin Solution (Sigma Aldrich, UK) for 
five minutes, followed by another five minute wash in running tap water. Slides were 
rinsed in deionized water, and then stained in Biebrich Scarlet-Acid Fucshin solution 
(Sigma Aldrich, UK) for five minutes, followed by another deionized water wash.  
Slides were immersed in working Phosphotungstic/Phosphomolybdic Acid Solution 
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(Sigma Aldrich, UK), and then immediately transferred to Aniline Blue Solution (Sigma 
Aldrich, UK); five minutes immersion in both.  Acetic acid, 1% was used to wash all 
slides (two minutes duration) after which they were rinsed in deionized water, and 
dehydrated through a series of washes in alcohol, and cleared in xylene washes as 
summarised in Table 2.5.  Immediately after dehydration, 1–2 drops of permanent 
mounting medium DPX (Sigma-Aldrich, UK) were added onto each section, and 
covered with a glass coverslip, ready to be observed by light microscopy. Following 
Masson‘s trichrome protocol, nuclei were stained black, cytoplasm and muscle fibres 
were stained red and collagen was stained blue in each tissue section. 
Images of Masson‘s trichrome stained cervical tissue sections were taken using AZ100 
multizoom microscope and NIS-Elements version 4.0 software (Nikon Instruments 
Europe, UK); images were taken at x10 magnification of original.  Collagen content in 
each cervical section was expressed as the area of blue stain (collagen stain) 
calculated as a percentage of total section area (binary units) measured using NIS-
Elements Version 4.0 software (Nikon Instruments Europe, UK).  To avoid bias during 
analysis, images were assigned numbers so that experimental conditions of the 
sections were unknown. 
 
2.8.5 Immunohistochemical labelling 
Immunohistochemistry is the localisation of antigens in tissue sections by the use of 
labelled antibodies as specific reagents through antigen-antibody interactions that are 
visualized by a marker such as fluorescent dye, enzyme, radioactive element or 
colloidal gold.  Albert H. Coons and his colleagues (Coons and Kaplan, 1950, Coons et 
al., 1955) were the first to label antibodies with a fluorescent dye, and used it to identify 
antigens within tissue sections.  With the expansion and development of 
immunohistochemistry, enzyme labels have been introduced such as horseradish 
peroxidase (Kiernan, 2000, Stevens and Lowe, 2005) and alkaline phosphatase 
(Mason and Sammons, 1978). 
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2.8.6 Identification of optimal primary antibody dilution 
In order to ensure that the optimum primary antibody (anti-MMP2 ab37150; Abcam, 
UK) dilution was used in subsequent experiments, a dilution series of 1:100 to 1:1000 
was first conducted (Figure 2.12); these were set around the manufacturers‘ 
recommendations.  One section for each dilution was then stained (method described 
in section 2.8.7) and viewed under a light microscope to establish the optimum dilution.  
Optimum dilution is one that produces good staining, with the majority of positive 
staining lost when the next more diluted antibody is used  (Stevens and Lowe, 2005, 
Ross and Pawlina, 2003) (Figure 2.11). 
 
Figure 2.11 Graph illustrating how the optimum primary antibody dilution was 
established 
Figure from Dr Hiten Mistry (2008). 
 
Images of primary antibody dilutions were captured using AZ100 multizoom 
microscope and NIS-Elements version 4.0 software (Nikon Instruments Europe, UK) 

















Figure 2.12  Cervical sections from mice stained for MMP2 to identify the optimal dilution of primary antibody 
    Dilution of 1:500 was selected as optimal; all sections shown at x10 magnification.                                                                      
1000 m 1000 1:100 1000 1:250 1:500 




2.8.7 Immunohistochemical labelling protocol 
The ImmunoCruz rabbit LSAB Staining System (Santa Cruz Biotechnology, Germany) 
was used for immunohistochemistry staining.  Slides were initially de-waxed by 
washing sections in a number of washes as detailed in Table 2.4.  After which excess 
liquid was aspirated from slides.  Slides were then placed in a microwave-safe 
container and covered with a 10 mM Tris-EDTA buffer (10 mM Tris Base, 1 mM EDTA, 
0.05% Tween 20, pH 8.0), and heated at highest power for ten minutes in a 
microwave.  This heat treatment was needed to unmask antigens in the tissue 
sections.  Slides were allowed to completely cool back down to room temperature for 
approximately an hour and a half, after which they were washed in deionized water 
three times for two minutes each on stir plate.  
 
Table 2.4 Protocol used to de-wax mouse cervical tissues sections 
Reagent Time (minutes) 
Xylene  5 
Xylene  5 
100% Ethanol 5 
80% Ethanol 3 
50% Ethanol 3 







All subsequent steps were carried out at room temperature in a humidified chamber.  
Endogenous peroxidase activity was quenched by incubating sections for five minutes 
in 1–3 drops of peroxidase block (provided in ImmunoCruz rabbit LSAB Staining kit).  
Slides were then rinsed with phosphate buffered saline (PBS; Sigma-Aldrich, UK), and 
transferred to a PBS wash for two minutes on a stir plate. Sections were then 
incubated for 20 minutes in 1–3 drops of serum block (provided).  Primary antibody 
(Anti-MMP2 ab37150; Abcam, UK) was diluted in serum block (provided) to 0.5–5 
μg/ml as determined by titration.  
In order to ensure that the optimum primary antibody dilution was used, a dilution 
series was first conducted based on the manufacturer‘s recommendations (for 
example: 1: 50, 1:100, 1:250 and 1: 500); optimal dilution of 1:500 was selected for the 
anti-MMP2 antibody ab37150 (section 2.8.6).  A border was defined around each 
section using a PAP pen for Immuno Staining (Sigma-Aldrich, UK), after which the 
diluted primary antibody was added in sufficient volume to cover each tissue section. 
Slides were incubated overnight in the humidified chamber at room temperature. 
The following day, the slides were rinsed with PBS, and then washed in PBS twice for 
two minutes each on a stir plate.  Sections were incubated for 30 minutes in 1–3 drops 
of biotinylated secondary antibody (provided). Again, the slides were rinsed with PBS, 
and then washed in PBS twice for 2 minutes each on a stir plate.  Next, the sections 
were incubated for 30 minutes in 1–3 drops of HRP-streptavidin complex (provided), 
and again rinsed in a series of PBS washes as before.  The HRP substrate was 
prepared as per the manufacturer‘s recommendations, and 1-3 drops were added to 





Slides were then rinsed with deionized water and transferred to a deionized water 
wash for two minutes on a stir plate.  Slides were counterstained in Gill‘s formulation 
number 2 Hematoxylin (Sigma-Aldrich, UK) for five seconds, and then immediately 
washed with several changes of deionized H2O.  Brief destaining of Hematoxylin was 
carried out by dipping the slides in 0.5 % acid alcohol (0.25 ml Hydrochloric acid in 50 
ml of 70% ethanol) for 1- 2 seconds, followed by a wash with tap water.  Sections were 
then dehydrated in a number of washes as detailed in Table 2.5.  Immediately after 
dehydration, 1–2 drops of permanent mounting medium DPX (Sigma-Aldrich, UK) 
were added onto each section, and covered with glass coverslip, ready to be observed 
by light microscopy. 
Table 2.5 Protocol used for dehydration of mouse cervical tissues sections 
Reagent Time (minutes) 
50% Ethanol 3 
80% Ethanol  3 
100% Ethanol 5 
Xylene  5 
Xylene  5 
  
Images of immunohistochemical labelled cervical tissue sections were taken using 
AZ100 multizoom microscope and NIS-Elements version 4.0 software (Nikon 
Instruments Europe, UK); images were taken at x10 magnification of original.  Brown 
staining was quantified using ImageScope (Aperio Technologies Ltd, UK).  The total 
percentage of positive labelled cells per x10 magnification field was determined using 
the ‗positive pixel count‘ function. Results were then expressed as ‗positivity‘ which 
takes into account both the number of positive pixels and the intensity of staining.  To 
avoid bias during analysis, images were assigned numbers so that experimental 
conditions of the sections were unknown. 
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2.9 Mitochondrial DNA Copy Number in Mouse Myometrium 
 
Mitochondria are double membrane organelles located in the cytosol of most 
eukaryotic cells.   They are responsible for maintaining cellular energy balance, 
specifically by carrying out oxidative phosphorylation (OXPHOS) energy production to 
produce adenosine-5'-triphosphate (ATP).  The majority of mitochondrial proteins are 
encoded by nuclear DNA.  However, mitochondria possess their own genome 
consisting of a circular duplex molecule, approximately 16569 base pairs long 
encoding 37 genes, 13 of which code for components of the electron transport chain, 
and the remainder code for 2 rRNAs and 22 tRNAs essential for mitochondrial 
polypeptide synthesis (Rothfuss et al., 2010, Malik and Czajka, 2012).  Mitochondrial 
protein content has been shown to be tissue specific and can vary between 500 to 
over 1000 proteins in different studies (Taylor et al., 2003, Johnson et al., 2007, Malik 
and Czajka, 2012, Smith et al., 2012a). The number of mitochondria in a cell varies 
depending on the specific energetic requirements of the cell, and can also depend on 
factors such as the stage in the cell cycle, the environment and redox balance of the 
cell, the stage of differentiation, and a number of cell signalling mechanisms 
(Rodriguez-Enriquez et al., 2009, Michel et al., 2012). 
Various methods have been developed to measure mitochondrial biogenesis and 
mass, such as staining with MitoTracker dyes and transmission electron and 
fluorescent microscopy have been used to visualise mitochondria in cells (Rodriguez-
Enriquez et al., 2009, Barbieri et al., 2011).  Another approach includes measurement 
of mitochondrial enzyme activities in tissue lysates (Cerqueira et al., 2011), which is 
described further in section 2.10.  Oxygen consumption can also be measured to 
quantify the respiratory function of mitochondria (Lehman et al., 2000, Fernandez-
Vizarra et al., 2011).  In recent years it has become more popular to measure 
mitochondrial DNA content as an index of mitochondrial content.  As mitochondria 
contain DNA distinct from the nuclear genomic DNA, a convenient way to measure 
mitochondrial DNA content in a cell is to measure mitochondrial versus nuclear 
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genome ratio, termed Mt/N (Malik et al., 2011) otherwise known as mitochondrial ―copy 
number‖.  The amount of mitochondrial DNA in a cell could provide a major regulatory 
point in mitochondrial activity, as the transcription of mitochondrial genes is 
proportional to their copy number (Hock and Kralli, 2009, Williams, 1986).  This 
approach involves isolation of genomic DNA from cells or tissues of choice, and the 
use of qPCR to quantify a mitochondrial and a nuclear gene (Malik and Czajka, 2012). 
 
2.9.1 Mitochondrial DNA content in mouse myometrium protocol 
Genomic DNA was extracted from mouse myometrium from non-pregnant females in 
oestrous and late pregnant (day 18) mice (as described in section 2.2.6).  Real Time 
qPCR (as described in section 2.3.9) was performed for the primers listed in Table 2.6.  
Primer sequences were acquired from Dr Afshan Malik‘s group (Diabetes & Nutritional 
Sciences Division, King‘s College London, UK), who have identified unique regions in 
the mouse mitochondrial sequence which are not duplicated in the nuclear genome.  
These sequences are yet to be published.  Data were expressed as Mt/N ratio: the 
qPCR derived copy number for the mouse mitochondrial genome relative to the mouse 












Table 2.6 Oligonucleotide primer sequences used to determine mitochondrial copy 
number 
Primer Sequences 
mouse mitochondrion complete genome 
(Accession number: NC_005089.1) 
Forward  primer:  
5‘-CTAGAAACCCCGAAACCAAA -3‘ 
Reverse primer:  
5‘-CCAGCTATCACCAAGCTCGT-3‘ 
mouse 2M (beta-2 microglobulin) 




Reverse primer:  
5‘-CAGTCTCAGTGGGGGTGAAT-3‘ 
















2.10 Mitochondrial Electron Transport Chain Enzymatic Activities in 
Mouse Myometrium 
 
The mitochondrial electron transport chain, compromising four mitochondrial 
complexes and an ATP synthase complex, pumps protons into the mitochondrial 
intermembrane space.  This builds up a proton gradient which can be used by ATP 
synthase to produce ATP by oxidative phosphorylation (Figure 2.13).  ATP is then 
transported to the region(s) of the cell it is required and broken down to ADP, releasing 
usable energy (Cox and Nelson, 2008). 
 
 
Figure 2.13 Mitochondrial oxidative phosphorylation 
Within the mitochondria, electrons from NADH and other oxidized substrates pass through a 
chain of carriers/complexes arranged asymmetrically in the inner membrane.  Electron flow 
coupled with proton transfer across the membrane, producing both a chemical gradient (ΔpH) 
and an electrical gradient (Δψ). The inner mitochondrial membrane is impermeable to protons; 
protons can re-enter the matrix only through proton-specific channels (Fo). The proton-motive 
force that drives protons back into the matrix provides the energy for ATP synthesis, catalyzed 
by the F1 complex associated with Fo (ATP synthase complex).  Figure from: Lehninger 




Reactive oxygen species are normal by-products of the mitochondrial electron 
transport chain.  ROS progressively damage the components of mitochondria, inducing 
the dysfunction of the electron transport chain (oxidative phosphorylation) and 
increased ROS production through a vicious cycle, ultimately leading to cellular 
dysfunction and ageing (Lagouge and Larsson, 2013).  Oxidative phosphorylation in 
myometrial tissues was measured as part of this thesis, since it was hypothesized that 
tissues from older mice compared to younger would exhibit ROS-induced dysfunction 
of the electron transport chain that would consequently result in reduced ATP 
generation and energy availability for effective uterine contractions during labour. 
The assay used in this study evaluates the maximal activity of three of the enzyme 
complexes preceding ATP synthase of the mitochondrial electron transport chain 
complex enzymes.  This assay was carried out using snap frozen tissues collected 
over a two year time span.  ATP synthase and ATP production cannot be measured 
after freezing as this disrupts the membrane and no membrane potential can  build up 
for ATP production.  This method was developed at the National Hospital for 
Neurology and Neurosurgery (University College London) for the analyses of biopsies 
from patients considered to be suffering from mitochondrial based disorders.  The 
major strength of this assay is that it directly measures mitochondrial enzyme activity 
and does not rely on indirect markers. 
 
The principle of measuring citrate synthase activity:  
Citrate synthase [EC 2.3.3.1] is a pacemaker enzyme in the Krebs cycle. It is nuclear 
encoded and synthesized on cytoplasmic ribosomes, but transported into and localized 
in the mitochondrial matrix.  Citrate synthase is therefore used as a quantitative marker 
enzyme for intact mitochondria (Holloszy et al., 1970, Williams et al., 1986, Hood et al., 
1989), although this role of citrate synthase has been questioned in age related studies 
(Marin-Garcia et al., 1998).  Proliferation of mitochondria in pathological studies is 
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usually associated with an increase in citrate synthase activity per cell, but citrate 
synthase activity in a specific tissue is frequently constant when expressed per 
mitochondrial protein.  Mitochondrial respiration whether cellular or tissue, can 
therefore be expressed per citrate synthase activity for specific applications 
(Kuznetsov et al., 2002, Hutter et al., 2004, Renner et al., 2003). 
The principle of this assay is that it catalyses the condensation of oxaloacetate and 
acetyl-CoA to form citryl-CoA and free Coenzyme A.  The activity of citrate synthase is 
measured by the reaction of free CoA with DTNB at an absorbance of 412 nm 
(Shepherd and Garland, 1969, Kuznetsov et al., 2010).  This assay is routinely used as 
an index of mitochondrial content.   
Oxaloacetate + Acetyl CoA  Citrate + Coenzyme A 
Coenzyme A + DTNB  DTNB-CoA (absorbs at 412 nm) 
 
The principle of measuring complex I activity:  
Complex I, NADH: ubiquinone oxidoreductase [EC 1.6.5.3] is the first complex in 
oxidative phosphorylation.  It is the entry point for electrons into the respiratory chain 
by oxidation of NADH and transport of electrons to coenzyme-Q10.  Complex I also has 
proton-transporting activity over the inner mitochondrial membrane to the 
intermembrane space.  The most commonly used technique for measuring complex I is 
a spectrophotometric assay measuring rotenone-sensitive NADH oxidations at 340 nm 
in tissue homogenate.  Complex I is sensitive to different pathologies, particularly to 
oxidative stress, which is involved in ageing, ischemia-reperfusion injury, and 
anoxia/reoxygenation (Kuznetsov and Gnaiger, 2010, Rouslin, 1983, Rouslin and 
Millard, 1981, Rouslin and Ranganathan, 1983). 
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Complex I catalyses the oxidation of NADH.  Electrons are transferred from NADH 
through complex I to ubiquinone-1 (CoQ1) as an electron acceptor, which is reduced to 
ubiquinol.  Complex I activity is measured as the rotenone-sensitive decrease in NADH 
at 340 nm to its non-absorbing oxidised form NAD+ (Hatefi and Stiggall, 1978). 
NADH + H+ + ubiquinone-1 (CoQ1)             NAD
+ + dihydroubiquinone-1 (CoQH2) 
 
The principle of measuring complex II activity: 
Complex II, succinate-ubiquinone oxidoreductase [EC 1.3.5.1], is the only membrane-
bound enzyme in the Kreb‘s cycle and is the second complex of the mitochondrial 
electron transport system. It catalyses electron transfer from succinate to the electron 
carrier, ubiquinone, but unlike the other four complexes it is not a proton pump. 
Succinate is oxidised to fumerate and ubiquinone is reduced to ubiquinol.  Ubiquinol is 
utilized by complex III in the respiratory chain and fumarate is necessary to maintain 
the Kreb‘s cycle (Cecchini, 2003, Sun et al., 2005, Gnaiger, 2011). 
 
Succinate + ubiquinone (Q)                Fumarate + ubiquinol (QH2) 
 
In this reaction, succinate oxidation by complex II reduces decylubiquinone which 
spontaneously transfers its electrons to the dye DCPIP (2,6-diclorophenolindophenol). 
The change (usually decrease) in absorbance is measured at 600 nM. 
 




The principle of measuring complex III activity: 
Complex III, Ubiquinone- cytochrome c- oxidoreductase [EC 1.10.2.2] is the third 
enzyme complex of the mitochondrial electron transport chain.  Complex III transfers 
two electrons from ubiquinol to ferricytochrome c and translocates four protons per pair 
of electrons transported into the intermembrane space (two from ubiquinol and two 
from the mitochondrial matrix). The function of complex III is crucial for the activity of 
the entire electron transport chain, since complex III can be rate-limiting in 
mitochondria activity (Krahenbuhl et al., 1994). 
Complex III activity is measured by monitoring the reduction of cytochrome c when 
reduced decylubiquinone is used as a substrate and complexes I and IV activities are 
blocked by specific inhibitors (Krahenbuhl et al., 1994). The change in absorbance at 
550 nm is measured.  KCN is used to inhibit complex I by blocking electron transfer 
from NADH, via complex I to ubiquinone, thereby assuring that all reduction of 
cytochrome c is via complex II. KCN also inhibits complex IV, ensuring that there is no 
re-oxidation of cytochrome c.  The specificity of this assay is determined by measuring 
the absence or presence of antimycin A, a specific inhibitor of complex III activity.  The 
activity of complex III is measured by following the increase in the absorbance at 550 
nm that corresponds to the reduction of cytochrome c.  Complex III activity is then 
determined by the difference of the slopes before and after the addition of antimycin A. 
Ubiquinol—cytochrome-c oxidoreductase catalyzes the chemical reaction: 
Decylubiquinol +2 ferri-(Fe3+) cytochrome c           quinone +2 ferro-(Fe2+)cytochrome c  




2.10.1 Mitochondrial electron transport chain enzyme activity protocol 
Experiments were carried out during a laboratory visit to Joseph Fourier University, 
Grenoble, France.  Experimental protocols adopted were those that were routinely 
used within the laboratory by Dr Luc Demaison and Dr Evangelia Mourmoura 
(Mourmoura et al., 2011). 
 
Uterine muscle sample preparation  
Non-pregnant (oestrous) and late pregnant (day 18) uterine tissues were dissected 
and immediately snap frozen in liquid nitrogen as described in section 2.1.3.  Uterine 
samples (50 mg) were homogenised in 1:9 (w/v) 100 mM potassium phosphate 
(K2HPO4∙3∙H2O) buffer; pH adjusted to 7.4 using 100 mM potassium dihydrogen 
phosphate (KH2PO4) buffer.  Homogenisation was carried out at 4°C in 2 ml RNAse-
free round bottomed microcentrifuge tubes (Eppendorf, Germany), using a 
TissueLyser (Qiagen, UK; 2 minutes at 30Hz using two 5mm steal beads) until the 
tissue had been visibly broken down.  The homogenates were centrifuged (1,500×g, 5 
min, 4°C), and the resulting supernatants were stored at −80°C until determination of 









Measurement of enzymatic activities  
Enzymatic activities of the NADH-ubiquinone oxydo-reductase (complex I), succinate-
ubiquinone oxydo-reductase (complex II), ubiquinol cytochrome c reductase (complex 
III) and citrate synthase were assayed using a spectrophotometer (Uvikon 941; 
Kontron Instruments, UK) in cuvettes containing 1 ml final volumes. 
NADH-ubiquinone oxydo-reductase, complex I activity was determined 
spectrophotometrically by measuring the depletion of NADH at 340 nm in the presence 
of decylubiquinone.  For each test sample, a 1 ml cuvette was placed into the 
spectrophotometer, and the reaction medium (pH 7.4) was made up by adding 47.5 
nM potassium phosphate (K2HPO4∙3∙H2O) buffer, bovine serum-albumin (3.75 mg/ml), 
0.1 mM NADH and 0.1 mM decylubiquinone to the cuvette.  The reaction was initiated 
by adding 5 l of 1: 200 diluted sample to the cuvette.  The change in absorbance at 
37°C was measured for two minutes, after which absorbance reading was stopped, 
and 10 μM rotenone was added to the cuvette.  The change in absorbance was 
measured again for two minutes to evaluate the specific and nonspecific activities of 
complex I. 
Succinate-ubiquinone oxydo-reductase, Complex II activity was again determined 
spectrophotometrically in the presence of succinate by measuring the disappearance 
of dichloro-inophenol (DCIP).  In this reaction, oxidation of succinate by complex II 
causes reduction of decylubiquinone which spontaneously transfers its electrons to 
DCIP.  For each test sample, a 1 ml cuvette was placed into the spectrophotometer.  
The reaction medium (pH 7.4) was made up by adding 45.4 mM potassium phosphate 
(K2HPO4∙3∙H2O) buffer, bovine serum-albumin (2.5 mg/ml), 9.3 M antimycin A, 5 M 
rotenone, 100 M DCIP, 30 mM succinate, and 10 l of 1: 200 diluted sample to the 
cuvette.  The reaction mixture was stirred at 37°C inside the spectrophotometer for ten 
minutes, after which the reaction was initiated by addition of 50 M decylubiquinone. 
The change in absorbance was then measured at 600 nM for five minutes. 
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Ubiquinol cytochrome c reductase, Complex III activity was spectrophotometrically 
determined for each test sample by measuring the depletion of cytochrome c when 
decylubiquinol was used as substrate and complexes I and IV were blocked by specific 
inhibitors. The change in absorbance at 550 nm was first evaluated at 30°C for one 
min in the presence of 90.7 mM potassium phosphate buffer (pH 7.4), 50 μM EDTA, 
bovine serum-albumin (1 mg/ml), 1 mM KCN, 100 μM oxidized cytochrome c, 0.11 mM 
decylubiquinol and 5 l of 1: 200 diluted sample in order to evaluate total activity. Then 
the non-specific activity was measured for two minutes with the addition of antimycin A 
(5 μg/ ml) to the cuvette.  Complex III activity was then calculated by subtraction of this 
non-specific activity. 
Finally, citrate synthase activity was also measured spectrophotometrically.  Citrate 
synthase catalyses the condensation of oxaloacetate and acetyl-CoA to form citryl-
CoA and free Coenzyme A.  Citrate synthase activity was measured for each test 
sample by the reaction of free Coenzyme A with DTNB at 412 nm. The reaction 
medium was made up by the addition of 84.5 mM Tris-Triton (Tris/0.1% [v/v] Triton) 
buffer (pH 8), 150 mM DTNB, 250 mM Acetyl CoA, and 5 l 1: 200 diluted sample into 
a 1 ml cuvette placed into the spectrophotometer.  The change in absorbance at 37°C 
was measured for two minutes, after which the reading was stopped, and 500 μM 
oxaloacetate was added to the cuvette. The absorbance was measured for a further 
two minutes.  The difference in absorbance values before and after oxaloacetate was 
calculated to determine citrate synthase activity. 
Protein content in each of the sample homogenates was determined by a commercially 
modified Lowry method (DC Protein Assay; Bio-Rad, UK) as per manufacturer‘s 
recommendations. The activities of the electron transport chain complexes were 




2.11 Statistical Analysis 
 
Power calculations 
Power calculations were carried out for each study based on published data.  Animal 
numbers were calculated to give a minimum of 80% power to detect a minimum of 
20% difference between groups at the p<0.05 level.   
 
Statistical tests 
For most analyses, data were tested for normal/ Gaussian distribution using the 
D‗Agostino-Pearson omnibus normality test before running further parametric statistical 
analyses (as recommended by GraphPad Prism version 5.0; GraphPad Software, 
USA).  Parametric statistical analyses such as Student‘s t-test and one-way analysis of 
variance (ANOVA) assume that the data being analysed follows a normal distribution 
(Ghasemi and Zahediasl, 2012).  It was therefore important to test whether my data 
were normally distributed before confirming that Student‘s t-test and ANOVA were the 
most appropriate tests to identify statistical differences. GraphPad Prism version 5.0 
offers three normal distribution tests, of which it highly recommends the D‗Agostino-
Pearson omnibus normality test.  At first, this test computes the skewness (how 
symmetrical the distribution is) and kurtosis (whether the shape of the data distribution 
matches the Gaussian distribution) to quantify how far from Gaussian the distribution 
is. It then calculates how far each of these values differs from the value expected with 
a normal distribution, in order to compute a single p value from the sum of these 
discrepancies (D‘Agostino et al., 1990).  Student‘s t-test was used to assess data 
between two groups, and one-way analysis of variance (ANOVA) followed by all 
pairwise multiple comparison (Tukey‘s test) when comparing three or more groups.  
Data were expressed as mean ± standard error of the mean (SEM) and p < 0.05 was 
considered significant; ‗n‘ refers to the number of animals per test group.  Linear 
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regression analyses were carried out using Stata version 11.2 (StataCorp, College 
Station, USA), p<0.05 was considered significant.  Specific details of any other 





Timing of Parturition in Mice 









As detailed in Chapter 1, the average maternal age of primiparous mothers in 
developed countries has risen steadily over the last decade, with women over the age 
of 35 comprising a significant proportion of the pregnant population (Bewley et al., 
2009). Such trends are reflected by a simultaneous rise in the reported incidence of 
complications in pregnancy and during labour, which include miscarriage, stillbirth, 
preterm labour as well as post-term inductions, increased Caesarean section and 
instrumental delivery rates, failure to progress in labour, and postpartum haemorrhage 
(Gilbert et al., 1999, Ecker et al., 2001, Ziadeh and Yahaya, 2001, Tough et al., 2006, 
Jahromi and Husseini, 2008, Smith et al., 2008, Chan and Lao, 2008, Bewley et al., 
2009, Ludford et al., 2012, Karabulut et al., 2013, Khalil et al., 2013).  It raises the 
question as to how maternal age impacts on reproductive physiological processes, 
particularly in relation to parturition.    
In animal studies of reproductive ageing, an increased length of gestation has been 
reported in a variety of species including goat, cow, sheep, hamster, rat and mouse 
(Asdell, 1929, Brakel et al., 1952, Terrill and Hazel, 1947, Soderwall et al., 1960, 
Moore, 1963, Holinka et al., 1978).  Some have also reported an association of 
increased fetal mortality with prolonged gestation in rodents (Kroc et al., 1959, Moore, 
1963, Holinka et al., 1978).  However there is very limited information available about 
the impact of ageing in relation to parturition in mice, particularly in the C57BL/6 strain.  
The prime objective for this part of my thesis was to validate the use of an aged 
primiparous pregnant mouse model by demonstrating that it successfully reflects the 
human situation with regard to increased gestation and length of labour.  
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Mice make convenient models for experimentation since they have a short gestation 
duration of 19 days compared to that of approximately 280 days in humans.  However, 
there are distinct differences between human and mouse reproductive physiology 
which may limit the extent to which these models can provide meaningful evidence 
regarding the physiological mechanisms of human gestation.  As detailed in Chapter 1, 
humans have a single chamber uterus whereas mice have two uterine horns.  Mice 
also have a larger litter size of six to ten pups on average compared to a single fetus in 
most human pregnancies (Mitchell and Taggart, 2009, Ratajczak et al., 2010).  The 
most important drawback of a mouse model of human parturition is that humans and 
mice regulate the production of progesterone differently.  In humans, the initial site of 
progesterone production during gestation is the corpus luteum.  However, five to six 
weeks after conception, the placenta is the major source of progesterone thereafter 
(Mitchell and Taggart, 2009).  In mice, the corpora lutea are responsible for 
progesterone production throughout gestation, and their luteolysis induces a rapid fall 
in maternal progesterone concentrations triggering the onset of labour; however this is 
not consistent with the triggers for the onset of labour in humans (Ratajczak et al., 
2010).  It is also important to note that average life span of C57BL/6 mice is less than 
two years (Storer, 1966), whereas humans can live in excess of 80 years old, with an 
estimated maximum life span of 120 years (Ruiz-Torres and Beier, 2005) suggesting 
that the ageing processes between the two species may differ.  Although there are 
limitations for the use of a mouse model to represent human parturition, it is technically 
difficult to obtain myometrial and cervical samples from women of advanced maternal 
age that do not have any confounding factors such as high BMI associate with them.  
Therefore it is difficult to fully explore the mechanisms of how maternal age impacts on 
reproductive physiological processes, particularly in relation to parturition in humans 






Full descriptions and details of the methods used are described in Chapter 2, section 
2.5.  The age of mice as indicated within this chapter relate to the age of the dam at 
conception.  The precise time of birth, marking the end of gestation, was determined 
by the appearance and complete delivery of the first pup.  The precise duration of 
parturition was measured as the exact difference in time between the complete 
delivery of the first pup and the complete delivery of the last pup.  Both time of first 
birth and duration of parturition were determined by either direct observation or by 
examination of video footage.  Gestation length was counted as the number of days 
between conception and complete delivery of the first pup.  Each pup (both live and 
stillborn) delivered per mouse was individually weighed within 6 hours after completion 
of parturition.   
All data within this chapter were found to be normally distributed using the D‘Agostino-
Pearson omnibus normality test (GraphPad Prism version 5.0; GraphPad Software, 
USA) unless otherwise stated.  Student‘s t-test was used to assess data between the 
two groups.  Data were expressed as mean ± standard error of the mean (SEM) and 
p<0.05 was considered significant; ‗n‘ refers to the number of animals per sample 











3.3.1 Determination of gestation length by continuous infra-red video recording 
and direct observation  
 
An increased length of gestation of 20.1 ± 0.2 days was recorded in the older pregnant 
(eight month old) mice (n = 6), compared to 19.1 ± 0.1 days in younger pregnant (three 
month old) mice (n = 8, p<0.001) (Figure 3.1). Overall, 66.6% of the 8 month old mice 
had a gestation of 20 days, and 25% of mice in this group failed to maintain pregnancy 
to term (Table 3.1). 
 
Table 3.1 Individual gestation lengths between C57BL/6J mice aged three months versus 
eight months 
Mouse ID Gestation length 
(Days) 
% Mothers that exhibited 
spontaneous labour  
3 month (1) 19.1  
3 month (2) 19.1  
3 month (3) 19.1  
3 month (4) 19.1  
3 month (5) 19.4  
3 month (6) 18.5  
3 month (7) 19.1  
3 month (8) 18.9 100% (n = 8 of 8) 
   
8 month (1) 20.4  
8 month (2) 20.3  
8 month (3) 19.5  
8 month (4) 19.5  
8 month (5) 20.1  
8 month (6) 20.7  
8 month (7) Failed to maintain pregnancy  









































Figure 3.1 Eight month old pregnant mice have a longer gestation length than three 
month old pregnant mice 
Scatter graph presenting individual gestation lengths in three month old (n = 8, light blue 
circles) and eight month old (n = 6, dark blue squares) pregnant mice.  Gestation was 
significantly longer in eight month old mice, *** p<0.001, Student‘s t-test.  Horizontal bars 
indicate means, and error bars indicate ± SEM. Gestations with similar lengths are shown as 






3.3.2 Duration of parturition as a function of maternal age 
Direct observation combined with infrared video recording indicated that pregnant mice 
of both age groups exhibited common behavioural signs prior to and during labour; 
these included whole body quivering, grooming of vaginal area, and repeated cycles of 
standing on hind legs followed by stretching out rear body in a lordosis-like movement.  
Figure 3.2 shows some still images captured from the video recording to illustrate 
common labour behaviours.  
Labour duration was influenced by reproductive age; eight month old pregnant mice 
had a significantly longer mean duration of parturition (3.7 ± 0.3 hours, n = 6) 
compared to 1.0 ± 0.2 hours exhibited by the three month old group (n = 8, p<0.001) 
(Figure 3.3).  Parturition in older mice was prolonged by approximately 2.7 hours (162 




























Figure 3.2 Representative images from continuous infrared video recording showing common movements displayed prior to and during labour 


































Figure 3.3 Eight month old pregnant mice have a longer duration of labour than three 
month old pregnant mice 
Scatter graph presenting individual labour durations in three month old (n = 8, light blue circles) 
and eight month old (n = 6, dark blue squares) pregnant mice.  Parturition was significantly 
longer in older eight month old mice, *** p<0.001, Student‘s t-test. Horizontal bars indicate 







3.3.3 Litter size as a function of maternal age 
The number of pups (live and stillborn) delivered per mother was influenced by 
reproductive age; eight month old pregnant mice (n = 6) had a significantly reduced 
mean litter size of 4.8 ± 0.9 pups compared to 7.5 ± 0.2 pups delivered by the three 
month old mothers (n = 8, p<0.01) (Table 3.3, Figure 3.4).  Litter size in older mothers 
was reduced by 36% compared to younger mothers.  As shown in Table 3.2, 50% of 
the mothers in the eight month old group delivered stillborn pups, whereas none of the 
younger mothers did so.   
 
Table 3.2 Individual litter sizes born to C57BL/6J mice of maternal ages three month old 
versus eight month old 
Mouse ID Litter size 
 (Days) 
% Mothers that 
delivered stillborn 
pups 
3 month (1) 8  
3 month (2) 8  
3 month (3) 7  
3 month (4) 7  
3 month (5) 7  
3 month (6) 7  
3 month (7) 8  
3 month (8) 8 0% (n= 0 of 8) 
   
8 month (1) 1  
8 month (2) 4 (1 still born)  
8 month (3) 7 (1 still born)  
8 month (4) 7  
8 month (5) 5  
8 month (6) 5 (1 still born)  
8 month (7) Failed to maintain pregnancy  
8 month (8) Failed to maintain pregnancy 50% (n= 3 of 6) 






As highlighted in Table 3.2, two of the eight month old mice failed to deliver by day 22.  
All mice, regardless of age group, were confirmed pregnant on day 15 of gestation, but 
by day 22 the two older mice had intrauterine fetal loss and fetal resorption, as 
determined by uterine dissection. Taking this into account, four of the total eight (50%) 
older pregnant mice experienced some degree of fetal loss; no fetal loss was evident 
in the younger pregnant mice. 
 































Figure 3.4 Eight month old pregnant mice have a reduced litter size compared to three 
month old pregnant mice 
Bar graph illustrating litter size for three month old (n = 8) and eight month old (n = 6) pregnant 
mice.  Litter size was significantly reduced in older eight month old mice, ** p<0.01, Student‘s t-






3.3.4 Pup weight as a function of maternal age 
Reproductive age had no effect on the mean pup weight of the litter. There was no 
significant difference between the mean pup weight delivered by older pregnant mice: 
1.59 ± 0.07 g (n = 29, from n = 6 mice) compared to 1.54 ± 0.04 g delivered by the 
younger mice (n = 60, from n = 8 mice) (Figure 3.5).   
 
 




























Figure 3.5 Mean pup weight delivered by three month old pregnant mice was similar to 
that of eight month old pregnant mice 
Bar graph presenting mean pup weight delivered by three month old pregnant mice (n = 60, 
from n = 8 mice) and eight month old pregnant mice (n = 29, from n = 6 mice).  Statistical 







3.3.5 Length of gestation as a function of maternal age and/or litter size 
Linear regression analyses were carried out to determine whether the prolongation of 
gestation in older mice could be explained not only by an influence of maternal age but 
also mechanistically because of a reduction in litter size in this group.  The impact of 
older maternal age on gestation length was 1.03 days (95% CI: 0.59 to 1.47; p<0.001), 
which remained significant after adjustment for litter size, the effect of maternal age on 
gestation length, was 0.64 days (95% CI: 0.12 to 1.16; p<0.05).  This result indicates 
that 62% of the increase in gestation length in older mice is due to maternal age 
(Figure 3.6). 
Conversely, the impact of increasing litter size by one pup would reduce gestation 
length by 0.26 days (95% CI: -0.38 to -0.14; p<0.001), but after adjustment for 
maternal age the impact of increasing litter size by one pup was a reduction in 
gestation length by 0.15 days (95% CI: -0.28 to -0.01; p <0.05) (Figure 3.6).   
A final linear regression showed there was no significant interaction between maternal 
















Figure 3.6 Gestation length in C57BL/6J mice as a function of maternal age and litter size 
Scatter plot illustrating the relationship between gestation length and litter size in three month 
old (n = 8, dark blue triangles) and eight month old (n = 6, red circles) pregnant mice. Gestation 
length is prolonged with older maternal age, and with smaller litter size; however, there is no 
significant interaction between maternal age and litter size on the control of gestation length; 










3.3.6 Duration of parturition as a function of maternal age and/or litter size 
Further linear regression analyses were carried out to determine whether the 
prolonged duration of labour in older mice could be explained not only by an influence 
of maternal age but also mechanistically because of a reduction of litter size in this 
group.  The impact of maternal age on labour duration was 2.67 hours (95% CI: 1.93 to 
3.41; p<0.001); after adjustment for litter size, the effect of maternal age on labour 
duration was 1.77 hours (95% CI: 1.14 to 2.39; p<0.001).  These data indicate that 
66% of the increase in labour duration in older mice is due to maternal age (Figure 
3.7). 
Conversely, the impact of increasing litter size by one pup would reduce labour 
duration by 0.65 hours (95% CI: -0.89 to -0.42; p<0.001); this remained significant after 
adjustment for maternal age, the impact of increasing litter size by one pup was a 
reduction in labour duration by 0.34 hours (95% CI: -0.50 to -0.18; p<0.001) (Figure 
3.7). 
A final linear regression found no significant interaction between maternal age at 
















Figure 3.7 Labour duration in C57BL/6J mice as a function of maternal age and litter size  
Scatter plot illustrating the relationship between duration of labour and litter size in three month 
old (n = 8, dark blue triangles) and eight month old (n = 6, red circles) pregnant mice.  Labour 
duration is prolonged with older maternal age, and with smaller litter size; however, there is no 
significant interaction between maternal age and litter size on the control of labour duration; 










This study which focused on the impact of maternal age (at conception) on gestation 
length indicates that older mice are more likely to have prolonged pregnancies and 
longer labours compared to younger mice.  Pregnancy in older mice is also associated 
with a reduced litter size and increased number of failed pregnancies/still births. This 
study supports the use of three month and eight month old pregnant C57BL/6J mice as 
a useful model of reproductive ageing in relation to parturition, and is also the first 
study to demonstrate that an aged primiparous C57BL/6J pregnant mouse model can 
successfully reflect increased gestation and length of labour as seen in humans.   
Observations of gestation length, accurately recorded by infra-red recording and/or 
direct observation in C57BL/6J mice, clearly demonstrated that pregnancy duration is 
significantly prolonged by 1.03 days or 5% of a normal 19 day gestation in older eight 
month old primiparous mice.  This observation confirms data from a series of historic 
studies and some more recent reviews that also report a marked increase in gestation 
length seen with advancing maternal age across various species including C57BL/6J 
mice and humans (Asdell, 1929, Brakel et al., 1952, Terrill and Hazel, 1947, Soderwall 
et al., 1960, Moore, 1963, Holinka et al., 1978, Silk et al., 1993, Jolly et al., 2000, Roos 
et al., 2010).  The only known study to report prolonged gestation in aged C57BL/6J 
mice used the direct observation method and proven breeders up to the age of 11 to 
12 months.  They reported a gestation increase of 2.2 days in these aged mice 
(Holinka et al., 1978).  The present study provides novel data showing that the length 
of gestation in primiparous C57BL/6J mice is prolonged from the age of eight months, 






Labour duration was also significantly lengthened by 3.6 fold in older mice compared 
to the younger age group; previous studies have not examined this in any detail in 
other animal species, including C57BL/6J mice. The novel use of infra-red video 
recording greatly facilitated data collection, as can be seen by the representative 
images extracted from 80 hours of video. The methodology employed in this study is 
similar to that previously published (Brown et al., 2009), but the combined use of video 
recording and direct observation where possible allowed for identification of 
behavioural labour signs and therefore accurate determination of pregnancy length (to 
delivery of first pup) and the duration of labour, which are rarely reported in the 
literature. As far as can be ascertained, this is the first study to confirm that labour 
duration in first pregnancies is increased with age in C57BL/6J mice. 
The present study identified a negative relationship between reproductive age at 
conception and resultant litter size at term.  Older mice delivered smaller litters and 
had a greater incidence of stillbirth. Additionally, a small number of older (eight month 
old) mice failed to deliver by 22 days of gestation and this was most likely due to pup 
resorption.  A reduction in litter size in older animals has been reported previously 
across various species including C57BL/6J mice (Soderwall et al., 1960, Finn, 1963, 
Holinka et al., 1978, Holinka et al., 1979, Lopes et al., 2009, Monclus et al., 2011, 
Kong et al., 2012).  Increased rates of resorption of conceptuses, intrauterine fetal 
deaths as well as stillbirth rate have also been reported in various studies of ageing 
rodents (Talbert, 1971, Holinka et al., 1979, Niggeschulze and Kast, 1994, Akiyama et 







Similarly, this present study identified a general negative relationship between litter 
size and gestation, independent of age, which confirms reported observations by 
others across many species including C57BL/6J mice (Biggers et al., 1963, McLaren 
and Michie, 1963, Holinka et al., 1978, Rydhmer et al., 2008).  There is little/no 
published data as far as can be ascertained relating to litter sizes in first pregnancies 
of reproductively aged C57BL/6J mice, the strain used in the current study.  The 
relative contribution of maternal age and litter size to gestation length and labour 
duration were statistically explored further and found that there is a contribution of 
both.  However, the influence of maternal age on both gestation and labour was 
greater than litter size. There was no interaction between maternal age and litter size, 
suggesting that these factors affect the process of parturition via independent 
mechanisms.   
An inverse relationship between fetal weight and litter size has been discussed by 
many authors (Biggers et al., 1963, Romero et al., 1992a, Damgaard et al., 2003, 
Freetly and Leymaster, 2004, Ishikawa et al., 2006, Akdag et al., 2009, Murray et al., 
2010), however in this present study there was no significant relationship found 
between mean pup weights and litter size, and likewise between pup weights of older 
and younger mothers. This may be a consequence of the relatively smaller sample 
size used in the present study compared to others.  
Data obtained in the current study is in agreement with both existing reproductive 
models of ageing in animals and published observations on reproductive ageing in 
humans. The length of labour and risk of prolonged labour has been reported to 
increase with increasing maternal age in humans (Greenberg et al., 2007).  In this 
human study, older nulliparous and multiparous women were found to have a higher 
risk of experiencing prolonged second stage of labour than did younger women, with 
an odds ratio of 3.90 for nulliparous women who were older than 39 years old, 
compared with women who were younger than 20 years old (95% CI, 2.70-5.62). 
Stillbirth and fetal loss are also common risk factors for mothers of advanced maternal 
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age; a recent study by Haavaldsen et al. (2010) found women older than 40 years of 
age had the highest risk of fetal death throughout pregnancy, particularly in term- and 
post-term pregnancies (Haavaldsen et al., 2010).  Another study reported the relative 
risk of stillbirth at 37-41 weeks of gestation was 1.88 (95% CI, 1.64-2.16) for women 
aged 40 years or over compared to women aged under 35 years (Reddy et al., 2006). 
There are a number of possible explanations for the maternal age related prolonged 
gestation length, but all still require further investigation. The most likely is a delay in 
the initiation of progesterone withdrawal, which is essential for the onset of parturition 
in rodents (Weiss, 2000).  Theoretically, the onset of progesterone withdrawal may 
either be delayed or the decline in circulating progesterone concentrations less rapid in 
older mice compared to younger mice.  Luteolysis, the structural and functional 
degradation of the corpus luteum driven by the release of prostaglandin F2from the 
endometrium (Mitchell and Taggart, 2009), induces the necessary fall in maternal 
progesterone concentrations in mice before labour.  A disruption in this pathway could 
alter the timing of luteolysis and hence cause a delay in progesterone decline in older 
mice.  However, the earliest significant decline in murine corpus luteum function has 
been reported to occur at 10 to 11 months of age (Harman and Talbert, 1970), so may 
not be as relevant to the 8 month old mice model used in this study.  Interestingly, 
Harman and Talbert reported that pregnant mice aged 12 to 13 months old mice had 
no recognisable corpus lutea or implantation sites.   
Luteolysis in the cow is believed to be caused by a pulsatile release 
of prostaglandin F2from the uterus with a positive feedback mechanism between 
endometrial prostaglandin F2and luteal oxytocin; luteal oxytocin has a physiologic 
role in the promotion of luteolysis (Shirasuna et al., 2007).  Based on this theory, luteal 
oxytocin may also be involved in the control of murine luteolysis. Therefore, one can 
postulate that oxytocin release from the corpus luteum in older mothers may also be 
delayed or impaired, preventing successful luteolysis.  
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In the present study, an attempt was made to obtain terminal blood samples from all 
mice to determine serum progesterone concentrations immediately postpartum.  
However, many of the samples obtained were of insufficient volume, which resulted in 
an inadequate sample size available for analysis. Also, terminal samples would not 
have been fully informative, as the majority of mice had gone into labour at this point.  
Ideally, to accurately measure the exact rate of maternal serum progesterone decline 
and determine whether this changes with maternal age in C57BL/6J mice, it would be 
more valuable to take serial blood samples from pregnant mice throughout pregnancy.  
This in itself would be likely to cause stress to the animals which is commonly 
associated with increased fetal loss and premature delivery. To overcome this, a pilot 
study could be carried out whereby bleeding takes place every other day from day 13 
(or even day 15) of gestation onwards. Alternatively, a cross sectional study might be 
more appropriate. Animals would be sacrificed at a range of gestations in both age 
groups. This approach would also allow accurate assessment of implantations sites 
and identify at which gestations fetal loss/resorption occurs.  
The reduction in litter size in older mothers in this study supports  well-established data 
from both humans and rodent models that indicate that viability decreases with an 
increase in maternal age (Khalil et al., 2013, Nagaoka et al., 2011, Qiao et al., 2013, 
Kermath and Gore, 2012, Kong et al., 2012).  Possible causes for fetal loss in older 
mothers in this study can be a result of reproductive senescence changes such as 
oocyte depletion and poor oocyte quality in aged ovaries resulting in the development 
of fewer and/or non-viable fetuses (Liu et al., 2013).  Decreased litter size is directly 
related to an increase in the number of defective blastocysts (as a consequence of 
abnormal embryonic development patterns) available for implantation. These 
observations suggest that pre- and peri-implantation failures may account for the 
decline in reproductive capacity displayed by aged mice (Day et al., 1991).  
Additionally, the reduction in litter size in older mothers could be explained by the 
failure of the aged uterus to maintain embryonic development (Talbert, 1971, Holinka 
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et al., 1979, Kong et al., 2012).  An increase in collagen has been reported in the 
uterus of female rodents as a function of age, which is proposed to play an important 
role in the decline in embryonic survival.  Increased collagen content is thought to 
mechanistically interfere with uterine vascularisation, which is required for successful 
implantation and embryonic survival (Biggers et al., 1962, Mulholland and Jones, 1993, 
Kong et al., 2012). 
Uterine stretch studies in multiple pregnancies in humans and rodents have implicated 
that there is a stretch-induced increase in the expression of oxytocin receptor, 
cytokines and gap junctions, such as connexin-43 in the myometrium, that trigger the 
development of co-ordinated uterine contractions at the onset of labour (Ou et al., 
1997, Lyall et al., 2002, Turton et al., 2013).   This stretch induced myometrial 
activation in rodents is thought to occur under low progesterone levels.  Therefore, if 
progesterone withdrawal is unaffected in the older mice in this study, the delay in the 
onset of labour and the increased duration of labour could be a result of reduced 
uterine stretch (due to fewer fetuses), meaning that the myometrium is not stretch- 
activated for co-ordinated contractions. 
In summary, the primiparous eight month old pregnant mouse was found to 
successfully reflect some of the key risk factors seen in pregnancies in older women 
such as delayed onset of parturition, prolonged duration of labour as well as greater 
risk of fetal loss.  In the following results chapters the myometrial expression of 
contractile associated proteins that are necessary for the onset of uterine contractions 
at labour and the ability of the myometrium to contact (both spontaneous and agonist 
induced) will be investigated in the older pregnant mouse model.  In addition, common 
markers of cervical ripening such as collagen degradation and the degree of cervical 
softening at term will be determined.  
These data will aim to determine whether there is a myometrial and/or cervical function 




Study limitations and future work 
Although the present study successfully validated a novel primiparous mouse model of 
reproductive ageing, further work may help to strengthen the model.  As mentioned 
above, the primary limitation to this study is that terminal blood samples were not 
collected for the entire sample set.  It would be advantageous to repeat this study and 
collect blood samples from day 13 of gestation onwards, to track maternal 
progesterone levels over late gestation.  This would give a better understanding of 
whether the delayed onset of labour in older primiparous mice is caused by a 
sustained elevation of maternal serum progesterone or via other mechanisms. Since a 
quarter of the older mothers experienced intra-uterine fetal loss and did not labour, it 
would also be valuable when repeating this study to use a larger sample size. 
Implantation sites were not examined; however, if done so, it would have given a better 
understanding of the degree of reproductive ageing in eight month old pregnant mice. 
  
Conclusions 
The outcome of this study adds to the existing data pertaining to reproductive ageing in 
mice and confirms that both gestation and parturition are prolonged in a primparous 
mouse model of maternal ageing, as well as deterioration in reproductive capacity 
reflected by a decline in litter size.  The mouse model mimics characteristics of the 
problems associated with ageing in humans and is a suitable model to further assess 
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Chapter 4 : Alterations in Cervical Remodelling as a 
Consequence of Reproductive Ageing in Mice 
4.1 Introduction 
 
As detailed in Chapter 1, cervical remodelling towards the end of pregnancy in mice 
can be divided into four stages: softening, ripening, dilation and postpartum repair 
(Word et al., 2007, Leppert, 1995, Timmons et al., 2010).  Cervical softening, the first 
stage, is defined as a change in the biomechanical properties of the cervix, specifically 
a measurable decline in tissue tensile strength when compared with the non-pregnant 
cervix and is characterised by a progressive decrease in tissue stiffness without loss of 
tensile strength (Leppert and Yu, 1994). The ability of the cervix to soften yet remain 
resistant to forces exerted upon it involves a dual mechanism in which there is an 
increase in the size of the cervix along with maintained stiffness of the cervical wall 
(Read et al., 2007). The ―strength‖ of cervical extracellular matrix is determined by the 
content and organisation of collagen.  Cervical softening is associated with 
disorganisation of the collagen network (House et al., 2009).  Final cervical ripening 
precedes the biomechanical dilation of the cervix during parturition.  Increased 
collagenases have been observed in the cervix during ripening, which degrade 
collagen and contribute to the reorganisation of the extracellular matrix before 
parturition.  Gelatinases such as MMP2 and MMP9 have been reported to cleave and 
consequently activate pro-collagenases and also target denatured collagen IV, and 
hence have been indicated to play a role in the cervical ripening process (Stygar et al., 
2002, Mahendroo, 2012). 
Since proper cervical function is essential for successful parturition to occur, the prime 
objective for this part of the thesis was to determine whether cervical softening, 
collagen content and expression of MMP2 were altered in aged eight month old 
primiparous pregnant mice and conclude whether the physiological preparation of 





Full descriptions and details of the methods are described in Chapter 2, sections 2.7 
and 2.8.  In summary, ex vivo tensile strength measurements of the cervix were used 
to assess cervical canal distension in three, five and eight month old non-pregnant and 
late pregnant mice.  Tension generated at the limit at which no further distension of the 
cervical canal could be achieved was recorded as maximum tension of the cervical 
tissues (understood as another measurement of cervical biomechanical properties).  
Collagen was detected by Masson‘s trichrome blue staining and MMP2 expression 
was detected by immunohistochemical staining in cervical tissues from non-pregnant 
and late pregnant mice of all ages.  All non-pregnant cervical tissues were collected 
when mice were in oestrous stage of their reproductive cycle and all late pregnant 
cervical tissues on day 18 of gestation.  The age of late pregnant mice (three, five and 
eight months) as indicated within this chapter relates to the age of dams at conception. 
All data within this chapter were found to be normally distributed using the D‘Agostino-
Pearson omnibus normality test (GraphPad Prism version 5.0; GraphPad Software, 
USA), unless otherwise stated.  Student‘s t-test was used to assess data between two 
groups and one-way analysis of variance (ANOVA) followed by all pairwise multiple 
comparison (Tukey‘s test) was used when comparing three or more groups.  Data 
were expressed as mean ± standard error of the mean (SEM), and p<0.05 was 










4.3.1 Biomechanical assessment of cervical softening 
Ex vivo tensile strength measurements in isolated cervices demonstrated that maximal 
distension (increase in cervical canal diameter) was significantly greater in mice of all 
ages in the late pregnant state compared to non-pregnant, implicating that some 
degree of cervical softening had occurred in all groups by day 18 of gestation (Figures 
4.1 and 4.2).  The maximal distension achieved by late pregnant cervical tissues 
compared to age matched non-pregnant tissues was 2.59, 2.88 and 1.82 fold higher 
for three, five and eight month old mice respectively (n = 6-9, p<0.0001 for all) (Figure 
4.2).   There was no significant difference between maximal distension obtained in 
tissues from non-pregnant mice aged three and five months of age, however there was 
a 1.72 fold increase in cervical distension in tissues from eight month old non-pregnant 
mice (10.6 ± 0.2 mm, n = 8) compared to the three month old group (6.2 ± 0.2 mm, n = 
6, p<0.001), and a 1.70 fold increase compared to the five month old non-pregnant 
group (6.3 ± 0.2 mm, n = 8, p<0.001) (Figure 4.2).  In late pregnant mice, cervical 
tissues from eight month old mice demonstrated a 1.21 fold increase in maximal 
cervical distension (19.3 ± 0.4 mm, n = 6) compared to the three month old late 
pregnant group (16.0 ± 0.5 mm, n = 9, p<0.001), and there was a 1.13 fold increase in 
tissues from five month old mice (18.0 ± 0.3 mm, n = 6) compared to the three month 































Figure 4.1 The impact of age on cervical distension induced by stretch in non-pregnant 
and late pregnant tissues 
Tension generated by the cervix is plotted as a function of incremental stretch of the cervical 
canal diameter as stress-strain curves.  Tissues obtained from non-pregnant three month (n = 
6, black/light blue circles), five month (n = 8, black/light purple triangles), and eight month (n = 
8, blue diamonds) old mice, as well as late pregnant three month (n = 9, light blue squares), five 
month (n = 6, black/ blue inverted triangles), and eight month (n = 6, black/dark blue circles) old 
mice.  Summary measure means were significantly different between non-pregnant mice aged 
three months compared  to eight months, and five months compared to eight months (** 
p<0.01), as well as non-pregnant compared to late pregnant mice of all three age groups (*** 













































Figure 4.2 Maximum distension of cervical canal is enhanced in older eight month old 
mice both in non-pregnant and late pregnant states compared to younger age group 
Cervices from non-pregnant three month [NP(3), n = 6], five month [NP(5), n = 8], and eight 
month [NP(8), n = 8] old mice, as well as late pregnant three month [LP(3), n = 9], five month 
[LP(5), n = 6], and eight month [LP(8), n = 6] old mice were distended until no further stretch of 
the cervical canal was possible.  Transition from non-pregnant to pregnant state, significantly 
increased maximal cervical distension in all three age groups, *** p<0.001.  Advance in age 
from three to eight months, and five to eight months in non-pregnant mice, and from three to 
five to eight months in late pregnant mice also significantly increased maximal cervical 
distension, ** p<0.01 and *** p<0.001; ANOVA followed by all pairwise multiple comparison 







Maximal tension of cervical tissues was significantly reduced by a factor of 0.78 in late 
pregnant mice of three months of age (34.2 ± 2.3 g, n = 9) compared to age matched 
non-pregnant cervical tissues (44.0 ± 1.0 g, n = 6, p<0.05).  Similarly, maximal tension 
was significantly reduced in cervical tissues from five month old late pregnant mice 
(32.5 ± 1.5 g, n = 6) by a factor of 0.79 compared to cervices from non-pregnant mice 
of five months of age (41.1 ± 1.6 g, n = 8, p<0.05) (Figure 4.3).   This difference was 
not apparent in tissues taken from eight month old mice.  There was no age-specific 
change in maximal tension developed in cervical tissues taken from non-pregnant mice 
(three, five and eight month age groups). Likewise, the maximal tension values 
developed in cervical tissues taken from three, five and eight month old late pregnant 
mice were similar, again displaying no age induced effect (Figure 4.3).   
Cervical stiffness was determined as the slope of cervical distension stress-strain 
curves as demonstrated in Figure 4.1.  Cervical stiffness was significantly reduced in 
mice of all ages in the late pregnant state compared to non-pregnant by a factor of 
0.32, 0.27 and 0.49 for three, five and eight month old mice respectively (n = 6-9, 
p<0.0001 for all) (Figure 4.4). There was no significant difference in cervical stiffness 
between tissues from non-pregnant mice aged three and five months of age, however 
there was a decline by a factor of 0.48 between the three (7.1 ± 0.2 g/mm, n = 6) and 
eight (3.4 ± 0.2 g/mm, n = 8, p<0.001) month old non-pregnant groups, and a factor of 
0.5 between the five (6.584± 0.2 g/mm, n = 8) and eight month old non-pregnant 
groups (p<0.001) (Figure 4.4). There was no difference in cervical stiffness measured 







































Figure 4.3 Maximum cervical tension is reduced in late pregnant mice of three and five 
months of age compared to age matched non-pregnant mice 
Cervices from non-pregnant three month [NP(3), n = 6], five month [NP(5), n = 8], and eight 
month [NP(8), n = 8] old mice, as well as late pregnant three month [LP(3), n = 9], five month 
[LP(5), n = 6], and eight month [LP(8), n = 6] old mice were distended via the cervical canal until 
no further increase in tension was generated by cervical tissues.   Transition from non-pregnant 
to pregnant state significantly reduced maximal cervical tension in three and five month old 
mice, *p<0.05; however this was not apparent in eight month old mice; ANOVA followed by all 
pairwise multiple comparison Tukey‘s test. Data expressed as mean ± SEM maximum tension 







































Figure 4.4 Cervical stiffness is reduced in tissues from late pregnant mice of three, five 
and eight months of age compared to age matched non-pregnant mice 
Bar graph presenting cervical stiffness as determined by the slope of cervical distension stress-
strain curves.  Tissues obtained from non-pregnant three month [NP(3), n = 6], five month 
[NP(5), n = 8], and eight month [NP(8), n = 8] old mice, as well as late pregnant three month 
[LP(3), n = 9], five month [LP(5), n = 6], and eight month [LP(8), n = 6] old mice.  Transition 
from non-pregnant to pregnant state, significantly reduced cervical stiffness in three, five and 
eight month old mice, ***p<0.001.  Advance in age from three to eight months and five to eight 
months in non-pregnant mice also significantly reduced cervical stiffness *** p<0.001, however 
advance in age did not change cervical stiffness in tissues from late pregnant mice; ANOVA 








4.3.2 Determination of collagen proportion in cervical tissues 
Representative images of Masson‘s trichrome blue-stained collagen in cervical tissues 
from non-pregnant and late pregnant mice of three, five and eight months of age are 
shown in Figures 4.5, 4.6 and 4.7.  The proportion of Masson‘s trichrome blue staining 
(expressed as a percentage of the total cervical area) was not significantly altered 
between the three age groups in both the non-pregnant and late pregnant cervical 
tissues (Figure 4.8).  For both non-pregnant and late pregnant mice, the greatest mean 
collagen content was detected in tissues from eight month old mice, but these 
differences did not reach significance (p = 0.197).  Non-pregnant cervical tissues from 
all ages exhibited a high proportion of blue stained collagen, which was noticeably the 
most prominent tissue component (Figures 4.5, 4.6 and 4.7).  The transition from non-
pregnant to late pregnancy in all mice significantly deteriorated the collagen content in 
cervical tissues (Figure 4.8).  The collagen content percentage decline in late pregnant 
cervices compared to non-pregnant was -28 % in three month old mice (63.0 ± 4.2 
reduced to 34.6 ± 3.5 %, p<0.001), -29 % in five month old mice (64.1 ± 3.4 reduced to 
34.9 ± 1.7 %, p<0.001), and -32 % for eight month old mice (69.8 ± 2.4 reduced to 37.8 
± 2.1 %, p<0.001); n = 6 for all groups.  These data were also evident by the weaker 
and more sparse blue staining seen in images of cervical tissues from late pregnant 
compared to non-pregnant mice.  
Although not quantified in this present study, it was observed that smooth muscle cells 
(stained red) appeared to form tight bundles within the collagen and along the edges of 
the cervix in non-pregnant tissues of all ages.  This tight bundling of smooth muscle 
appeared disrupted along with collagen in late pregnant cervical tissues (Figures 4.5, 






Figure 4.5 Representative images of Masson’s trichrome staining of collagen in cervical 
tissues from three month old non-pregnant (NP) and late pregnant (LP) mice 
Masson‘s trichrome staining for collagen (blue) and smooth muscle (red) in cervical tissues 
obtained from non-pregnant three month old [NP(3)], and late pregnant three month old [LP(3)] 
mice.  Collagen localisation is predominantly in the extracellular matrix in both NP(3) and LP(3) 






                                 
 
Figure 4.6 Representative images of Masson’s trichrome staining of collagen in cervical 
tissues from five month old non-pregnant (NP) and late pregnant (LP) mice 
Masson‘s trichrome staining for collagen (blue) and smooth muscle (red) in cervical tissues 
obtained from non-pregnant five month old [NP(5)], and late pregnant five month old [LP(5)] 
mice.  Collagen localisation is predominantly in the extracellular matrix in both NP(5) and LP(5) 









Figure 4.7 Representative images of Masson’s trichrome staining of collagen in cervical 
tissues from eight month old non-pregnant (NP) and late pregnant (LP) mice 
Masson‘s trichrome staining for collagen (blue) and smooth muscle (red) in cervical tissues 
obtained from non-pregnant eight month old [NP(8)], and late pregnant eight month old [LP(8)] 
mice.  Collagen localisation is predominantly in the extracellular matrix in both NP(8) and LP(8) 
images, however the collagen and smooth muscle staining is noticeably weaker in the LP(8) 

























































Figure 4.8 Collagen content is lower in cervical tissues from late pregnant mice 
compared to non-pregnant mice as determined by Masson’s trichrome stain for collagen 
Bar graph presenting percentage of collagen content in cervical tissues obtained from non-
pregnant three month [NP(3), n = 6], five month [NP(5), n = 6]  and eight month [NP(8), n = 6] 
old mice, as well as late pregnant three month [LP(3), n = 6], five month [LP(5), n = 6], and 
eight month [LP(8), n = 6] old mice. Transition from non-pregnant to pregnant state, significantly 
reduced cervical collagen content in three, five and eight month old mice, ***p<0.001. It 
appears that advancing age correlates with marginally greater collagen content in both non-
pregnant and late pregnant tissues, but this did not reach significance; ANOVA followed by all 
pairwise multiple comparison Tukey‘s test.  Data expressed as mean ± SEM content expressed 





4.3.3 Expression of MMP2 in cervical tissues 
MMP2 expression was detected by immunohistochemical brown staining 
predominantly in the epithelium and stromal matrix in all cervical tissues from non-
pregnant three, five, and eight month old mice, as well as late pregnant  three, five, 
and eight month old mice (Figures 4.9, 4.10 and 4.11). MMP2 protein expression, 
quantified by mean ± SEM arbitrary units of positivity, was not significantly altered 
between the three age groups in both non-pregnant and late pregnant cervical tissues 
(Figure 4.12).  In both non-pregnant and late pregnant mice, a greater degree of 
MMP2 expression was found in tissues from eight month old mice, but this did not 
reach significance.  Comparison of MMP2 staining in cervical tissue from age matched 
non-pregnant and late pregnant mice suggested that MMP2 expression was generally 
higher in non-pregnant mice (Figure 4.12), but this again did not reach significance.  
These data are also suggested by the stronger brown staining seen in images of non-






Figure 4.9 Representative images of immunohistochemical staining of MMP2 in cervical 
tissues from three month old non-pregnant (NP) and late pregnant (LP) mice 
Cervical tissues obtained from non-pregnant three month old [NP(3)], and late pregnant three 
month old [LP(3)] mice.  MMP2 localisation as defined by the brown staining can be found in 
the columnar and squamous epithelium and stroma in NP(3) but this is greatly reduced in the 






Figure 4.10 Representative images of immunohistochemical staining of MMP2 in cervical 
tissues from five month old non-pregnant (NP) and late pregnant (LP) mice 
Cervical tissues obtained from non-pregnant five month old [NP(5)], and late pregnant five 
month old [LP(5)] mice.  MMP2 localisation as defined by the brown staining can be found in 
the columnar and squamous epithelium and stroma in NP(5) but to a lesser degree in the LP(5) 







Figure 4.11 Representative images of immunohistochemical staining of MMP2 in cervical 
tissues from eight month old non-pregnant (NP) and late pregnant (LP) mice 
Cervical tissues obtained from non-pregnant eight month old [NP(8)], and late pregnant eight 
month old [LP(8)] mice.  MMP2 localisation as defined by the strong brown staining can be 
found in the columnar and squamous epithelium and stroma in both NP(8) and LP(8) images.  











































Figure 4.12 Expression of MMP2 is not significantly altered by the effect of age in 
cervical tissues from both non-pregnant and late pregnant mice 
Bar graph presenting expression of MMP2 in cervical tissues obtained from non-pregnant three 
month [NP(3), n = 6], five month [NP(5), n = 6]  and eight month [NP(8), n = 6] old mice, as well 
as late pregnant three month [LP(3), n = 6], five month [LP(5), n = 6], and eight month [LP(8), n 
= 6] old mice.  Comparisons across all groups did not reach significance; ANOVA followed by 










This study reports a generalised preservation of both cervical biomechanical properties 
as well as relative collagen content in cervices from non-pregnant mice compared to 
late pregnant mice. The functional properties of cervices from non-pregnant animals 
declined at eight months as distensibility increased and cervical stiffness reduced. An 
impact of age was also detectable in tissues from primiparous late pregnant mice, but 
the magnitude of this effect was suppressed in comparison and limited to a change in 
distensibility. It seems unlikely, therefore, that age-induced changes in cervical 
properties will have a major impact on the progress of labour in this model.   
The direct comparison of cervical structure and function in tissues from non-pregnant 
and younger pregnant mice clearly demonstrated that in late pregnancy, cervices were 
more distensible, developed less tension in response to stretch and exhibited reduced 
stiffness compared to those from non-pregnant animals. This change was associated 
with an approximate two fold reduction in cervical tissue collagen content, but not 
MMP2 expression, in pregnancy. These data complement the existing body of 
literature in rodents related to cervical remodelling (Harkness and Harkness, 1959, 
Read et al., 2007, Word et al., 2007). They reported an incremental decline in tissue 
stiffness from day 12 of gestation onwards reaching a maximum decrease at the time 
of birth (Harkness and Harkness, 1959, Read et al., 2007, Vargis et al., 2012).   
In the present study, collagen content or proportion of Masson‘s trichrome blue stained 
collagen was reduced in all late pregnant cervical tissues compared to age-matched 
non-pregnant tissues, which fits the common understanding that either collagen is 
degraded or there is an alteration in collagen structure during cervical softening, 
resulting in an overall reduced collagen proportion in the cervix.  A recent study 
published by Vargis et al., (2012) reported similar findings in Masson‘s trichrome 
stained histological studies of pregnant mouse cervical tissues.  
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They examined samples from multiple time points (non-pregnant, gestation days 4–19, 
and one day postpartum) throughout pregnancy.  They reported that non-pregnant, 
early pregnant and postpartum cervical tissues exhibited a dense blue stained collagen 
network, which was noticeably the most prominent tissue component, but by the end of 
gestation on day 19, the dense collagen network appeared to become disorganized 
and sparse (Vargis et al., 2012).  The loss of dense blue staining representative of 
collagen was also seen between non-pregnant and late pregnant cervical samples in 
this study 
As far as can be determined, there has been little or no previous assessment of 
cervical biomechanical properties in rodents of different ages. The studies highlighted 
above compared cervical properties of non-pregnant and pregnant adults and did not 
specifically address the issue of reproductive age at conception. Most stated using 
―adult‖ animals and only Read et al., (2007) reported an age range of three- six months 
for the adults in their pregnancy group.  In the non-pregnant state, tissue compliance 
was mainly compromised in cervical tissues taken from eight month old mice. This 
appears to mirror the generalised age-associated changes reported for other collagen 
rich tissues and organs such as skin and bone (Baroni Edo et al., 2012, Quan et al., 
2010, Varani et al., 2006, Wang et al., 2002). However, there wasn‘t a significant 
change in collagen content in cervices from older mice. This may be because the 
approach was only semi-quantitative or that the changes in distensibility and stiffness 
precede any visually detectable changes in collagen content. Extending the study to 
include groups of mice beyond the reproductive age span (e.g. >12 months) would 






In late pregnancy, there are less apparent age-induced differences in cervical 
biomechanical properties. Indeed, the tissues from eight month old pregnant mice only 
display enhanced distensibility and not reduced stiffness compared to tissue from three 
and five month old pregnant animals. There is also not a loss of collagen content or 
activation of MMP2. The age effects seen in non-pregnant animals are most likely 
masked by the considerable changes induced by pregnancy itself, which include 
enhanced distensibility and reduced cervical stiffness/ collagen content. Given the 
similarity of cervical change induced by age and pregnancy, it is unlikely that the 
impact of advancing maternal age on the cervix plays a key role in delaying parturition 
in older mice.  
To definitively confirm this, experiments would need to also take into account the 
delayed parturition of approximately 24 hours in the eight month old mice.  All cervices 
were harvested on day 18 of gestation for this part of the study (protocol decided prior 
to analysing the data for gestation length). It may have been more appropriate to use 
cervices taken on day 19 for the eight month group as in normal pregnancy the peak of 
cervical change occurs just before parturition (Read et al., 2007, Timmons et al., 
2010).   
As for non-pregnant mice, there was no significant change in collagen or MMP2 
content associated with ageing in pregnant animals which may have been related to 
the limited age span that could be used in this pregnancy focussed study. The 
literature reporting age-induced alterations in pregnant cervix collagen content is 
sparse, but there has been one study in punch biopsies of human cervix from non-
pregnant women.  The mean collagen concentration (62.2 +/- 6.6%) was found to 
increase with age (0.5% per year, r = 0.45, p = 0.003).  Normalized maximum stiffness 
also increased with age (r = 0.32, p = 0.017), whereas no change in collagen tensile 
strength with respect to age was found (Oxlund et al., 2010).  These results 
demonstrate that collagen contributes to cervical tissue tensile strength and age 
should be considered a confounding factor.   
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Current data in the field support the theory that changes in collagen processing, 
assembly and structure contribute to the progressive alterations in tensile strength of 
the cervix through pregnancy (Akins et al., 2011, Timmons et al., 2010, Mahendroo, 
2012). Although this present study examined relative collagen content, further 
investigations could provide a more detailed understanding of how collagen structure 
and/or concentration are altered throughout gestation and by age.  Increased collagen 
solubility in late pregnant cervix compared with non-pregnant has been reported 
(House et al., 2009, Read et al., 2007, Timmons et al., 2010).  Collagen that is soluble 
in acetic acid and pepsin reflects newly synthesized collagen or collagen that is less 
organised.  In addition, total cervical collagen content can be determined; methods 
described by Read et al. (2007).  Concentration of collagen can then be more 
accurately determined by dividing the total collagen (mg) by the wet weight (mg) of the 
tissue.  Polarized light microscopy and transmission electron microscopy have also 
proven useful methods to visualise and quantify collagen organisation and 
microstructure in the cervix (Clark et al., 2006) and would be an ideal technique to 
examine collagen organization in the late pregnant cervix directly.   
Decline in expression/enzymatic activity of lysyl oxidase and lysyl hydroxylase have 
also been reported in the pregnant mouse cervix; these catalyse the formation of 
strong collagen crosslinks. Loss of this activity could be responsible in part for early 
changes in collagen structure resulting in an increase in collagen solubility.  
Expression of three genes that encode lysyl hydroxylase (Plod1, -2, and -3) can be 
measured by qPCR throughout gestation to gain an understanding of any potential 
loss of collagen crosslinks which could contribute to increased collagen solubility and 





MMPs were examined in this study because they participate in cervical remodelling by 
aiding the degradation of the network of collagen fibres and thus increase the 
distensibility required for delivery (Choi et al., 2009, Stygar et al., 2002, van Engelen et 
al., 2008) and it was surprising that no change in expression was noted in late 
pregnancy.  Previously, immunohistochemistry and qPCR studies have confirmed that 
cervical columnar epithelial cells are capable of synthesizing MMP2 at term in mice.  
However, this requires low progesterone concentrations and is thought to be triggered 
as a consequence of progesterone withdrawal and local cervical progesterone 
metabolism at term in mouse parturition (Gonzalez et al., 2011).  Similarly, proteins 
localised by immunohistochemistry and mRNA levels of MMP2 were found to be 
increased in the human cervix at term pregnancy compared with the non-pregnant 
state (Stygar et al., 2002).  
In both mice and humans, MMP2 is thought to play a key role in cervical remodelling 
during the ripening phase rather than the softening.  This may explain why there were 
no significant differences seen between MMP2 expression in non-pregnant and late 
pregnant cervical tissues in the current study.  Mouse cervical ripening usually occurs 
within 24 hours prior to parturition (Read et al., 2007), therefore since cervical tissues 
were collected on day 18 of gestation, this time point may not have captured the 
initiation of the cervical ripening phase, particularly in relation to the eight month old 









Study limitations and future work 
Cervical remodelling is a complex mechanism which involves numerous interlinked 
pathways and steps, eventually resulting in maximal loss of tissue compliance and 
integrity to facilitate cervical dilation at parturition (Timmons et al., 2010, Mahendroo, 
2012).  With time permitting, there are many more technical approaches that could 
have provided valuable supplementary data.  One of the key experiments, as 
mentioned above would be to quantify collagen solubility and collagen concentrations 
in cervical samples.  To directly measure enzymatic activity of MMP2 in cervical 
tissues, gelatin zymography would be a key approach for future work (Kelly et al., 
2004).  Alternatively, the gene and/or protein expression of MMP 8 and 9 as well as 
ADAMTS1 (a distintegrin-like and metalloproteinase with thrombospondin type 1 motif) 
could have been assessed as these are also proteases important in the breakdown of 
ECM molecules such as collagen and proteoglycans (Holt et al., 2011).   Gene 
expression profiles using qPCR of components of the ECM architecture such as 
proteoglycans (e.g. versican, decorin, and biglycan) and matricellular proteins 
(tenascins, thrombospondins, and SPARC protein) which modulate matrix organisation 
and consequently tissue strength would assist in building up the complex picture of the 
cervical softening processes in the pregnant and ageing cervix (Akins et al., 2011).  
Finally, it has been reported that the amount of smooth muscle appears to increase in 
cervical insufficiency (House et al., 2009); increased smooth muscle content more than 
likely results in a reduction in cervical rigidity.  Therefore, in addition to collagen, 
quantification of Masson‘s trichrome red stained smooth muscle as a percentage of 
total cervical area would have been useful to identify any possible age-related 
alterations. 
The fundamental limitation to this current study would be that cervical tissues were 
collected on day 18 of gestation.  An extension of this study would be to collect cervical 
tissues on gestation day 19 and possibly day 20 for the older eight month old mice in 
order to capture tissues in the ripening phase.  This would determine whether there are 
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any age-related changes that occur specifically to cervical ripening.  Since cervical 
softening initiates on day 12 of gestation, it would also be of interest to repeat this 
experiment and examine cervical tissues on day 12, 15, 18 and 19/20 of gestation, 
which would identify whether there is a shift in timing of cervical softening and ripening 
onset in older primiparous mice.  Another key limiting factor is that cervical ripening 
occurs when progesterone levels have dropped nearing the onset of parturition 
(Mahendroo, 2012).  Therefore, as for results regarding timing of parturition in older 
primparous mice, it would also have been beneficial in this study to know the serum 
progesterone profiles in late gestation in these mice. 
 
Conclusions 
Pregnancy induces a significant decrease in cervical tensile strength in preparation for 
labour. There is a limited impact of age on cervical function in pregnancy although at 
eight months there appears to be a change in distensibility. Further studies are 
required to determine whether this difference is further enhanced at the onset of 
parturition, since cervical remodelling in the ripening phase continues to takes place in 
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As discussed in Chapter 1, for the majority of pregnancy, the uterus demonstrates 
limited contractile activity (quiescence), with sporadic, low amplitude and arrhythmic 
contractions.  During this state, the contractile function of the myometrial smooth 
muscle is thought to be suppressed by the upregualtion of pro-quiescence pathways 
such as NF-B and the down-regulation of contractile associated proteins (CAPs) 
including the oxytocin receptor (OXTR), prostaglandin-endoperoxide synthase 2 
(PTGS2, also known as prostaglandin G/H synthase and cyclooxygenase 2), and the 
gap junction protein connexin-43 (Cx43).  Uterine activation, the myometrial switch 
from a quiescent state to a muscle that is spontaneously active and sensitive to 
endogenous uterotonins during labour, is an essential step in the onset of parturition.  
Significant increases in CAPs are associated with uterine activation at term in both 
humans and animals, which support the theory for a role for CAPs in the control of 
parturition onset (Ou et al., 1997, Ou et al., 1998, Norwitz et al., 1999, Bernal, 2001, 
Lopez Bernal, 2003, Smith, 2007, Smith et al., 2007, Shynlova et al., 2009). 
There are a plethora of studies examining the effect of maternal age on oocyte number 
and function as well as the success of IVF; however the function of the myometrium 
and how it may be altered with advancing age has not been studied in detail.  The 
current study has looked at the expression of CAPs, spontaneous contractile activity, 
as well as agonist-induced contractile responses in the myometrium in an attempt to 
elucidate if an impairment in the coordinated up-regulation of CAP genes, has a 
negative impact on the physiological preparation and hence the function of the 






Full descriptions and details of the methods are described in Chapter 2, sections 2.3, 
2.4, and 2.6.  All non-pregnant myometrial tissues were collected when mice were in 
oestrous stage of their reproductive cycle and all late pregnant myometrium on day 18 
of gestation.  The age of late pregnant mice as indicated within this chapter relate to 
their age at conception.   
Genome-wide, age-induced changes in uterine gene expression (normalised against 
paired bladder expression) were studied using mouseWG-6 v2.0 Expression BeadChip 
microarrays (Illumina, UK) in late pregnancy of three month old versus eight month old 
mice.  Differential expression analysis was carried out using the differential expression 
module and Student‘s t-test was used for calculating the statistical significance 
between groups.  Benjamini and Hochberg multiple testing correction was applied to 
adjust p-values (Benjamini and Hochberg, 1995).  Differentially expressed genes were 
identified based on the adjusted p-value <0.05 (Diff Score >= ±13).  In addition, gene 
expression profiles of PTGS2, Cx43 and OXTR measured by qPCR were examined in 
non-pregnant and late pregnant myometrium from three, five and eight month old mice.  
Data for qPCR were expressed relative to the geometric mean of the most stable 
housekeeping genes -2 microglobulin (2M), glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH), and -actin as determined by GeNorm software 
(Vandesompele et al., 2002). 
Spontaneous and oxytocin augmented contractile activity were examined in non-
pregnant and late pregnant myometrium from three, five and eight month old mice 
using isometric tension recordings.  To confirm that any observed differences in 
contractile activity were not due to bias in dissecting the myometrial strips or their 
relative weights, measurements were normalised to the cross-sectional area of each 




In order to analyse the contractile response of late pregnant myometrium to oxytocin, 
the mean integral tension (MIT) generated under increasing oxytocin concentrations 
(from 10-12 to 10-7 M) were represented as percentages of the baseline spontaneous 
activity.  For each strip, the concentration response was calculated as the rate of 
change per tenfold increase in concentration by linear regression (Matthews et al., 
1990); first using all concentrations, and then using only higher concentrations (10-9 to 
10-7 M), where graphical evidence suggested a change in slope.  Linear regression of 
the dose response on animal age (three, five and eight months) with a Random-effects 
GLS (generalised least squares) model (Swamy and Arora, 1972) was used.  The 96 
strips by the 24 animals were grouped, allowing robust standard errors (Arellano, 
1987).  Differences between the age groups were estimated with 95% confidence 
intervals.  Linear regression analysis was carried out using Stata version 11.2 
(StataCorp, USA). 
All other data within this chapter were found to be normally distributed using the 
D'Agostino-Pearson omnibus normality test (GraphPad Prism version 5.0, GraphPad 
Software, USA).  Student‘s t-test was used to assess data between two groups and 
one-way analysis of variance (ANOVA) followed by all pairwise multiple comparison 
(Tukey‘s test) when comparing three or more groups.  Data were expressed as mean ± 
standard error of the mean (SEM) and p<0.05 was considered significant; ‗n‘ refers to 










5.3.1 Microarray analysis of late pregnant myometrial gene expression 
Microarray analysis was unable to identify any differentially expressed genes between 
three month and eight month old late pregnant myometrium with the differential score 
cut-off  >= ±13.  Although significance was not reached, genes with the highest and 
lowest difference scores as identified in this study are shown in Tables 5.1 and 5.2 
respectively. 
 
5.3.2 Contractile-associated protein gene expression analysis in late pregnant 
myometrium 
Expression of PTGS2 mRNA determined by qPCR was low in non-pregnant and late 
pregnant myometrium.  There were no significant age-induced differences in 
expression in myometrium from non-pregnant or late pregnant mice.  Although PTGS2 
copy number was higher in late pregnant myometrium from mice of all ages, the 
differences again were not significant (three month old non-pregnant vs. late pregnant, 
p = 0.597, n = 8 for both groups; five month old non-pregnant vs. late pregnant, p = 
0.673, n = 8 for both groups; eight month old non-pregnant vs. late pregnant, p = 
0.699, n = 8 for both groups; Figure 5.1). 
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Table 5.1 Microarray identification of genes with the highest differential expression scores between three (LP3) and eight (LP8) month old late pregnant 
mouse myometrium corrected for expression in paired bladder tissue 
Gene LP(3) Mean Expression 
Signal 




LP(8)/LP(3) fold change 





Matrin 3 (Matr3) 4930.6 5735.4 1.884 
 
1.163 





























            1.789 
 
2.150 

































No significant differentially expressed genes were identified.  
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Table 5.2 Microarray identification of genes with the lowest differential expression scores between three (LP3) and eight (LP8) month old late pregnant 
mouse myometrium corrected for expression in paired bladder tissue 
Gene LP(3) Mean Expression 
Signal 




LP(8)/LP(3) fold change 
Kidney androgen regulated protein             7152.3 
 






Ig heavy chain V region 3 precursor 
(LOC637785) 




Monoclonal antibody BBK-2 heavy chain 
(LOC677643) 






1998.9                757.3 
 





Ig kappa chain V-V region MPC11 
precursor (LOC637227) 




Ribosomal protein S16 (Rps16) 13798.8 11190.8 -1.872 0.811 
 
Immunoglobulin heavy chain (J558 family) 
(Igh-VJ558) 
12961.4 5303.1 -1.831 0.409 
 






Serine (or cysteine) peptidase inhibitor, 

















































Figure 5.1 Expression of prostaglandin-endoperoxide synthase 2 mRNA in non-pregnant 
and late pregnant mouse myometrium 
Bar graph presenting mRNA expression of prostaglandin-endoperoxide synthase 2 in 
myometrium from non-pregnant three month old (NP(3), n = 8) late pregnant three month old 
(LP(3), n = 8), non-pregnant five month old (NP(5), n = 8), late pregnant five month old (LP(5), n 
= 8) non-pregnant eight month old (NP(8), n = 8) and late pregnant eight month old (LP(8), n = 
8) mice.  Data expressed as log geometric mean of copy number ± SEM normalised to 
housekeeping genes 2M and GAPDH. All statistical comparisons across all groups were non-








Expression of Cx43 mRNA was extremely low in non-pregnant myometrium from three, 
five and eight month old mice.  However, late pregnancy appeared to be associated 
with a significant upregulation of expression in tissues from mice of all ages (fold 
change of 6.16, 9.12 and 8.17 for three, five and eight month old mice respectively 
compared to non-pregnant tissues; p<0.001, n = 8 for all groups)(Figure 5.2).  Cx43 
expression was lower in late pregnant myometrium from eight month old mice (4.18 ± 
0.03 log[Cx43 copy number]) compared with three month old mice (4.40 ± 0.03; 
p<0.01, n = 8 for both groups).  However there were no other age-induced, statistically 
different expression levels across groups. 
Late pregnancy was also associated with a significant upregulation of oxytocin receptor 
(OXTR) mRNA expression in all ages of mice, when compared with non-pregnant 
myometrium. OXTR copy number was low in non-pregnant tissues but was increased 
by a fold change of 2.1 in three month old (p<0.001, n = 8 for both groups), 2.4 in five 
month old (p<0.001, n = 8 for both groups), and 1.8 in eight month old (p<0.01, n = 8 
for both groups) late pregnant myometrium (Figure 5.3).  Similar to  Cx43 expression, 
there was reduced myometrial expression of OXTR in older (eight months) late 
pregnant mice (2.67 ± 0.19 log[OXTR copy number])  compared to younger mice (three 
months; 2.11 ± 0.12, p<0.05, n = 8 for both groups).  No significant difference in OXTR 




































Figure 5.2 Expression of connexin-43 mRNA increases in myometrium from late pregnant 
mice compared to non-pregnant mice 
Bar graph illustrating expression of connexin-43 in myometrium from non-pregnant three month 
old (NP(3), n = 8) late pregnant three month old (LP(3), n = 8), non-pregnant five month old 
(NP(5), n = 8), late pregnant five month old (LP(5), n = 8) non-pregnant eight month old (NP(8), 
n = 8) and late pregnant eight month old (LP(8), n = 8) mice.  Data expressed as log geometric 
mean of copy number ± SEM normalised to housekeeping genes 2M and GAPDH. Expression 
of connexin-43 was significantly increased in late pregnant myometrium of all age groups 
compared to non-pregnant, ***p<0.001, and significantly lower in late pregnant myometrium 
from eight month old mice compared to late pregnant three month old, ##p<0.01; ANOVA 


































Figure 5.3 Expression of oxytocin receptor mRNA increases in myometrium from late 
pregnant mice compared to non-pregnant mice 
Bar graph presenting expression of oxytocin receptor in myometrium from non-pregnant three 
month old (NP(3), n = 8) late pregnant three month old (LP(3), n = 8), non-pregnant five month 
old (NP(5), n = 8), late pregnant five month old (LP(5), n = 8) non-pregnant eight month old 
(NP(8), n = 8) and late pregnant eight month old (LP(8), n = 8) mice.  Data expressed as log 
geometric mean of copy number ± SEM normalised to housekeeping genes 2M and GAPDH. 
Expression of oxytocin receptor was significantly increased in late pregnant myometrium of all 
age groups compared to non-pregnant; ***p<0.001, **p<0.01, and significantly lower in late 
pregnant myometrium from eight month old mice compared to late pregnant three month old, 






5.3.3 Spontaneous contractile activity of non-pregnant and late pregnant 
myometrium 
 
The mean integral tension (MIT) of spontaneous myometrial contractions was 
significantly higher in all late pregnant mice compared to non-pregnant mice of all age 
groups (p<0.001, p<0.05, n = 32 tissue strips from n = 8 mice for each group) (Figure 
5.4).  The spontaneous contractile activity was similar between all age groups in both 
non-pregnant and late pregnant cohorts.  Although the mean integral tension values 
were numerically lower in myometrium from eight month compared to three month old 
mice in both non-pregnant and late pregnant cohorts, the differences were not 
significant (non-pregnant three month old vs. eight month old, p= 0.7755, n = 32 tissue 
strips from n = 8 mice for each group; late pregnant three month old vs. eight month 















































Figure 5.4 Spontaneous contractile activity is greater in myometrium from late pregnant 
mice compared to non-pregnant mice 
Bar graph presenting spontaneous contractile activity in myometrium from non-pregnant three 
month old (NP(3), n = 32 strips from n = 8) late pregnant three month old (LP(3), n = 32 strips 
from n = 8), non-pregnant five month old (NP(5), n = 32 strips from n = 8), late pregnant five 
month old (LP(5), n = 32 strips from n = 8) non-pregnant eight month old (NP(8), n = 32 strips 
from n = 8) and late pregnant eight month old (LP(8), n = 32 strips from n = 8) mice.  Data 
expressed as mean integral tension ± SEM.  Mean integral tension was significantly higher in 
late pregnant myometrium compared to non-pregnant across all age groups, 







The maximal contractile capacity, expressed as mean peak amplitude induced by K+ 
PSS (40 mM), was significantly increased in myometrium from late pregnant mice 
compared to tissues form non-pregnant mice in all three age categories; p<0.01, 
p<0.05, n = 32 tissue strips from n = 8 mice for each group (Figure 5.5).   High K+-
induced contraction amplitudes were similar in myometrium from all non-pregnant age 
groups. In late pregnant mouse myometrium, there was a trend towards an age-
associated reduction in high K+ induced contraction amplitude, but this was not 
significant; p = 0.071 (Figure 5.5). 
 




























Figure 5.5 Contraction amplitude under high K
+
 is greater in myometrium from late 
pregnant mice compared to non-pregnant mice 
Bar graph presenting force amplitude under high K
+
 in myometrium from non-pregnant three 
month old (NP(3), n = 32 strips from n = 8) late pregnant three month old (LP(3), n = 32 strips 
from n = 8), non-pregnant five month old (NP(5), n = 32 strips from n = 8), late pregnant five 
month old (LP(5), n = 32 strips from n = 8) non-pregnant eight month old (NP(8), n = 32 strips 
from n = 8) and late pregnant eight month old (LP(8), n = 32 strips from n = 8) mice.  Data 
expressed as mean depolarised contraction amplitude ± SEM.  Amplitude was significantly 
higher in late pregnant myometrium compared to non-pregnant across all age groups, 
**p<0.01,*p<0.05; ANOVA followed by all pairwise multiple comparison Tukey‘s test. 
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The frequency and duration of spontaneous contractions in myometrium from non-
pregnant mice was similar regardless of age (data not shown). In contrast, 
spontaneous contractions were twice as frequent in myometrium from late pregnant 
older eight month old mice (0.05 Hz, n = 32 tissue strips from n = 8 mice) compared to 
three month old mice (0.03 Hz, p<0.05, n = 32 tissue strips from n = 8 mice).    
However, statistical comparisons between late pregnant groups (three vs. five months 
and five vs. eight months) were non-significant (Figure 5.6 C). 
In tandem with contraction frequency, the duration of contractions in tissues from late 
pregnant mice aged eight months was reduced by – 36 % and – 41 % compared with 
five month old (31.7 to 20.2 seconds) and three month old (34.2 to 20.2 seconds) 
myometrium respectively, p<0.01 for both, n = 32 tissue strips from n = 8 mice for all 
groups.  No statistical difference was identified between mean contraction duration of 




























































































Figure 5.6 Effect of maternal age on the frequency and duration of spontaneous contractions in late pregnant mouse myometrium in vitro 
A: Representative trace showing spontaneous myometrial contractions from late pregnant three month old mouse, LP(3); B: Representative trace showing 
spontaneous myometrial contractions from late pregnant eight month old mouse, LP(8); C: Spontaneous myometrial contraction frequency was significantly 
greater in late pregnant eight month old mice,  LP(8) *p<0.05; D: Myometrial spontaneous contraction duration was significantly shorter in late pregnant eight 
month old mice,**p<0.01; ANOVA followed by all pairwise multiple comparison Tukey‘s test.  All data expressed as mean ± SEM.
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5.3.4 Effect of oxytocin on spontaneous contractions of non-pregnant and late 
pregnant myometrium 
 
In non-pregnant mice, application of oxytocin (10-12-10-7 M) did not significantly 
augment contractile activity in spontaneously contracting myometrium in vitro.  
Although, mean integral tension appeared numerically greater after the addition of 
oxytocin, this increase was not statistically different to baseline spontaneous 
contractile activity.    All statistical comparisons across all age groups were also non-
significant, n = 32 tissue strips from n = 8 mice for all groups (Figure 5.7).  There does 
not appear to be an influence of maternal age on oxytocin-induced contractile activity 


















































 M) on the contractile activity in myometrial 
tissues taken from non-pregnant mice at different ages 




 M) on contractile activity in myometrium 
from non-pregnant three month old (NP(3), n = 32 strips from n = 8, light purple squares), non-
pregnant five month old (NP(5), n = 32 strips from n = 8, light blue circles), and non-pregnant 
eight month old (NP(8), n = 32 strips from n = 8, dark blue triangles) mice.  Data expressed as 
mean integral tension ± SEM normalised to cross-sectional area of myometrial strips. All 
statistical comparisons across all groups were non-significant; linear regression analysis.  The 








The application of oxytocin at concentrations 10-12-10-7 M appeared to augment 
contractile activity (MIT) compared to baseline spontaneous contractile activity in late 
pregnant myometrium from mice in all age groups (Figure 5.8).  It was not possible to 
formally test this to obtain EC50 and Emax values as the response was not sigmoidal. 
However, the slope of the response across the concentration range could be analysed. 
Using this approach, a significant difference in the contractile activity was detected 
related to maternal age, particularly at higher oxytocin concentrations. Overall, the 
slope of the response was lower in the five month old mice (mean difference: -7.29, 
95% CI: -12.31 to -2.28, p<0.01) and eight month mice (mean difference: -7.63, 95% 
CI: -13.92 to -1.35, p<0.05) compared to three month old mice (actual slope 27.95, 
95% CI: 23.41 to 32.49).  In the higher concentration range (10-9 to 10-7 M), the mean 
slope differences were even greater for both the five month old mice (-12.77, 95% 
CI: -25.24 to -0.29, p<0.05) and the three month old mice (-17.22, 95% CI: -31.94 to -
2.51, p<0.05), compared to the slope of the three month old mice (actual slope 39.22, 




















 M) on the contractile activity in myometrial 
tissues taken from late pregnant mice at different ages 




 M) on contractile activity in myometrium 
from late pregnant three month old (LP(3), n = 32 strips from n = 8, light blue circles), late 
pregnant five month old (LP(5), n = 32 strips from n = 8, mid-blue squares), and late pregnant 
eight month old (LP(8), n = 32 strips from n = 8, dark blue triangles) mice.  Data expressed as 
mean integral tension expressed as a percentage increase of the baseline spontaneous activity 




M were able to augment mean 
integral tension in myometrium from mice of all ages; linear regression analysis.  The label “0” 










The aim of this study was to ascertain whether there is an inherent decrease in 
contractile function associated with increasing maternal age and if this is sufficient to 
explain the prolongation of pregnancy in older mice.  Whilst the microarray analysis 
was limited in usefulness, mRNA expression of two key CAPs, Cx43 and OXTR, was 
slightly reduced in the older group of mice. There was an associated alteration in 
contractile frequency and duration in myometrium from eight month old pregnant mice 
and although this was not reflected in a reduced MIT, it does represent less effective 
contractile activity. All of the changes related to age were specific to the pregnant 
state; very little difference in mRNA expression or contractile parameters were 
detected in non-pregnant animals of different age.  
The mouse genome-wide microarray was undertaken in order to identify new 
candidate genes, in addition to known contraction and pregnancy associated genes, 
which may be altered by age in pregnant mouse uterus.  Unfortunately, the results 
failed to identify any upregulation or downregulation of significant genes in mouse 
uterus for eight month compared to three month old mice.  This may have been for 
several reasons. Firstly, following advice from the bioinformatician involved, paired 
samples from bladder were run simultaneously with uterine tissues. This was to 
identify uterine specific gene regulation by ‗subtracting‘ general ageing effects on 
smooth muscle. Given this approach, it is not surprising that only a limited number of 
uterine genes were found to be altered with age, albeit not significantly. With hindsight, 
it may have been more useful to look at the uterus without adjustment for similar 
changes in the bladder.  Small fold changes in a variety of genes have been presented 
in the results, but the functional significance of these in the uterus are unknown. 




that might be relevant to the regulation of uterine contraction apart from perhaps, 
RASl11a member of the small GTPase protein family and dynactin. 
Of the three candidate genes assessed by qPCR, only Cx43 and OXTR were 
upregulated in late pregnancy compared to the non-pregnant state, which is similar to 
other studies in both mice and humans (Chow and Lye, 1994, Ou et al., 1997, Ou et 
al., 1998, Wathes et al., 1999, Cook et al., 2000, Liedman et al., 2009). However, there 
was a small but significant suppression of this pregnancy-induced response in 
myometrium from older mice, which has not been reported in the literature.  The 
functional impact of this change is hard to definitively elucidate as there is still relatively 
high expression levels in older animals and undoubtedly, assuming that mRNA levels 
translate to an increase in protein, there would be sufficient Cx43 to aid gap junction 
formation to promote uterine contractions. However, if this small decrease in mRNA is 
physiologically relevant, then a reduction in gap junction number could result in limited 
conduction of electrical activity in the uterus resulting in shortened and less effective 
contractions.  
Similarly, the dramatic increase in expression of OXTR in late pregnancy is thought to 
be a key priming event promoting the switch from quiescent to contractile activity when 
endogenous oxytocin is produced during labour (Kimura et al., 2013). Although OXTR 
expression was greatly upregulated in late pregnant myometrial tissues from older 
mice, there was a small reduction in expression when compared to myometrium from 
younger mice. As for Cx43, it is difficult to predict that this would be functionally 
relevant, however consideration of the data discussed below would strongly suggest 
that myometrium from older mice may be less responsive to oxytocin due to a 






Taken together, these data could suggest that ageing in primiparous mice suppresses 
the late pregnancy rise in contraction associated proteins leading to altered 
contractility.  There may be other contributing factors, however, that cannot be 
disregarded.  For example, a fall in maternal plasma progesterone and/or a reduction 
in myometrial stretch at term can activate Cx43 and OXTR expression in rat and 
human studies (Ou et al., 1997, Ou et al., 1998, Lyall et al., 2002, Terzidou et al., 
2005).  Since myometrial tissues were taken on day 18 of gestation, and parturition in 
older mice was delayed by one day (as shown in Chapter 3), it is possible that a 
delayed fall in maternal plasma progesterone may be responsible for this slight change 
in Cx43 and OXTR expression.  Therefore, it would be beneficial to repeat this study 
using myometrial tissues collected on day 19 of gestation in older primiparous mice.  
Since eight month old mice had reduced litter sizes, there may have also been less 
mechanical stretch of the myometrium at term in these animals which could also 
contribute to the reduction in CAPs gene expression in older mice at term. There is 
also a need to confirm protein expression levels of these important CAP genes in 
tissues from late pregnant mice of different ages.   
There is copious evidence to support the role for prostaglandins and PGHS1 and 2 in 
mouse pregnancy. PGHS1 derived prostaglandins are thought to be important during 
uterine preparation for implantation (Reese et al., 1999).  Uterine expression of 
PGHS2, another key CAP, has been reported to be induced at labour in mice and 
humans, suggesting the involvement of PGHS2 in producing uterotonic prostaglandins 
during parturition (Slater et al., 1999, Tsuboi et al., 2000, Tsuboi et al., 2003, Renthal 
et al., 2013). Interestingly, expression of PTGS2 in this study was not induced by 
pregnancy or indeed regulated by age. This might be explained by the use of 
myometrium taken at day 18 of gestation, a day before delivery in the younger mice 
and two days before the eight month old group. Tsuboi et al., (2000) reported an 




day before parturition, but strong signals for PGHS2 mRNA were detected in the 
myometrium on the day of parturition (Tsuboi et al., 2000).   
To the best of my knowledge, this is the first study to investigate the influence of age 
on spontaneous and oxytocin-induced myometrial contractions in primparous C57BL/6 
mice. The data strongly suggest that spontaneous contractions are less effective in 
tissues from older mothers as they are more frequent but of shorter duration, which is 
likely to limit propulsive force. These data add to the limited amount of information 
related to contractile activity in human myometrium from older mothers. Smith et al. 
(2008), reported that there is a negative correlation between contractile activity in 
human myometrial tissues (quantified by calculating the ratio of the mean integral 
tension during spontaneous contractile activity and the mean integral tension under in 
the presence of 50 mM potassium) with increasing maternal age (Smith et al., 2008). 
In non-pregnant mice, application of oxytocin (10-12-10-7 M) did not augment contractile 
activity in spontaneously contracting myometrium in vitro.  OXTR mRNA expression 
was lower in non-pregnant tissues but was increased by an approximate two fold 
change in late pregnant myometrium from mice of all ages.  Assuming that mRNA 
levels translate to an increase in protein, this data would suggest that there would be 
fewer oxytocin receptors present in non-pregnant myometrium compared to late 
pregnant, explaining why oxytocin was unable to successfully augment contractile 
activity in non-pregnant tissues.  Supporting this assumption, many studies have 
shown that oxytocin receptor density in the myometrium sharply increases at the end 
of pregnancy in species including the rat (Kaneko et al., 1995), guinea pig 






Application of oxytocin was able to augment contractile activity in late pregnant 
myometrium; however, tissues from older pregnant mice were less responsive to 
oxytocin and appeared to require higher concentrations of oxytocin to generate equal 
contractile activity as myometrium from younger mice.  These data are consistent with 
findings from a recent study that show contractile responses to oxytocin (10 nM) were 
reduced in myometrium from pregnant women aged 40 and above compared to 
myometrium from women aged 39 years and under.  This study also reported that 
there were no age-induced alterations in spontaneous contractions seen in pregnant 
human myometrium at term, but frequency and duration of contractions were not 
assessed (Arrowsmith et al., 2012).  In the present study, there was no specific age-
induced decrease in contractile activity of non-pregnant mouse myometrium. In 
contrast, Arrowsmith and colleagues have reported a striking reduction in spontaneous 
contractile force in non-pregnant human myometrium from older women (post 30 years 
old) when compared to myometrium from non-pregnant 25-29 year olds (Arrowsmith et 
al., 2012). 
Future work 
The two human studies discussed above, suggest that perhaps there are age-induced 
changes to myometrial morphology, increased cholesterol in the myometrium of older 
women, and decreased expression of L-type calcium channels in the myometrium of 
older women which may be contributing to the age-induced change in spontaneous 
contractile activity (Smith et al., 2008, Arrowsmith et al., 2012).  Therefore, potential 
future work could examine myometrial morphology, measure cholesterol concentration 
and expression of L-type calcium channels as well as potassium channels and whether 
these change with age in pregnancy. There is also an opportunity to dissect the 
interactions between pregnancy, age, obesity and dyslipidemia using the validated 





The outcome of this study indicates that maternal age influences expression of CAPs; 
specifically, expression of Cx43 and OXTR in late pregnant myometrium and that 
spontaneous contractions and oxytocin augmented activity is altered in older mice.  It 
can be hypothesised that longer acting, coordinated contractions are necessary for 
producing sufficient cumulative force for the successful expulsion of pups, hence 
duration of labour was found to be considerably shorter in the three month old mice 
compared with older eight month old mice (Chapter 3). These data suggest that 
myometrium from older mice on day 18 of gestation may not be fully ―activated‖ for 
parturition. If this were to be translated into the human situation, it would have 
implications for the management of labour in older mothers and influence the debate 







Mitochondrial Number and 











In the previous results chapter, there was a marked reduction in contractile potential in 
myometrium from older mice when compared to younger controls. The working 
hypothesis is that mitochondrial dysfunction may be involved in this process.  The 
mitochondrial theory of ageing is that ageing is a consequence of mitochondrial 
reactive oxygen species (ROS) accumulation, which causes progressive damage to 
MtDNA and other mitochondrial constituents during an individual‘s lifetime.  It is widely 
accepted that mitochondrial oxidative stress is a major factor in the pathophysiology of 
ageing in many organs, including skeletal muscle, heart, and brain.  There is evidence 
that in these organs, mitochondrial biogenesis is deregulated, since cumulative MtDNA 
mutations result in dysfunction of the mitochondrial electron transport chain, causing 
further ROS production in mitochondria and subsequently more MtDNA mutations and 
decline in cellular mitochondrial mass (Lee and Wei, 2007, Wei et al., 2009, Ivanova 
and Yankova, 2013, Lagouge and Larsson, 2013). There is also some evidence that 
mitochondrial dysfunction may play a key role in age-related smooth muscle 
deterioration such as in the bladder and blood vessels (Lin et al., 2000, Ungvari et al., 
2008). This raises the question as to whether there are similar ageing-induced 
alterations in mitochondrial biogenesis and/or decline in functional mitochondrial mass 
in the mouse myometrium, which would result in an insufficient supply of energy to 
drive adequate uterine contractions. 
Thus, the objective of the present study was to test the hypothesis that ageing leads to 
a decline in mitochondrial mass as reflected by a decline in mitochondrial copy 
number, and a dysfunction in mitochondrial biogenesis via measurement of the 






Full descriptions and details of the methods are described in Chapter 2, sections 2.9 
and 2.10.  In summary, mitochondrial copy number and enzymatic activities of the 
mitochondrial electron transport chain complexes were measured in non-pregnant and 
late pregnant myometrium from three, five and eight month old mice.  All non-pregnant 
myometrial tissues were collected when mice were in oestrous stage of their 
reproductive cycle and all late pregnant myometrium on day 18 of gestation.  The age 
of late pregnant mice as indicated within this chapter relate to their age at conception. 
All data within this chapter were found to be normally distributed using the D‘Agostino-
Pearson omnibus normality test (GraphPad Prism version 5.0; GraphPad Software, 
USA), unless otherwise stated.  Student‘s t-test was used to assess data between two 
groups and one-way analysis of variance (ANOVA) followed by all pairwise multiple 
comparison (Tukey‘s test) when comparing three or more groups.  Data were 
expressed as mean ± standard error of the mean (SEM) and p<0.05 was considered 














6.3.1 Mitochondrial DNA (MtDNA) content in myometrium. 
There was a significant reduction (-26%) in MtDNA copy number as measured by Mt/N 
ratio in myometrium from non-pregnant eight month old mice (23.56 ± 1.59) compared 
with myometrium from non-pregnant three month old mice (31.75 ± 2.07 units; p<0.05) 
(Figure 6.1). Mt/N was slightly smaller (-9%) in non-pregnant myometrium from five 
month old mice (28.79 ± 1.78) compared with three month old myometrium, and 
greater (+22%) than eight month old myometrium, but these did not reach significance.  
In myometrium from late pregnant mice, there was a significant reduction in Mt/N 
between three month old mice (48.63 ± 1.67) compared with five month (38.61 ± 1.60; 
-25%, p<0.01) and compared with eight month (28.80 ± 1.72; -41%, p<0.001) old mice.  
There was also a significant reduction (-21%) in Mt/N between late pregnant 

































Figure 6.1 MtDNA copy number ratio declines by the influence of maternal age in non-
pregnant and late pregnant mouse myometrium 
Bar graph depicting Mt/N in myometrium from non-pregnant three month old [NP(3), n = 8], 
non-pregnant five month old [NP(5), n = 8] and non-pregnant eight month old [NP(8), n = 8], 
late pregnant three month old [LP(3), n = 8], late pregnant five month old [LP(5), n = 8] and late 
pregnant eight month old [LP(8), n = 8] mice.  Mt/N was significantly reduced by the influence of 
age between NP(3) and NP(8) myometrium, * p<0.05, but not NP(5); Mt/N was significantly 
reduced by the influence of age between LP(3) and LP(8) myometrium, ***p<0.001, LP(3) and 
LP(5) myometrium, **p<0.01, and LP(5) and LP(8) myometrium, **p<0.01; ANOVA followed by 





There was a significant increase in Mt/N between non-pregnant and late pregnant 
myometrium from three month old mice (+53%, p<0.001) and likewise between non-
pregnant and late pregnant myometrium from five month old mice (+34%, p<0.01).  
Although there was an increase (+22%) in Mt/N between non-pregnant and late 
pregnant myometrium from eight month old mice, this difference did not reach 
significance; p = 0.052 (Figure 6.2). 














Figure 6.2 MtDNA copy number ratio increases by the influence of pregnancy in 
myometrium from young mice 
Scatter graph presenting Mt/N in non-pregnant three month old [NP(3), n = 8] late pregnant 
three month old [LP(3), n = 8], non-pregnant five month old [NP(5), n = 8], late pregnant five 
month old [LP(5), n = 8] non-pregnant eight month old [NP(8), n = 8] and late pregnant eight 
month old [LP(8), n = 8] mice.  Mt/N was significantly increased by the influence of pregnancy 
between NP(3) and LP(3) myometrium, ***p<0.001, and NP(5) and LP(5) myometrium, 
**p<0.01; ANOVA followed by all pairwise multiple comparison Tukey‘s test.  Data expressed 




6.3.2 Mitochondrial electron transport chain enzyme activities in myometrium 
Figure 6.3 demonstrates that citrate synthase activity in myometrial tissue protein was 
not significantly affected by age in neither non-pregnant (three months vs. eight 
months, p = 0.896, n = 8 for both groups); nor late pregnant mice (three months vs. 
eight months, p = 0.952, n = 8 for both groups).  However for both age groups, citrate 
synthase enzyme activity was numerically lower in the late pregnant mouse 
myometrium compared to the non-pregnant state, although these differences were not 
significant (n = 8 for all groups; Figure 6.3).  
Similarly, complex I (NADH dehydrogenase) activity in myometrial protein was not 
modified by age in neither non-pregnant (three month old vs. eight month old, p = 
0.465, n = 8 for both groups) nor late pregnant mice (three month old vs. eight month 
old, p = 0.075 n = 8 for both groups) (Figure 6.4).  Myometrial tissue NADH 
dehydrogenase activity was not significantly altered by pregnancy in either age group 










































Figure 6.3 Citrate Synthase activity is unchanged by the influence of maternal age and 
pregnancy in mouse myometrium 
Bar graph depicting citrate synthase enzyme activity in myometrium from non-pregnant three 
month old [NP(3), n = 8] late pregnant three month old [LP(3), n = 8], non-pregnant eight month 
old [NP(8), n = 8] and late pregnant eight month old [LP(8), n = 8] mice.  Statistical comparison 
was non-significant; ANOVA followed by all pairwise multiple comparison Tukey‘s test. Data 





































Figure 6.4 Complex I/NADH dehydrogenase activity is unchanged by the influence of 
maternal age and pregnancy in mouse myometrium 
Bar graph depicting NADH dehydrogenase enzyme activity in myometrium from non-pregnant 
three month old [NP(3), n = 8] late pregnant three month old [LP(3), n = 8], non-pregnant eight 
month old [NP(8), n = 8] and late pregnant eight month old [LP(8), n = 8] mice.  Statistical 
comparison was non-significant; ANOVA followed by all pairwise multiple comparison Tukey‘s 







Complex II (succinate dehydrogenase) activity was not significantly altered by age in 
both non-pregnant (three months vs. eight months, p = 0.205, n = 8 for both groups) 
and late pregnant mice (three months vs. eight months, p = 0.654, n = 8 for both 
groups) (Figure 6.5).  However, succinate dehydrogenase activity was significantly 
increased by pregnancy in myometrium from both three month and eight month old 
mice (p<0.001, p<0.01 respectively, n = 8 for all groups) (Figure 6.5).  Succinate 
dehydrogenase was higher in myometrium from pregnant three month old (64%) and 
eight month old (43%) mice compared to age-matched non-pregnant controls for both 
groups. 





























Figure 6.5 Complex II/succinate dehydrogenase activity is unchanged by age but raised 
by pregnancy in mouse myometrium 
Bar graph depicting succinate dehydrogenase enzyme activity in myometrium from non-
pregnant three month old [NP(3), n = 8] late pregnant three month old [LP(3), n = 8], non-
pregnant eight month old [NP(8), n = 8] and late pregnant eight month old [LP(8), n = 8] mice.  
Transition from non-pregnant to pregnant state significantly increased succinate 
dehydrogenase activity in myometrium from both ages *** p<0.001, ** p<0.01; ANOVA followed 




Complex III (ubiquinol cytochrome c reductase) activity was also not significantly 
altered by age in non-pregnant (three months vs. eight months, p = 0.299, n = 8 for 
both groups) and late pregnant mice (three months vs. eight months, p = 0.399, n = 8 
for both groups) (Figure 6.6).  For both age groups, the enzyme activity in the 
myometrium was numerically higher in myometrial tissues from pregnant mice 
compared to the non-pregnant state but these did not reach significance (n = 8 for all 
groups; Figure 6.6).   



























Figure 6.6 Complex III/Ubiquinol cytochrome c reductase activity is unchanged by the 
influence of maternal age and pregnancy in mouse myometrium 
Bar graph presenting ubiquinol cytochrome c reductase enzyme activity in myometrium from 
non-pregnant three month old [NP(3), n = 8] late pregnant three month old [LP(3), n = 8], non-
pregnant eight month old [NP(8), n = 8] and late pregnant eight month old [LP(8), n = 8] mice.  
Statistical comparison was non-significant; ANOVA followed by all pairwise multiple comparison 






This study provides, as far as can be ascertained from the literature, a unique set of 
data assessing mitochondrial number and activity in myometrium from primiparous 
mice in early stages of reproductive ageing. There was a clear reduction in Mt/N seen 
with age in myometrial tissues from both pregnant and non-pregnant animals. 
Interestingly, there was a pregnancy-associated enhancement in the Mt/N in younger 
mice, but this difference was suppressed in older mice.  In contrast, activities of 
mitochondrial electron transport chain enzymes NADH dehydrogenase and ubiquinol 
cytochrome c reductase (complexes I and III), as well as citrate synthase activity in 
mouse myometrium were not influenced by age or pregnancy state.    Succinate 
dehydrogenase (complex II) activity was also unaltered by age, but was considerably 
increased in the pregnant state.   
These data are somewhat different from the bulk of published data for other muscles, 
cardiac and skeletal and to some degree smooth muscle in both humans and rodents, 
where the process of ageing has often been associated with an alteration in the 
enzymatic activities of all or some of the mitochondrial electron transport chain 
complexes (Yen et al., 1989, Cooper et al., 1992, Torii et al., 1992, Sugiyama et al., 
1993, Takasawa et al., 1993, Ojaimi et al., 1999, Kwong and Sohal, 2000, Lin et al., 
2000, Short et al., 2005, Muller et al., 2010).  Citrate synthase activity in skeletal 
muscle, as well as the activities of electron transport chain complexes II and III in 
cardiac muscle have been found to be significantly decreased in mature C57BL/6 male 
mice aged 18 months (compared to 3 months) and 25 months (compared to 2 months) 
respectively (Figueiredo et al., 2008, Padrao et al., 2012). Although a reduction in the 
activities of mitochondrial respiratory complexes is commonly reported in ageing 
muscles, contradictory data also exist, with some studies showing an increase in 




activities are not apparent across all tissues in aged animals.  A study measuring the 
activities of respiratory complexes in mitochondria isolated from brain, heart, skeletal 
muscle, liver, and kidney of young (3.5 months), adult (12–14 months) and old (28–30 
months) C57BL/6 male mice reported that complex I activity did not vary with age in 
any of the tissues (Kwong and Sohal, 2000); a similar finding to the present study.  
Changes to complex II activity differed across tissues, with no age-related alteration in 
the kidney and liver, an 11% increase in activity in cardiac muscle after the age of 12 
months (compared to young mice) and a 30% increase in activity in skeletal muscle in 
aged 28-30 month old mice (compared to young).  Complex III activity was reduced by 
40% in brain tissues from aged 28 month old mice (compared to young mice), yet 
increased by 20% in skeletal muscle at the age of 28 month old (compared to young 
mice).  Again, age-induced alterations in enzyme activity were not constant throughout 
all tissues, with no change in complex III activity being reported in the kidney, liver, and 
heart across all ages of mice (Kwong and Sohal, 2000).  In summary, age-related 
alterations in enzyme activities of the mitochondrial electron transport chain complexes 
are widely reported, but there does not seem to be a uniform pattern of whether these 
activities are increased or decreased as a result of ageing.     
The reasons for not detecting age-related changes in enzyme activities of 
mitochondrial electron transport complexes I-III in myometrium in the present study 
may be related to the ages of mice used.  The three and eight month groups were 
selected because they were at suitably separate reproductive periods relative to the 
lifetime of a mouse.  However, the majority of studies published to date have reported 
age-induced alterations in mitochondrial electron transport chain complex enzyme 
activities in muscles from animals far older than eight month of age.  It could be 
proposed that although there may be some mitochondrial ROS damage by this age, it 





The present mitochondrial copy number data is interesting as it clearly shows that 
there is a generalised age-related reduction in copy number both in the non-pregnant 
and pregnant states at eight month of age. It suggests that the reduction in 
mitochondrial copy number precedes any change in mitochondrial complex activity.  
Reduced MtDNA copy number has been previously reported as a consequence of 
ageing in rodent and human skeletal muscle (Barazzoni et al., 2000, Short et al., 2005, 
Peterson et al., 2012).  Barazzoni et al. have reported a 23 - 40% reduction in MtDNA 
copy number in skeletal muscle from 27 month old rats compared to rats of 6 month of 
age (Barazzoni et al., 2000).  According to the mitochondrial theory of ageing, a 
decline in MtDNA, is a direct result of mitochondrial ROS accumulation which in turn 
causes progressive damage to MtDNA and other mitochondrial constituents.  MtDNA 
is particularly susceptible to oxidative damage because it is near the major site of ROS 
production, lacks protective histones, and has weaker DNA repair mechanisms. 
However, there are discrepancies over mtDNA mutation frequencies and to what 
extent ROS production is responsible; there is increasing evidence that perhaps a 
majority of mutations are due to the inherent error rate of mtDNA polymerase gamma 
(Peterson et al., 2012).   
In relation to pregnancy-induced changes in complex activity, irrespective of age, only 
the activity of complex II was found to be significantly increased in pregnant 
myometrium in this study.  The acceleration of complex II enzyme activity can 
potentially be explained by the fundamental uterine changes essential for successful 
pregnancy.  Physiological growth of the pregnant uterus occurs by two mechanisms: 
an increase in cell number (hyperplasia), and an increase in cell size (hypertrophy).  
Hypertrophy usually results in an increase in cell organelles, including mitochondria 
(Douglas et al., 1988, Shynlova et al., 2006).  Since there are more mitochondria 
present in pregnant myometrium, as indicated by the increased MTDNA copy number 




explain the greater complex II enzyme activity. The impact of pregnancy on 
mitochondrial electron transport chain enzyme activities in myometrium appears to 
have only been previously studied by one other group (Geyer and Riebschläger, 1974) 
and whilst they only measured cytochrome c-oxidase/complex IV activity, it was also 
significantly increased in pregnant human and rat myometrium compared to non-
pregnant myometrium (ages of human subjects were not reported; pregnant rats were 
40 days of age) (Geyer and Riebschläger, 1974). 
The rise in complex II activity is mirrored by a generalised rise in mitochondrial copy 
number in myometrium from young pregnant mice compared to young non-pregnant 
mice.  It again suggests that in younger animals, such an increase in mitochondrial 
copy number is a physiological adaptation to pregnancy.  These observations are also 
similar to data originating from human myometrium (Geyer and Riebschläger, 1974), 
where in addition to the increase in mitochondrial complex IV activity in pregnancy, 
there is also evidence of an increase in the number of mitochondria. This again is likely 
to be linked to pregnancy-induced hypertrophy of the myometrium (Shynlova et al., 
2006).   
This hypertrophic adaptation is far less apparent as the mice age within the 
reproductive window. This failure to increase mitochondrial copy number in older 
animals, particularly in pregnancy, is likely to have physiological consequences in the 
parturition phase of pregnancy.  Indeed, the marked reduction in contractile potential in 
myometrium from older mice shown in the previous results chapter may be explained 
in part by a reduction in functional mitochondria, as reflected by the decline in Mt/N in 
these aged animals.  The level of MtDNA in a cell could provide a major regulatory 
point in mitochondrial activity, as the transcription of mitochondrial genes is 
proportional to their copy number. Therefore, the reduction in Mt/N could potentially 
reflect a concurrent reduction in capacity to generate sufficient cellular energy (ATP) to 




Myometrial contractions arise from spontaneous action potentials that permit the entry 
of calcium ions and elevate the intracellular calcium concentration (Tribe, 2001).  In 
addition, actin filaments in association with myosin are also essential for muscle 
contraction.  The binding of ATP to ATPase on the myosin heavy chains catalyses the 
dephosphorylation of ATP to ADP yielding energy to drive the sliding of myosin over 
actin filaments (cross-bridge cycling) creating the movement that establishes 
myometrial contraction (Moore and Bernal, 2001, Wray, 2007).  For these reasons 
intracellular calcium ion modulation and ATP availability are of importance when 
investigating the control of myometrial contractions.   
The role of mitochondria and ATP provision in the control of uterine contractions has 
previously been studied in mouse myometrium (Gravina et al., 2010).  Mitochondria 
were investigated here since they are able to take up, store and release calcium via 
the mitochondrial Ca2+ uniporter (Kirichok et al., 2004), indicating that they may play an 
important role in uterine contraction activation through the modulation of intracellular 
calcium.  Cumulative concentration–response experiments were performed to 
determine the effects of speciﬁc mitochondrial inhibiting drugs on the force of 
spontaneous contractions of myometrium.  Response curves were determined for: 
carbonylcyanide-3-chlorophenylhydrazone (CCCP), a protonophore uncoupler that 
abolishes the mitochondrial membrane potential, and rotenone, a respiratory chain 
inhibitor of mitochondrial electron transport chain complex I.  These agents decreased 
the force of contractions in a concentration-dependent manner (Gravina et al., 2010).  
An ATP synthase inhibitor, oligomycin had no effect over a wide concentration range 
for at least 30 minutes, a period over which CCCP, and rotenone markedly reduced 
contraction amplitude. The authors suggested that this indicated  these actions did not 
occur through lack of ATP within the uterine cells and is consistent with the view that 
mitochondria can modulate intracellular Ca2+ concentration without compromising ATP 




of contractile force was not due to ATP depletion suggests that mitochondrial Ca2+ 
handling has an independent role in determining uterine contractility (Chalmers and 
McCarron, 2008, Gravina et al., 2010, Gravina et al., 2011).  Since mitochondria have 
been shown to be important regulators of contractility as well as intracellular Ca2+; in 
the present study we can also hypothesise that an age-related reduction in contractile 
potential in the myometrium, and the concurrent reduction in MtDNA copy number 
could indicate that fewer mitochondria present in the myometrium would impact on the 
uptake/release of intracellular Ca2+ and in turn disrupt uterine contractions. 
 
Study limitations and future work 
A clear limitation of this study is that only the enzyme activities of mitochondrial 
electron transport chain complexes I-III were measured in aged non-pregnant and 
pregnant myometrium.  It would have been advantageous to also measure the 
activities of complex IV, and interactions between complexes such as NADH 
cytochrome c reductase (activity of complex I+III) and succinate cytochrome c 
reductase (activity of complex II+III), as well as complex V, ATP synthase.  Knowledge 
of how all of these electron transport chain enzyme activities differ between three 
month  and eight month of age in mouse myometrium may help to clarify the degree, if 
any, of how ageing impacts on oxidative phosphorylation and hence, mitochondrial 
ATP synthesis. 
There are many more methods to study mitochondria, and if time and cost permitted, it 
would have been of interest to investigate the role of mitochondria in ageing 
myometrium further.  Future work includes electron microscopy to study whether 
mitochondria exhibit common signs of ageing such as enlargement/mitochondrial 
swelling, matrix vacuolisation, and altered cristae (Picard et al., 2013). Staining dyes 




mitochondria in cells.  This method can provide additional data to support the finding 
that mitochondrial numbers are reduced in myometrium from eight month old mice 
(Barbieri et al., 2011).  Measurement of oxygen consumption using a Clarke-type O2 
electrode can quantify respiratory function in mitochondria, which would provide data 
to support the mitochondrial electron transport chain enzyme activities (Mourmoura et 
al., 2011).  Cumulative dose response curves for CCCP, rotenone and oligomycin on 
pregnant myometrium can determine whether the reduction in mitochondrial copy 
number in older eight month old mice is exerting an effect by altering intracellular Ca2+ 
concentration without compromising ATP production (Gravina et al., 2010).  Oxidative 
stress caused by mitochondrial ROS can result in the formation of highly reactive and 
unstable lipid hydroperoxides (Negre-Salvayre et al., 2010). Therefore as an indicator 
of oxidative damage, lipid hydroperoxides can be quantified in myometrial tissues from 
mice of all ages (TBARS assay kit; Cayman Chemical, USA). One final study of 
interest would be to perform a mouse mitochondria PCR array, as sold by Qiagen (The 
Mouse Mitochondria RT² Profiler PCR Array System; Qiagen, UK) which profiles the 
expression of 84 genes involved in the biogenesis and function of mitochondria.  This 
would help to identify any other potential biomarkers within mitochondria, which could 
contribute to the maternal age-induced alterations in myometrial contractility.  
Conclusions 
The influence of maternal age of eight months cannot be linked to any significant 
alterations in the mitochondrial electron transport chain complex activities in 
myometrium from non-pregnant or pregnant mice.  The significant reduction in Mt/N 
seen in myometrium from eight month old mice can potentially influence two 
mitochondrial-controlled routes of uterine contractions: reduction in overall ATP 
synthesis or decrease in intracellular Ca2+.  Further studies are necessary to fully 













Chapter 7 : General Discussion and Future Work 
Life expectancy in women has risen from 42 years of age in 1838 to 82 years of age in 
2010 (Office for National Statistics for England and Wales, 2011a) and concurrent with 
this, there has been a trend for women to extend childbirth into their later years of 
fertility which has introduced the term ‗advanced maternal age‘ to describe mothers 
who have babies at the age of 35 years and beyond (Kirz et al., 1985, Bewley et al., 
2009, Bayrampour and Heaman, 2010).  The principal aim of this thesis was to 
determine whether advanced maternal age has a detrimental impact on uterine and/or 
cervical function at the end of gestation.  This thesis provides the first comprehensive 
study of the impact of ageing in pregnant mice and demonstrates that advancing 
reproductive age not only prolongs gestation, but duration of labour as well.  Such 
delays are unlikely to be underpinned by impaired cervical softening, but more likely 
related to disrupted uterine activation at term.  This is evidenced by a reduction in 
spontaneous contractile and oxytocin augmented myometrial activity in older mice 
coupled with reduced gene expression of contractile associated proteins.  The 
significant reduction in MtDNA copy number ratio in myometrium from older mice could 
also potentially contribute to less effective contractile activity because of a reduction in 
overall ATP synthesis or decrease in intracellular Ca2+.  The collective data from this 










7.1 Is progesterone withdrawal delayed in older pregnant mice? 
 
The initiation of progesterone withdrawal is essential for the onset of parturition in 
rodents (Sugimoto et al., 1997, Weiss, 2000). The data from this thesis would strongly 
suggest that timing of progesterone withdrawal at term in older nulliparous mice may 
be a key regulator in the initiation of labour.  Therefore, the most pertinent question to 
be answered by future work is whether there is a delay in progesterone withdrawal at 
term in older mice that could explain the delay in parturition and related uterine 
activation.  To accurately measure the exact rate of maternal serum progesterone 
decline and determine whether this changes with maternal age in C57BL/6J mice, 
serial blood samples from pregnant mice could be taken throughout pregnancy until 
day of parturition.  Alternatively, to reduce stress to mice, a cross sectional study might 
be more appropriate, whereby mice of three and eight months of age would be 
sacrificed over a range of gestations in order to acquire terminal blood samples.  
Another key contributing factor to progesterone sensitivity would be progesterone 
receptor availability and turnover. To determine whether delayed parturition in older 
nulliparous mice may be due to greater availability of progesterone receptors 
compared to younger mice, immunohistochemistry can be used to determine presence 
and localisation of progesterone receptor isoforms in myometrial and cervical samples, 









7.2 Is cervical ripening delayed as a result of reproductive ageing in 
mice? 
 
The physiological alterations to the cervix in pregnancy were studied at day 18 of 
gestation in this thesis.  At this time point it is only possible to assess cervical 
softening, since cervical ripening in mice occurs in the hours preceding birth (Read et 
al., 2007).  Cervical ripening at the end of gestation may be more important than the 
cervical softening phase, since it is when there is maximal loss of cervical tissue 
compliance and integrity (Timmons et al., 2010, Mahendroo, 2012).  Ripening is the 
most accelerated phase of cervical remodelling and occurs when maternal plasma 
progesterone concentrations have dropped nearing the onset of parturition 
(Mahendroo, 2012), again emphasizing the importance of progesterone withdrawal in 
the control initiation of parturition.  An extension of the study described in Chapter 4, 
would be to repeat all experimental techniques using cervical tissues collected on 
gestation day 19 (for three months old mice) and 20 (for eight months old mice) in 
order to capture tissues in the ripening phase.  This would determine whether there are 
any age related changes that occur specifically to cervical ripening, and whether this 










7.3 Is spontaneous myometrial contractile activity in older mice 
altered by a reduction in ion channel expression?  
 
A number of Ca2+ and K+ channels, including voltage-regulated L-type Ca2+channels 
and Ca2+-activated K+ channels have been implicated in the control of myometrial 
membrane potential and subsequent regulation of  contractions (Sanborn, 2000, Tribe, 
2001, Khan et al., 2001).  In ageing rodent studies, decreased expression of voltage 
and Ca2+-activated K+ channels have been reported in coronary smooth muscle (Marijic 
et al., 2001).  This highlights the need to examine ion channel expression in 
myometrium from pregnant aged mice, since lower expression of Ca2+ and/or K+ 
channels could potentially contribute to the less effective spontaneous contractile 
activity exhibited by these older mice compared to the younger age group.   
 
7.4 Is spontaneous myometrial contractile activity in older mice 
altered by increased body weight?   
 
In addition, consideration of the dual impact of body mass index (BMI) and age is 
worth considering. In humans it is difficult to assess the impact of age alone as body 
mass index and maternal fat mass (kg) increases as women age (Maple-Brown et al., 
2013).  Ageing also results in increased in myometrial cholesterol.  Both cholesterol 
and BMI have been shown to depress myometrial contractility (Zhang et al., 2007, 
Arrowsmith et al., 2012).  Pharmacological addition of cholesterol to contracting strips 
of human and animal myometrium in vitro inhibits contractile activity; furthermore, 
human myometrial strips with high cholesterol content contract less effectively in vitro 
compared to those with lower cholesterol content (Shmygol et al., 2007, Noble et al., 
2009, Arrowsmith et al., 2012).  The use of animal models provide a unique 
opportunity to dissect out the potentially confounding factors of obesity and age in vivo 




quantification of cholesterol in myometrium from pregnant older mice, would determine 
whether the less effective spontaneous contractility of myometrium from older mice 
compared to younger is a consequence of cholesterol accumulation with age. 
Moreover, in vivo studies of ageing in obese and non-obese mice using video imaging 
and uterine telemetry, would allow assessment of gestation and parturition length.   
 
7.5 Are uterine contractions less effective in older mice due to 
reduced ATP synthesis or decreased intracellular Ca2+? 
 
A significant reduction in MtDNA copy number was exhibited in myometrium from older 
pregnant mice compared to younger mice in this thesis.  Since mitochondria are a key 
site for ATP production and can also modulate intracellular Ca2+ concentrations  
(Davidson and Duchen, 2007), it raises the question whether the reduction in the 
number of myometrial mitochondria, result in less effective uterine contractions due to 
a reduction in overall ATP synthesis, or by decreasing intracellular Ca2+ 
concentrations.  Future work would involve cumulative concentration response 
experiments to determine the effects of specific mitochondrial inhibitors such as 
carbonylcyanide-3-chlorophenylhydrazone, as well as an ATP synthase inhibitor such 
as oligomycin on spontaneous contractile activity of mouse myometrium (Gravina et 
al., 2010).  There is also a need to examine the ability of aged myometrial tissues to 
generate prolonged contractions in vivo using uterine telemetry to determine whether 
function correlates to in vitro MtDNA copy number ratio in both human and mouse 






7.6 What is the current understanding of the impact of advanced 
maternal age on myometrial function? 
 
Limited data has been published on the impact of advanced maternal age on 
myometrial contractility in vitro.  One study reports a negative correlation between 
contractile activities in myometrial tissues from pregnant women with age (Smith et al., 
2008), however, the only other existing study reports that age-induced reduction in 
spontaneous myometrial contractions is evident only in non-pregnant human 
myometrium and not in pregnant myometrium (Arrowsmith et al., 2012).  Preliminary 
data on the impact of maternal age (> 35 years of age; BMI < 30; n = 23) on 
spontaneous contractions in human myometrium in vitro, would suggest that over a 
period of an hour, spontaneous contractile activity is not significantly different to that of 
myometrium from younger women (< 25 years of age; BMI < 30; n = 12); Student‘s t-
test. Spontaneous contractile mean integral tension is 358 ± 34.8 mN/cm2 in 
myometrium from younger women, and 338 ± 27.1 mN/cm2 in myometrium from 
women of advanced maternal age.  It could be possible that experimental examination 
of short time periods of contractions may not reveal any age induced alterations in 
myometrial contractility, but prolonged observations, over hours or days may identify 










In summary, the data from this thesis emphasise the physiological and cellular 
changes that occur with reproductive ageing, and have begun to answer some of the 
questions as to what mechanisms and reproductive tissues are predominantly affected 
by ageing. This work highlights the need for additional research in this nascent area 
and there is   broad scope for future experimental work in both mouse models and 
human tissues in order to develop a more detailed understanding of the mechanistic 
impact of maternal ageing on labour.  A more complex understanding of the 
relationship between age and reproductive outcomes will ultimately influence the 
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